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ABSTRACT
Skeletal complications from radiation therapy have been described for breast, brain,
pelvic, and blood cancers. These problems include atrophy, fractures, and
osteoradionecrosis. Improved survivorship rates of cancer patients receiving radiotherapy
increases the importance of understanding the causal mechanisms and long-term effects
of radiation-induced bone loss. One such long-term effect is bone fractures following
radiation therapy for cancer treatment. The incidence of hip fractures is significantly
increased following targeted radiotherapy for cancer. This decline in bone health can
have a severe impact on the patient’s functional capabilities. This damage to bone
following irradiation is thought to involve damage to both osteoblasts and vascularity
within bone. However, the relationship between radiation and osteoclast activity (bone
resorption) is unknown and poorly studied. Very few studies have examined the effects of
radiation on osteoclast number and activity, and those that have reveal conflicting results.
The studies presented herein will examine the response of bone to ionizing radiation in
order to assess if radiation can increase osteoclast activity. The primary goal is to
determine if increased osteoclast activation and number occur as a result of exposure to
ionizing radiation, thus contributing to radiation-induced osteoporosis. Our hypothesis is
that exposure to ionizing radiation increases osteoclast activity and number, resulting in
elevated resorption early after exposure.
The results from these studies indicate that exposure to ionizing radiation can induce
osteoporosis within two weeks of treatment. The degree of bone loss at this point is
substantial, with corresponding deterioration of trabecular microarchitecture. Osteoclast
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number and function as determined by in vitro assays is likewise increased during the
first two weeks of treatment. Histological evidence identifies an increase in the surface of
irradiated trabeculae covered by osteoclasts by three days after treatment. Serum proteins
indicate overall whole-body increase in resorption by only one day after exposure.
Similar patterns of reduced bone volume and microarchitecture are observed in irradiated
rat tibia by two weeks after treatment with doses of X-rays modeling what human pelvic
bones might receive during cancer treatment. Administration of bisphosphonates largely
mitigates these changes. Thus ionizing radiation increases bone resorption within these
animal models early after exposure.
Future studies must more specifically identify how radiation induces osteoclast
activation. This information can then be used to identify targets to suppress bone
resorption after irradiation. Ultimately, these data need to be correlated with the effects of
radiation on bone strength and how radioprotective (or antiresorptive) agents can
influence this response. These investigations may prove useful in eventually reducing the
incidence of hip fractures among cancer survivors.
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CHAPTER 1: PROJECT RATIONALE
1.1 Clinical Concern
Skeletal complications from radiation therapy have been described for breast, brain,
pelvic, and blood cancers. These problems include atrophy, fractures, and
osteoradionecrosis. Improved survivorship rates of cancer patients receiving radiotherapy
increases the importance of understanding the mechanisms and long-term effects of
radiation-induced bone loss. In a recent study of more than 6,000 women over the age of
65 treated for cervical, rectal, and anal cancers, it was reported that radiation therapy
significantly increased the risk of pelvic fracture (relative risks of 1.66, 1.65, and 3.16,
respectively, for cervical, rectal, and anal cancers) (Baxter et al., 2005a). Radiation thus
compromises bone health and can have a severe impact on patients’ functional
capabilities. The damage to bone following irradiation is thought to involve changes to
both osteoblasts and vascularity within bone (Dudziak et al., 2000; Hopewell, 2003;
Sakurai et al., 2007). However, the relationship between radiation and osteoclast activity
(bone resorption) is unknown and poorly studied.

1.2 General Hypothesis
The general hypothesis for this dissertation is that radiation increases osteoclast
activity. An increase in resorption via radiation-induced stimulation of osteoclast number
or activity may represent a component of the atrophy observed in bone following
irradiation (Figure 1.1). Our intent is to use an animal model in order to describe the
association between spaceflight and clinically-applicable radiation, bone volume,
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architecture, and cellular responses. The approach for examining this hypothesis includes:
1) Establishing that atrophy occurs after both directly irradiating bone as well as from
within bone shielded from otherwise total body irradiation; 2) Determine if atrophy
occurs at very early (days), early (weeks) and late (9 month) time-points; 3) Collect in
vitro and in vivo evidence that osteoclast activity or number has increased; and 4)
Examine the response of irradiated bone after resorption has been blocked by an
osteoporosis therapy.

Figure 1.1. Proposed causes for observed reduction in bone mass following
irradiation. Vascular and osteoblast damage, leading to bone damage and loss of
bone mineral density, are well documented. We propose that an increase in
osteoclast activity (i.e. bone resorption) occurs concurrently with cellular and tissue
damage, thus elevating bone resorption
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1.3 Specific Aims
1.3.1 Aim 1
Evaluate the trabecular and cortical bone response (i.e., connectivity, bone volume, polar
moment of inertia) in a bone that has been shielded from exposure to a source of radiation
present within the spaceflight environment (56Fe26+).

1.3.2 Hypothesis Aim 1
Bone atrophy occurs as a long-term systemic effect after exposure to spaceflightrelevant radiation exposure.

1.3.3 Approach Aim 1
Using male Sprague-Dawley rats and excluding the hind limbs and pelvis, we
irradiated the animals with doses of 0, 1, 2, and 4 Gray (Gy)

56

Fe26+ (n = 10 each) and

euthanized them after 9 months. From these shielded bones. histomorphometric indices
and serum markers for bone resorption were quantified via microcomputed tomography
(microCT) and ELISA. Mineralization data, indicative of overall bone turnover, was
determined via ashing.

1.3.4 Aim 2
Quantify bone volume, connectivity, and general histomorphometric parameters for
both trabecular and cortical bone at an early time-point after mice are exposed to a single,
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whole-body (no shielding provided) dose of 7 Gy γ-radiation, equivelant to the dose
administered prior to stem cell transplantation.

1.3.5 Hypothesis Aim 2
Exposure to a single, high dose of γ-radiation would result in an observable difference
in bone following exposure even at a short time-point post exposure, likely the initial
stages of atrophy characteristic of bone irradiation.

1.3.6 Approach Aim 2
Nine-week old C57BL/6 mice (n = 6) received 7 Gy γ-radiation, with nonirradiated
controls (n = 6). After two weeks the animals were euthanized, hind limbs removed, and
tibiae analyzed via microCT for histomorphometric parameters (i.e. bone volume,
trabecular connectivity). Standard histological analysis of the metaphysis evaluated
osteoclast and osteoblast surfaces as well as presence of osteoclasts (TRAP staining) to
provide insight into overall turnover status of the bone.

1.3.7 Aim 3
Examine osteoclast presence, number, and activity within the tibia (histologically)
and from culture following an acute, whole-body dose of 2 Gy X-rays applied to a
mouse.
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1.3.8 Hypothesis Aim 3
Osteoclast number (both in vivo and in vitro) and in vitro resorption will be
substantially elevated at a very early time point-post exposure.

1.3.9 Approach Aim 3
A single 2 Gy dose of X-rays (similar in dose to a single fraction during radiotherapy)
was delivered to two groups of mice, n = 6 each. After 1 day, one set of mice was
sacrificed, and marrow plated on chamber slides and hydroxyapatite disks to measure the
effect of irradiation on osteoclast proliferation and resorption. After 3 days, another set of
mice was sacrificed, and hind limbs were evaluated via microCT and histology to
quantify bone resorption and osteoclast presence.

1.3.10 Aim 4
Examine the response of irradiated bone after resorption has been blocked by an
antiresorptive osteoporosis treatment.

1.3.11 Hypothesis Aim 4
Radiation therapy results in increased osteoclast activation and turnover, and thus
treatment with an antiresorptive will prevent the loss of bone.
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1.3.12 Approach Aim 4
In collaboration with Dr. Michael Robbins in the Radiation Oncology Department at
Wake Forest University, we irradiated three sets of rats (n = 24 per group). Each rat
received 16 Gy total administered to a single hind limb (right) in twice-weekly fractions
of 4 Gy; this represents a biologically equivalent dose for human exposure to the hip for
pelvic cancers. One irradiated group received administration of risedronate (0.04
µg/kg/day), the other received placebo (PBS). Rats from each group (n = 12) were
sacrificed at 2 and 4 weeks post-treatment. Non-irradiated control rats (+ placebo) were
sacrificed at each subsequent sacrifice (n = 12) for means of comparison.
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CHAPTER 2: GENERAL BACKGROUND

2.1 Background Information on Bone and the Chemical and Cellular Impacts of
Exposure to Ionizing Radiation

2.1.1 Bone Constituents
Bone is a material composed of an organic matrix (approximately 35% of mammalian
bone) and a mineral component (50-70% of bone) (Currey, 2002; Robey and Boskey,
2006). The organic matrix is almost entirely (90-95%) composed of the structural protein
collagen. The remainder is cells and ground substance of extracellular fluid and
proteoglycans, including chondroitin sulfate and hyaluronic acid. The mineral component
of bone is primarily calcium salts. The majority of the crystalline salts are in the form of
hydroxyapatite (Ca10(PO4)6(OH)2) and are deposited within the organic matrix, bound to
the collagen fibers. Other ions are present throughout bone, including magnesium,
sodium, potassium, and carbonate ions. As such, approximately 99% of the body’s
calcium is stored within bone (Specker, 1996).
Collagen represents the most abundant protein in vertebrates and about 85-90% of the
total protein in mature bone. Specifically, type I collagen is found within bone (Currey,
2002; Robey and Boskey, 2006; Viguet-Carrin et al., 2006). The collagen protein consists
of multiple fibrils of the polypeptide tropocollagen. Each tropocollagen protein is made
of three chains consisting of 2 identical α1 chains and an α2 chain, all of which are
approximately 300 nm long and 1.5 nm in diameter. These tropocollagen proteins are
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held together by stable trivalent bonds (cross-links) to form microfibrils of procollagen,
which further aggregate and mature to form collagen (Figure 2.1). Non-collagenous
protein present in bone matrix include chondroitin sulfate, proteoglycans (decorin and
biglycan), osteonectin, osteopontin, bone sialoprotein, albumin, and osteocalcin (Davison
et al., 2006; Robey and Boskey, 2006).
Specialized cells and coverings surround and reside within bony structures of the
body. The outer surface of bone is surrounded by periosteum, a highly vascular and
innervated double membrane consisting of a sheet of fibrous connective tissue with an
inner cellular layer (Figure 2.2) (Dempster, 2006; Martini, 2004). The inner surface of
bone is lined by a thin membrane of cells referred to as endosteum. The cells within the
bone coverings and embedded within bone include osteoprogenitors, osteoclasts,
osteoblasts, osteocytes, and bone lining cells.
Two main types of bone that exist in mammals are woven and lamellar bone. Woven
bone is bone that has been deposited rapidly, particularly in the developing fetus and
during fracture repair. Collagen fibrils are randomly oriented throughout the bone, as is
the arrangement of the crystals. Likewise the distribution of osteocytes within the bone is
random (Jee, 2002). Woven bone will ultimately be resorbed and replaced with lamellar
bone. Lamellar bone is more highly organized than woven bone, consisting of sheets
(termed “lamellae) of collagen and minerals (Figure 2.3A). Collagen fibers run
approximately in the same direction within individual domains found within each lamella
(Currey, 2002; Jee, 2002).
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Figure 2.1 The biosynthesis and organization of a crosslinked collagen fiber.
Reproduced from (Viguet-Carrin et al., 2006)
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Figure 2.2 Connective tissue coverings and bone cell linings of the periosteal and
endosteal surface of bone. Reproduced from (Martini, 2004).

Cells (osteocytes) exist within both woven and lamellar bone (Jee, 2002). Lacunae are
interconnected via canals (canaliculi) that extend throughout the bone (Figure 2.3B).
Cytoplasmic extensions within canaliculi connect adjacent osteocytes via gap junctions,
allowing communication with other bone cells as well as vasculature of the marrow and
throughout the bone. Within mature lamellar bone these structures can exist as part of
secondary osteons (Figure 2.3B). Osteons represent distinct structural units in which cells
arising from different developmental sources, referred to as the basic multicellular unit
(BMU), have replaced the previously existing bone surface (Jee, 2002; Robling et al.,
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2006). Vascular channels called perforating (Volkman’s) canals connect secondary
osteons.
The skeleton can be divided into two main subtypes: axial and appendicular. The
axial skeleton includes the skull, vertebrae, ribs, and sternum. The appendicular skeleton
includes the support elements for the axis, including limbs and limb girdles. The
classification of bones within these two categories is varied, depending on shape or
developmental origination of the bone. Shape of bones will be used as the designate for
this review, with bones being described as flat (i.e. skull, scapula, and bones of the
innominate such as the ilium), long (including tibia, femora, and humeri), short (carpals
and tarsals), irregular (vertebrae), sesamoid (patella),and wormian (intrasutural) (Martini,
2004).
Long bones support the body and resist much of the loads imparted during
locomotion and normal activity, and as such will be considered in detail herein. The
typical long bone consists of a cylindrical shaft, called a diaphysis, and two widened
ends, termed epiphyses (Figure 2.3C). The epiphyses are generally enlarged and rounded
and serve as articular surfaces with adjacent bones. In growing individuals a growth plate
is present as hyaline cartilage, or epiphyseal cartilage, at the ends of the bone. This plate
is fully ossified in adults, forming the epiphyseal plate. The metaphysis is a region of
primarily trabecular bone between the epiphyseal plate and the diaphysis, functionally
connecting the epiphysis to the diaphysis. Both epiphyseal and diaphyseal surfaces are
often covered by articular cartilage for joint surfaces (Jee, 2002; Martini, 2004).
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A

B

C

Figure 2.3. The structural organization of bone: A) the osteon and organization of
collagen within lamellae; B) secondary osteons within cortical and trabecular bone;
and C) the anatomy and distribution of cortical and trabecular bone within a long
bone. Modified from (Martini, 2004).
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Mature lamellar bone exists in two forms, cortical and trabecular (also termed
“cancellous” or “spongy”) bone (Figure 2.3A,B and Figure 5). Cortical bone is a dense
form of bone with little porosity comprising approximately 80% of the skeletal mass, and
serves the main supportive role in the body (Jee, 2002). This type of bone is found
primarily in the diaphyses of long bones and the outer shell of all bones (Figure 2.3 and
2.4). Cortical bone consists of three types of lamellae, including: 1) concentric lamella of
circular layers surrounding a central vascular canal, comprising a Haversian system; 2)
circumferential lamellae consisting of continuous layers around the entire shaft (or
diaphysis) of bone, and; 3) fragments of former concentric or circumferential lamella
between existing lamella (Figure 2.3A and B) (Baron, 2003; Currey, 2002).
Trabecular bone comprises approximately 20% of the skeletal mass, however it
accounts for nearly 70% of bone surface (Jee, 2002). This highly porous form of bone
exists as a mesh-like lattice of struts within the interior of bones (Figure 2.3 and 2.4).
These struts, or trabeculae, exist as rods or plates found within the ends of long bones
(filling the epiphyses and metaphyses) or between the cortical shell of flat or irregular
bones. The individual spicules of trabecular bone are composed of interstitial lamella,
with osteons having saucer-shaped stacks of primary lamellar bone (Currey, 2002;
Dempster, 2006). Typically trabecular bone is less mineralized than cortical bone
(Heaney, 2003). It should be noted that the percentage of cortical versus trabecular bone
is bone and site specific, such that vertebrae are primarily (~75%) trabecular bone, the
diaphysis of some long bones are almost entirely cortical bone, and portions of long
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bones (such as the femoral head) are about equal in cortical and trabecular content
(Dempster, 2006).

Figure 2.4. The distribution of cortical and trabecular bone within the metaphysis
of a long bone (left) and a flat bone of the skull (right). Reproduced from (Martini,
2004).
2.1.2 Bone Cells
The mature osteoclast is responsible for resorption of skeletal elements. These
multinucleated cells develop from myeloid progenitor cells, which will also give rise to
the monocyte / macrophage lineage (Blair et al., 2006; Horowitz et al., 2005; Lam et al.,
2000). Mature osteoclasts result from the fusion of these hematopoietic mononuclear
cells (Figure 2.5) (Stenbeck, 2002; Väänänen and Zhao, 2002). The bone marrow
macrophage appears to be the primary precursor (Ross, 2006). Prior to resorbing bone,
osteoclasts are mobile cells that will migrate to surfaces to be resorbed (Stenbeck, 2002).
The osteoclast is a multinucleated cell with a unique morphology related to the
function of bone resorption. Two key features of functional osteoclasts, namely a series
of villi-like extensions of the bone-apposed plasma membrane (termed a “ruffled
border”) and the presence of a ring of actin proteins along the same surface, are observed
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on an actively resorbing osteoclast (Hurst et al., 2004; Stenbeck, 2002). A distinct
microenvironment is created between the osteoclast and the bone surface during
resorption, preventing digestive enzymes and protons from escaping into the surrounding
extracellular fluid and permitting an environment optimal for protease activity. To
establish this resorption compartment, a dense band of actin forms along the boneapposed plasma membrane due to cytoskeletal rearrangement. Adhesion of the osteoclast
to the bone occurs via the formation of podosomes present within the actin rings,
establishing a sealing zone (Ross, 2006; Stenbeck, 2002). The podosomes on osteoclasts
consist of actin proteins with attached integrins, the primary functional receptor of these
cells (Chellaiah, 2006; Zaidi et al., 2003). Integrins α2β3 of the podosome will bind to
extracellular matrix proteins containing Arg-Gly-Asp (RGD) motifs, such as osteopontin,
bone sialoprotein, and vitronectin (Väänänen and Zhao, 2002).
The ruffled border is formed when vessicles containing enzymes involved with bone
resorption (i.e. cathepsin K and matrix metalloproteases) fuse to the cell membrane
adjacent to the bone (Ross, 2006). Proton pumps embedded in the membrane of the
ruffled border, such as the vacuolar-type proton ATPase (V-ATPase), will function to
release H+ ions into the space between the osteoclast and the bone. Proteases will digest
collagen and bone matrix in this acidic microenvironment between the osteoclast and the
bone. Lysosomal proteases are involved in the digestion of matrix and include: cathepsin
K; tartrate-resistant acid phosphatase (TRAP); and matrix metalloproteases (MMPs) such
as MMP-1, MMP-9, and MT1-MMP (Dempster, 2006; Drake et al., 1996; Ross, 2006).
The acidity of the compartment will also mediate digestion of hydroxyapatite (Zaidi et

15

al., 2003). The digestion of the matrix forms a saucer-shaped resorption cavity on the
surface of the bone, often referred to as a Howship’s lacuna (Figure 2.6).

Figure 2.5. The development of osteoclasts (A) and osteoclasts (B), including
expression of transcription factors and cytokines necessary for differentiation,
proliferation, and maturation throughout the process. Reproduced from (Robling et
al., 2006).

Osteoblasts are cells responsible for the production of new bone. Osteoblasts
originate from mesenchymal cells that differentiate into multipotential progenitors within
the marrow (Figure 2.5) (Aubin et al., 2006). These progenitors form committed
progenitors via production and activation of several factors, including osteoblast
stimulating factor-1, IGF and PTH (Aubin et al., 2006). In the case of osteoblasts, the
transcription factors Runx2 and Osterix are activated via stimulation by factors such as
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TGFβ (early differentiation) and bone morphogenic proteins (BMP)-2 and -9, otherwise
the stem cell may commit to a progenitor for myocytes, chondrocytes, adipocytes, or
stromal cells (Bai et al., 2004; Horowitz et al., 2005; Kanaan and Kanaan, 2006; Komori
et al., 1997; Lian et al., 2004).
Fully differentiated osteoblasts secrete primarily collagenous osteoid, which
mineralizes over time to form mature bone. On the bone surface, osteoblasts are attached
to one another via adherens junctions consisting of cadherins, tight junctions, and
desmosomes (Aubin et al., 2006). Bone formation follows resorption by osteoclasts, such
that once resorption has occurred, a signal initiates the recruitment and function of
osteoblasts (Dempster, 2006). The nature of the signal is currently unclear, although
various growth factors have been considered and can induce osteoblast differentiation
and activation, including TGFβ, IGF-1, BMP’s, platelet derived growth factors (PDGFs),
and fibroblast growth factors (FGFs) (Dempster, 2006; Siggelkow et al., 1999).
Collagenous matrix (osteoid) is initially secreted, followed by deposition of minerals.
Following formation, the majority of the osteoblasts will die via apoptosis, but many will
become entrapped in the matrix and serve a role maintaining bone as osteocytes existing
within empty lacunae, or remain present on a quiescent bone surface as flat bone liningcells (Walsh et al., 2003).
2.1.3 Bone Remodeling
Despite the seemingly static nature of this generally stiff material, bone is a dynamic
tissue. Various portions of the skeleton are undergoing resorption while others are
simultaneously experiencing additional bone formation. Outside of pathological
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conditions (i.e. osteoporosis and bone malignant metastases) the rate of bone formation is
equal to the resorption rate of mature bone (Blair et al., 2006; Gass and Dawson-Hughes,
2006). Overall, approximately 2% of cortical bone is “remodeled” per year, or resorbed

Active Osteoclast
RANKL

RANK

Howship’s Lacuna
Figure 2.6. Diagram of an active multinucleated osteoclast after having created a
resorption pit (Howship’s lacuna) within bone.

with subsequent replacement with new bone (Dempster, 2006). Trabecular bone is
considered more metabolically active as the rate of remodeling, or turnover rate, is
considerably higher than cortical bone. An estimated 15-20% of trabecular bone is
remodeled per year (van der Linden et al., 2001). The remodeling of bone serves several
roles in the skeleton. First, the skeleton will respond to loading (particularly strain) by
changing size, shape, or matrix constituents (Bouxsein, 2005). The process also allows
for replacing older, less mechanically sound bone (e.g. via damage or increased
mineralization that occurs with age) with newer bone. For instance, data from canine
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models indicates that reducing the turnover rate using osteoporosis countermeasures can
lead to increased mineralization and microdamage (microfractures) within bones, as will
be highlighted later in this literature review on page 33 (Burr et al., 2003; Mashiba et al.,
2000). However the sites of remodeling within bone are significantly associated with
areas of microfractures, indicating that remodeling can target and repair damage (Burr,
2002b; Noble, 2003). Second, as bone serves as a mineral storage site, remodeling
permits the release of minerals such as calcium and phosphorus (Dempster, 2006).
Bone remodeling is a tightly controlled process – excess bone loss or formation can
result in structural or functional deficiencies (Blair et al., 2006; Parfitt, 1984). The
process of bone remodeling is typically considered coupled, as osteoclastic resorption
occurs prior to osteoblastic formation (Figure 2.7) (Fink Eriksen et al., 2007; Mundy et
al., 2003). The process by which this occurs is typically activation of cells necessary to
resorb bone, followed by resorption, and then subsequent formation (Baron, 2003;
Robling et al., 2006). Discrete areas of bone are remodeled by cells of the BMU.
Osteoclasts of the BMU move through bone, resorbing tissue at approximately the
diameter of the secondary osteon which will eventually be reformed, forming an effective
tunnel within the bone (Robling et al., 2006). Behind the osteoclasts are mononuclear
cells which line the resorption surface. The function of these cells is unclear, though they
may smooth off the scalloped edges of the Howship’s lacunae. The final layers are
comprised of osteoblast which lay down unmineralized osteoid.
Deposition of new bone occurs at the periphery of the resorption tunnel. As more
layers of osteoblasts move into the resorption cavity, layers of osteoid are deposited,
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ultimately forming the mature lamella of a secondary osteon. A canal will remain within
the center of the of the concentric lamella if the BMU are remodeling an Haversian
system within cortical bone, however the process of remodeling is very similar between
cortical and trabecular bone (Dempster, 2006; Robling et al., 2006). The entire osteon
will be separated from the rest of the bone by a cement line. Mineralization of the osteoid
occurs 5-10 days following the deposition of osteoid with secondary mineralization
continuing for years to decades (Davison et al., 2006). Primary mineralization occurs as
membrane-bound bodies released by osteoblasts localize calcium and phosphate ions as
well as provide a nucleation core of proteins, ions, and acidic phospholipids that induce
the formation of hydroxyapatite (Robey and Boskey, 2006). How these minerals localize
at discrete areas on collagen is unknown.

Figure 2.7. The bone remodeling cycle, from activation of osteoclast to formation of
new
bone
via
osteoblasts.
Reproduced
from
http://www.umich.edu/news/Releases/2005/Feb05/bone.htm.
2.1.4 Bone Biomechanics
A function of bone is to resist loads applied to the body. (Bouxsein, 2005; Turner,
2002). The loading regime on a bone is dependent on activity, and both rate and direction

20

of the applied load. Bone is an anisotropic material and thus exhibits different mechanical
properties depending on the direction of the load (Cullinane and Einhorn, 2002). Bone
fragility (or the susceptibility to fracture) under loading, imparted both from normal daily
loads such as walking or during traumatic events like falling, is dependent on several
factors. These factors include strength, brittleness, and work to failure (Turner, 2002).
Indeed, strategies to reduce risk of fracture involve reducing loads applied to bones as
well as increasing bone strength. The determinants of bone strength can be grouped into
two categories, namely structural (e.g. mass and distribution of bone) and material (e.g.
matrix constituents and microdamage) properties of bone (Bouxsein, 2005; Felsenberg
and Boonen, 2005).

2.1.5 Structural Properties: Bone Mass
Structural properties of bone are a function of the amount and distribution of bone
(Bouxsein, 2005; Felsenberg and Boonen, 2005). The measurement of bone mass within
a particular sample is the strongest determinant of strength and is referred to as bone
mineral density (BMD), a measurement of mass per area despite the implication that this
is a volumetric measurement (Ammann and Rizzoli, 2003). Typically this measurement
is determined as the amount of hydroxyapatite scanned by dual-energy X-ray
absortiometry (DXA) per unit area (Stauber and Muller, 2006; Turner, 2002).
Quantitative computed tomography (QCT), or magnetic resonance imaging (MRI), can
measure volumetric and areal bone mineral density. However, BMD itself only can
account for up to 60-70% of bone strength (Friedman, 2006; Turner, 2006).
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The

determinants of bone strength other than BMD (including other structural and mineral
properties) are defined as bone quality (Burr, 2004)

2.1.6 Structural Properties: Bone Shape
The shape of long bones assists with the function of resisting loads applied to the
body. Long bones are strongest in resisting compressive loads (Cullinane and Einhorn,
2002). Bones are weaker in tension, but weakest in resisting shearing loads. However,
limb bones are loaded primarily by bending moments (Rubin and Rubin, 2006), resulting
in a complex and dynamic combination of axial tension and compression in addition to
shear. The distribution of bone can help deal with these loading regimes, particularly in
resisting bending (Bouxsein, 2005; Burr and Turner, 2003; Forwood, 2001). A diaphysis
morphologically can resemble a hollow tube-like structure, maintaining strength while
reducing weight.

The area moment of inertia (Ixx, Iyy or Imin, Imax), a predictor of

resistance to bending in two directions (i.e. medial/lateral; anterior/posterior), of a cross
section from this “tube” can be increased by distributing mass farther away from the
neutral axis (Burr and Turner, 2003; Rubin and Rubin, 2006) (Figure 2.8). Thus having a
given amount of bone, by distributing the mass farther from the neutral axis and making
the tube hollow, the resistance to bending will increase while minimizing weight of the
bone. Polar moment of inertia (J) , resisting torsion, will increase as well as it is closely
related to bending moment of inertia (J = Ixx + Iyy).
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Figure 2.8. Three models representing cross-sectional bone architecture displaying
that for a given area, by distributing bone away from the neutral axis of bending,
the second moment of area (area moment of inertia) and thus resistance to bending
increases. Modified from (Burr and Turner, 2003). Areas not drawn exactly to scale.
The mass and mechanical properties of bone can also be influenced by pores within
the cortical bone, referred to as cortical porosity. Pores such as lacunae, canaliculi, and
vascular canals exist as necessary physiological structures; however resorption cavities
during remodeling can generate cortical porosity as well (Augat and Schorlemmer, 2006;
Mundy et al., 2003). Small increases in porosity will decrease Young’s modulus and can
lead to large decreases in strength, as porosity number and diameter account for
approximately 55% of yield stress and 70% of Young’s modulus in cortical bone (Augat
and Schorlemmer, 2006; Davison et al., 2006). As such, BMD and porosity are large
determinants of cortical bone strength and stiffness (Bouxsein, 2005). Unfilled resorption
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sites can also serve as sites for stress concentration, perhaps leading to microdamage (see
below) (Seeman and Delmas, 2006).
The highly porous meshwork of trabecular bone consists of bony struts resembling
plates and rods (Figure 2.9). The amount of trabecular bone is typically provided as a
three-dimension value and represented as the volume of bone per given unit volume, or
bone volume fraction (BV/TV) (Bouxsein, 2005). The volume fraction can be determined
from samples using microcomputed tomography (microCT). Alignment of these rods and
plates roughly follow the orientation of the greatest stresses and at right angles with one
another, exhibiting an example of Wolff’s law (Currey, 2002; Robling et al., 2006).
Struts transfer forces applied to the enlarged ends of long bones at joints down
through the metaphysis into the cortical bone of the diaphysis, which is then loaded in
compression and bending (Burr and Turner, 2003; Felsenberg and Boonen, 2005). The
vertical trabeculae within the network act as beams transferring loads during
physiological loading (bending and compression), with horizontal trabeculae connecting
adjacent vertical struts and maintaining efficient force distribution (van der Linden et al.,
2001). Trabecular bone serves a similar role of energy dissipation in flat or irregular
bones. Overall, trabecular bone can experience greater strains than cortical bone, and has
a lower Young’s modulus (fracture at approximately 7% strain as opposed to 2% in
cortical bone) (Cullinane and Einhorn, 2002)
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Figure 2.9. Four samples of trabecular architecture reconstructed from microCT
measurements from: a) bovine proximal tibia, b) human proximal tibia; c) human
femoral neck; and d) vertebral trabecular bone from a human. Note the presence of
plate-like and rod-like trabeculae. Reproduced from (Keaveny et al., 2001).
Trabecular architecture refers to the interconnectivity of the trabeculae, as well as
morphology of the struts (i.e. thickness, plate-like or rod-like), and orientation
(Felsenberg and Boonen, 2005). Plates are associated with increased mechanical strength
in the direction of bending (Stauber and Muller, 2006). The alignment of the trabeculae
results in anisotropy of the bone, as the trabecular network is stronger and stiffer in the

25

direction of alignment (Robling et al., 2006). Trabecular bone within the femoral neck are
strongest in resisting compression parallel to the long axis, whereas trabeculae within the
vertebrae are strongest in resisting compression perpendicular to the long axis (Cullinane
and Einhorn, 2002).
The BV/TV of bone in a given trabecular architectural sample is critical in
determining bone strength (Davison et al., 2006). The ultimate strength of trabeculae in
compression is related to the product of the apparent density (or the product of the
density of the indivual trabeculae and the BV/TV) so reduction in volume fraction would
result in a large decrease in compressive strength (Benhamou, 2006; Cullinane and
Einhorn, 2002; Keaveny and Hayes, 1993).
Loss of trabecular volume results in a loss of strength, with very elevated non-linear
loss of strength at very low bone volumes (Davison et al., 2006). But other architectural
factors besides BV/TV have an impact on bone strength. The connectivity of the struts
and the number and thickness of trabeculae can affect efficient transfer of forces
throughout the bone. The greater the trabecular connectivity, the shorter the length of the
unsupported vertical (load-supporting) strut length. The strength of the trabecular bone
strut is inversely proportional to the square of the unsupported length (Currey, 2002;
Davison et al., 2006), and is not dissimilar from Euler’s Buckling Theorem. A loss of
horizontal trabeculae can increase the length of unsupported vertical trabeculae, which
experience greater physiological stresses (van der Linden et al., 2001). Thus by
increasing the length of existing vertical trabeculae by reducing connectivity, the critical
buckling load is substantially reduced (Figure 2.10).
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For a similar loss in bone mass, reduction in connectivity of struts causes a substantial
greater loss of bone strength and Young’s modulus than thinning of the struts (Guo and
Kim, 2002; Seeman and Delmas, 2006; Silva and Gibson, 1997). Finite element models
indicate that once trabecular numbers and connectivity are reduced, bone strength cannot
recover due to increased thickness (Guo and Kim, 2002). Evidence suggests complete
fractures of trabeculae resulting in loss of connectivity are not repaired (van der Linden et
al., 2001). In patients with osteopenia (reduced bone mineral density), individuals with
vertebral fractures had 4 times the numbers of complete fractures of individual trabeculae
(Aaron et al., 2000). Thus the integrity of the trabecular microarchitecture is necessary to
maintain bone strength.

Length of
Trabecular
Strut

Length of
Trabecular
Strut

A

B

Figure 2.10. Two models of trabecular architecture exhibiting how reduction in
connectivity of horizontal trabeculae will result in an increased length of
unsupported vertical struts.
Thinning of the microarchitecture can cause stress concentrations to build at the site
of reduced bone within a resorption site. Resorption cavities of approximately 40-60µm
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in depth can be present within a strut that may be only 100 µm deep (Hernandez et al.,
2006; van der Linden et al., 2001). Excessive remodeling will, through the accumulation
of resorption pits, transform trabecular plates into trabecular rods. Finite element models
have shown that resorption cavities can have a significant impact on trabecular bone
strength, particularly in regions of high strain (Hernandez et al., 2006). The loss of bone
through resorption pit accumulation can have a greater impact than by thinning of the
trabeculae: a 20% loss of BV/TV due to resorption pits can result in a greater reduction in
overall trabecular network stiffness (50%) than by thinning (30%) (van der Linden et al.,
2001). High stresses and strains are experienced at these sites and can increase chance of
buckling and failure of the trabeculae. Cracks can initiate at sites of microfracture, further
reducing the quality of the bone (Parfitt et al., 1987; van der Linden et al., 2001). Bone
remodeling occurs, in part, to deal with loading. Loss of trabecular volume by resorption
pits, thinning, or total loss of the struts will transfer loads and strains to the surrounding
trabeculae (van der Linden et al., 2001). This could then result in elevating the frequency
of bone resorption and bone loss in the compromised and surrounding trabeculae.
Increasing stress surrounding resorption pits may also stimulate excess remodeling
(and loss of trabeculae) due to targeted repair of microdamage. An increase in strain at
areas of stress concentrations can result in remodeling of the bone in order to distribute
mass to best deal with loading (McNamara and Prendergast, 2005). This elevation of
stress can induce microdamage, which seems to be targeted for remodeling and repair
(Burr et al., 2003; Mashiba et al., 2000; Seeman and Delmas, 2006). Models suggest that
the response of the BMU to deal with both the microdamage and the increased strain can
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lead to larger resorption pits, enhanced stress and microdamage, excess resorption, and
ultimately disconnectivity of trabeculae (McNamara and Prendergast, 2005).

2.1.7 Material Properties: Matrix Minerals
The mineral content of bone (primarily hydroxyapatite) resists compression very
well, but poorly resists tension (Augat and Schorlemmer, 2006). In fact, the mineral
content of bone as well as BMD are the greatest contributors to stiffness. Young’s
modulus and strength of bone will increase with increasing mineralization (Bouxsein,
2005). The degree to which bone can absorb energy, however, will vary with increasing
mineral content depending on the initial state of the bone: toughness will increase if the
initial state was hypomineralized and decrease if already completely mineralized. Size of
the mineral crystals is also important in determining material properties. As secondary
mineralization occurs, the number and size of crystals increase (Augat and Schorlemmer,
2006). Increased crystal size and crystallinity is associated with a trend for increasing
brittleness. The number of microcracks can increase as the enlargement of crystal size
negatively impacts deformation to failure of the bone (Davison et al., 2006).

2.1.8 Material Properties: Organic Matrix
The organic matrix is a composite material composed mostly of type I collagen. Type
I collagen permits flexibility and a partially elastic nature, and has a profound effect on
bone toughness (Burr, 2002a; Davison et al., 2006; Wang et al., 2002).

However,

collagen has little influence on the stiffness of bone, particularly in compression. Long
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bones of the body which consist primarily of cortical bone and experience significant
tensile loading have collagen fibers that are typically oriented parallel to the long axis,
adding to tensile strength and greatly increasing energy that must be absorbed to fracture
the bone (Burr, 2002a; Skedros et al., 2006; Wang et al., 2002). However, variation of
collagen fibril orientation does exist between lamellae within a bone and even within a
single lamella (Figure 2.3A) (Currey, 2002). Collagen fibers can also enhance bone’s
toughness through fiber cross-linking. The decreased extent of collagen fiber crosslinking
after skeletal maturity is associated with reduced toughness (Burr, 2002a; Davison et al.,
2006)

2.1.9 Material Properties: Microdamage
Daily cyclical loading of forces below what is necessary to cause structural failure are
imposed on the skeleton. However, fatigue damage from this loading can result in
microcracks within the bone (Robling et al., 2006). The development of these
microcracks can depend on loading regimes, as crack propagation occurs transverse to
the direction of loading. These cracks are usually 30-100µm in length (Augat and
Schorlemmer, 2006). Linear microcracks can originate at areas of stress concentration
(such as lacunae and resorption cavities) during compressive loading. When induced by
tension, the microcracks typically stay within the cement line, thus the bounderies of the
osteons and lamellae can impede crack propagation (Davison et al., 2006). Crack
formation may effectively dissipate energy. Increased loading, however, can lead to
larger cracks, lowering bone stiffness, strength, toughness, and Young’s modulus, and
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can lead to fracture (Davison et al., 2006; Robling et al., 2006). Microdamage, as
previously mentioned, can be repaired by targeted remodelling (Burr et al., 2003;
Mashiba et al., 2000). Increased porosity and the resulting reduced bone mass can reduce
resistance to crack propagation by reducing fracture toughness, as the energy absorbing
capacity of the remaining bone is reduced (Augat and Schorlemmer, 2006; Seeman and
Delmas, 2006).

2.1.10 Osteoporosis
Osteoporosis is a condition in which bone resorption and formation are uncoupled,
leading to excess resorption and ultimately bone loss (Lane, 2006). The clinical diagnosis
of osteoporosis is made if a bone densitometry scan demonstrates a bone mineral density
(BMD) that is 2.5 standard deviations below the mean peak bone mass of that of a young
adult (Felsenberg and Boonen, 2005; Lane, 2006). The elevated turnover rate with
excessive resorption reduces bone mass, as well as overall bone geometry, trabecular
thickness, connectivity, cortical thickness, porosity, and mineral properties (including
decreased mineralization and increased crystal size) (Davison et al., 2006; Gass and
Dawson-Hughes, 2006; Harvey et al., 2006; Lane, 2006; Reginster and Burlet, 2006)
(Figure 2.11). As such, osteoporosis is a disease characterized by increased bone fragility
leading to an increased risk of fracture. Hip, vertebral, and distal forearm fractures are the
greatest contributors to the estimated 1.5 million fractures related to bone fragility each
year (Bouxsein, 2005; Harvey et al., 2006). Measures to prevent and reverse bone loss do
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exist as treatments for osteoporosis. These include bisphosphonates (antiresorptive) and
intermittent administration of parathyroid hormone (PTH; anabolic).

Figure 2.11. Normal (A) and osteoporotic (B) trabecular bone. Note the porosity of
the osteoporotic trabeculae in (B). Reproduced from (Martini, 2004).
Bisphosphonates represent a class of pyrophosphate analogues that bind to the
hydroxyapatite component of bone matrix (Coxon et al., 2006; Robey and Boskey, 2006).
Osteoclasts can endocytose bisphosphonates during resorption, leading to apoptosis by
inhibition of farnesyl diphosphate synthase, a key enzyme of the mevalonate pathway
(Hirbe et al., 2006). As such, resorption is prevented and turnover is suppressed. Several
bisphosphonates have been approved by the FDA for treatment of osteoporosis, including
alendronate (ALN), risedronate (RIS), and ibandronate (IBN).
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By reducing turnover bisphosphonates can increase BMD and strength. However,
observations suggest that antiresorptives can decrease the risk of fracture greater than
would be predicted by increasing BMD (Hernandez et al., 2006). A one-year treatment of
bisphosphonates decreased fracture risk by 50-60% with only 5% increase in bone
mineral density, providing evidence for a substantial role of different measures of bone
quality on ultimate bone strength (Burr, 2004). Studies in osteoporotic patients have
shown that bisphosphonates can preserve microarchitecture but may fail to restore
damage to trabecular connectivity (Borah et al., 2004; Dufresne et al., 2003). An increase
in mineralization can occur, elevating the stiffness of the bone and reducing the ultimate
displacement of the bone (Bouxsein, 2005; Turner, 2002). But this can also increase
brittleness (Davison et al., 2006). The work to failure tends to decrease with increasing
mineralization – thus requiring less energy before failure, and increasing fragility. Also,
by reducing the rate of remodeling, bisphosphonates can prevent repair of microcracks,
decreasing toughness of the bone (Burr, 2002a)
Parathyroid hormone (teriparatide, PTH 1-34) is an anabolic agent administered to
reduce bone loss by stimulating new bone formation. In patients with osteoporosis,
increased volume of trabecular bone, cortical thickness, connectivity (19%), and an
increase in the proportion of trabecular plates have all been observed after intermittent
PTH therapy (Jiang et al., 2003). In monkeys, bone formation has been shown to occur at
the periosteal surface following treatment. At the same time, the increase in remodeling
due to PTH also induces an increase in cortical porosity and partly counteracts the
positive effects on bone strength (Burr et al., 2003). However, the increased resistance to
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torsional and bending moments as a result of increased external diameter, more than
compensates for the porosity, as porosity develops at the endocortical surface which
experiences the least stress during bending (Ammann and Rizzoli, 2003; Burr et al.,
2001; Turner, 2002). In rabbits and rats, mechanical strength was increased or remained
stable following intermittent PTH therapy, as formation of bone occurred on both
endocortical and periosteal surface with increased porosity (Hirano et al., 1999; Lotinun
et al., 2004).
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2.2 The Generation of Reactive Oxygen Species Following Ionizing Radiation

2.2.1 Ionizing Radiation
Radiation therapy is an important method of treating cancer within the United States.
Approximately 4 million new cases of cancer developed in 2006 (The American Cancer
Society ) and approximately 50 percent of these patients will receive radiation therapy as
a treatment for the disease (Bentzen, 2006). Radiation therapy has been an important tool
in the ever-improving survival rates of cancer; estimated five year survival rates for
breast, colon, and prostate cancer are 88.2%, 64.1%, and 99.8% respectively (The
American Cancer Society #469). With improvements in radiotherapy and other treatment
modalities, the population of cancer survivors has increased by more than 200% in the 30
years prior to 2001 (Bentzen, 2006). Currently 62% of adults and greater than 75% of
patients with pediatric cancers survive past five years (Robbins and Zhao, 2004). The
effects of the radiation treatment on normal tissues will be the focus of this review, as
atrophy in irradiated normal bone surrounding a tumor is the clinical concern leading to
the investigations in this dissertation.
Matter can absorb energy when exposed to sources of radiation, and it is the
absorbance of this energy that imparts biologic effects within an organism (Hall, 2000).
Two classifications of radiation sources typically considered are electromagnetic and
particulate radiation. Electromagnetic radiation sources can include X-rays and gammarays, both being composed of photons consisting of zero mass and no charge (Hall, 2000;
Turner, 1986). X-rays are produced when electrons interact with a target atom
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(specifically the electrons), emitting a portion of the kinetic energy of the electron as a
photon while ejecting an electron from its orbit. Gamma rays are produced as the energy
discharged by the decay of an unstable nucleus (Hall, 2000; Turner, 1986). The
wavelength of these forms of electromagnetic radiation are very short, measuring an
estimated 10-8cm. Particulate radiation includes electrons (negative charge), protons
(positive charge), or heavy particles. Heavy particles can be elemental nuclei with a
positive charge due to absent electrons or uncharged, highly penetrating neutrons (Hall,
2000).
Ionizing radiation is radiation that has enough energy to remove electrons from atoms
as it passes through a material. Photons will ionize atoms in cells and tissue in several
ways. At lower energies, a photon can cause the ejection of a photoelectron when the
entirety of the energy is absorbed by the atom, referred to as the photoelectric effect.
Other photon interactions, namely inducing the scattering of an electron from an atom
while releasing photons of lower wavelengths (Compton effect) as well as the production
of electron pairs (electron and a positron), become more probable with increasing energy.
Charged particles move through matter in a near linear path, losing energy in small
quantities as energy is absorbed by electrons within the matter, causing direct ionization
of the atoms (Turner, 1986). The ionization density, or the number of ion pairs that are
formed along the length of the track (representing energy transfer per unit distance), is
referred to as the linear energy transfer (LET), defined in keV/µm (Hall, 2000).
Several factors are related to the impact of radiation on tissues. The units for absorbed
dose, the amount of energy absorbed per unit of mass of material, in this literature review
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will be Gray (Gy), 1 Joule per kg. The same dose of different types of radiation can have
very different effects, depending on the LET, dose rate, and number of fractions (as well
as radiosensitivity of the tissue) (Hall, 2000). For instance, the same absorbed dose of
heavy ion radiation can have a much greater negative impact on tissues than that of lowLET radiation such as photons (Hamilton et al., 2006). To help account for this difference
in types of radiation, an equivalent dose, Sievert (Sv), is often used. The Sievert is
defined as the absorbed dose multiplied by a weighting factor. The weighting factor for a
particular type of radiation is the ratio of the biological effects of 1 Gy of 250 kV X-rays
on a tissue (weighting factor of 1) relative to the biological effects of the particular
radiation of interest (Hall, 2000).

2.2.2 Ionizing Radiation and Reactive Oxygen Species Generation
When photons or charged particles of high energy strike an atom, the molecules
become excited. Electrons are raised to higher energy levels and can ultimately become
ejected, resulting in ionization (Hall, 2000; Riley, 1994). This process frequently occurs
in water, resulting in the production of free radicals, defined as atoms, molecules, or
compounds with one or more unpaired electron (Hall, 2000; Riley, 1994). The structure
of molecular oxygen allows for the acceptance of electrons and ultimately the formation
of partially reduced oxygen species, or reactive oxygen (or nitrogen) species, including
peroxyl radicals (ROO*), alkoxyl radicals (RO*), and nitric oxide (NO*) (Riley, 1994).
The hydroxyl radical (OH*) is the most reactive biologically and can induce the most
damage (Vijayalaxmi et al., 2004). Superoxide (O2* -) and hydrogen peroxide (H2O2) are
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also important reactive oxygen species in biological systems, although not as active as the
hydroxyl radical (Robbins and Zhao, 2004). Hydrogen peroxide (the two electron
reduction of oxygen) is a weaker oxidizing agent than superoxide.
Formation of these reactive intermediates can occur in various ways. Approximately
80% of the energy from ionizing radiation induces the loss of electrons from water. The
following reactions are derived from Slupphaug et al. (Slupphaug et al., 2003) and Riley
(Riley, 1994):
H2O → H2O+

+ e-

H2O+ + H2O →

HO* + H3O (formation of hydroxyl radical)

OH* + OH* → H2O2 (formation of hydrogen peroxide)

In the presence of oxygen, then, superoxide radicals will be formed:
e- + O2 → O2* - (formation of superoxide radical)

Superoxide can react with protons to form hydrogen peroxide. The following process is
referred to as dismutation:
2O*2- + 2H+ → O2 + H2O2

A single electron reduction of hydrogen peroxide can occur to form the hydroxyl radical,
thus hydrogen peroxide can serve as an intermediate for this more reactive radical:
H2O2 + e- → HO* + OH-
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Reactive transition metals (like Fe) can serve as electron donors and form hydroxyl
radical (OH*) by reacting with hydrogen peroxide (Courey et al., 1996; Robbins and
Zhao, 2004; Vijayalaxmi et al., 2004).

H2O2 + Fe2+ → HO* + Fe3+ + OH-

Most of these reactions occur very quickly, with the half life being from approximately
10-6 to 10-10 seconds. Superoxide and hydrogen peroxide are relatively more stable than
the hydroxyl radical, perhaps persisting within water for 101 seconds and more than 102
seconds, respectively (Robbins and Zhao, 2004; Vijayalaxmi et al., 2004).

2.2.3 Ionizing Radiation and Cellular Damage
Ionizing radiation induces cellular damage in several ways, particularly as a result of
DNA interactions with reactive oxygen species. The damage, if unrepaired, can result in
death of the cell, mutations, or induction of malignancy (Hall, 2000; Little et al., 2002).
Directly, radiation that hits DNA can induce either single or double strand breaks (Hall,
2000; Vijayalaxmi et al., 2004). Indirect damage to cells are due to reactive oxygen
species, producing: single and double strand breaks in DNA; mutations; and impairing
other cellular components, including organelles and membranes (Anscher et al., 2005;
Bonner, 2003; Little et al., 2002; Riley, 1994; Rothkamm and Lobrich, 2003). The
phosphodiester backbone of DNA can be attacked and cause single and double strand
breaks (Vijayalaxmi et al., 2004). Nucleotide damage can also occur. Guanine is the

39

nucleotide most susceptible to damage via free radicals producing 8-hydroxy2deoxyguanosine (8-OHdG), and is a measure of carcinogenesis (Slupphaug et al., 2003;
Vijayalaxmi et al., 2004). Additionally, DNA-DNA and DNA-protein crosslinks can
form as a result of DNA damage (Prise et al., 2005).
The damage to DNA due to ionizing radiation can have several impacts on the cell.
The failure of repair mechanisms to rejoin DNA strands via homologous recombination
or non-homologous end joining generally leads to cell killing when the cell enters mitosis
(Hall, 2000; Prise et al., 2005). Thus mitotically active cells are sensitive to cell killing
via radiation damage to DNA. Cell apoptosis can also occur by activation of the proapoptotic gene p53 and the transcription factors AP1 and NF-kB due to double strand
breaks (Habraken and Piette, 2006). Finally, mutations can result in oncogenic
transformation, particularly if it occurs in genes regulating proliferation or apoptosis,
such as the p53 (Prise et al., 2005).
Macromolecules other than DNA can be damaged by free radicals produced after
ionizing radiation. Free radicals can change the form and function of proteins. Damage to
DNA binding proteins can alter levels of gene expression. Such damage could
potentially change the expression of genes associated with preventing excess oxidative
stress or induce apoptosis in the cell (Riley, 1994). Lipids are susceptible to damage by
oxidative stress. Unsaturated sites on lipids react with free radicals causing lipid
peroxidation and alters the membrane permeability of lipid membranes (Riley, 1994;
Vijayalaxmi et al., 2004). This can alter diffusion of molecules and electrolytes within the
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cell, or cause leakage of destructive enzymes (i.e. lysozyme). Products of lipid
peroxidation (e.g. 4-hydroxynonenal) can damage proteins and nucleic acids.
Damage due to ionizing radiation and ROS can result in cell death. Yet the effects of
ROS may not be limited to irradiated cells. Reactive oxygen species have been implicated
in contributing to the bystander effect following ionizing radiation, in which irradiated
cells (perhaps through gap junctions or extracellular secretions) communicate with nonirradiated cells, and generate a response from that non-targeted cell or subsequent
generations. Such responses can include enhanced genomic instability, sister chromatid
exchange, signal transduction, and generation of micronuclei as well as generating an
inflammatory response (Kadhim et al., 2004; Lorimore et al., 2001; Lorimore and
Wright, 2003; Matsumoto et al., 2004; Morgan, 2003). Additionally, the state of
oxidative stress can linger for several days after total-body irradiation, likely not a result
of ROS produced as a result of the initial radiation exposure, but instead the propagation
of these reactive intermediates (Robbins and Zhao, 2004).

2.2.4 Physiological Presence and Function of ROS Within the Cell
Outside of ROS generated as a result of stressors such as ionizing radiation, the
presence and production of ROS within cells is normal. Superoxide is frequently
generated within mitochondria as a result of leakage from the electron transport chain
(Robbins and Zhao, 2004). Various enzymes also produce superoxide within the cell,
especially from membrane-oxidases such as phagocytic nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH) oxidase. Superoxide within the cell is
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eliminated by the enzyme superoxide dismutase (SOD), producing hydrogen peroxide.
Hydrogen peroxide is of particular note because it can diffuse across cell membranes and
can generate other reactive species, such as the hydroxyl radical (Riley, 1994). In
phagocytes such as neutrophils or macrophages, the production of ROS is an important
component of the “respiratory burst” and used as a defense versus bacteria, and can also
impact surrounding tissue by leaking outside of the cell (Nagata, 2005). In the neutrophil,
hydrogen peroxide can be used to form hypochlorous acid (a very reactive ROS) within
phagosomes due to the action of myloperoxidase (Robbins and Zhao).
Reactive nitrogen species are also important components of cellular metabolism.
Nitric oxide

(NO*) is formed from L-argenine by NO synthase, using an electron

transfer from NADPH (Korhonen et al., 2005; Robbins and Zhao, 2004). Like
superoxide, levels of NO* become elevated during inflammation. Peroxynitrite (ONOO-)
is metabolized from nitric oxide and superoxide by inducible nitric oxide synthase
(iNOS), and serves a role in preventing infection, although in excess can cause DNA
damage, cell apoptosis, necrosis, and tissue damage (Korhonen et al., 2005).
Antioxidant enzymes function to remove oxidants from the cell, including superoxide
dismutases (MnSOD in mitochondria, and CuZnSOD in cytoplasm), which convert
superoxide to hydrogen peroxide (Riley, 1994; Slupphaug et al., 2003). Hydrogen
peroxide can be removed and converted to water and O2 by catalase at high
concentrations. Glutathoine peroxidase (GPx) catalyzes the conversion of H2O2 water and
glutathione disulfide (GSSG) using glutathione (GSH) as an electron donor (Riley, 1994;
Robbins and Zhao, 2004). GSH has to be regenerated from GSSG from glutathione
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reductase, and this requires NADPH to donate electrons. These antioxidant systems are
vital to preventing ROS induced damage, yet the production of ROS within a cell as a
result of irradiation is much less than is what is produced by normal cell metabolism
(Bentzen, 2006; Robbins and Diz, 2006). However, as previously mentioned,
concentration of ROS can remain elevated for days after irradiation. This provides
evidence that radiation-induced changes in preservative antioxidant defenses may
account for much of the long-term radiation damage.
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2.3 Establishing the Link Between Ionizing Radiation and Bone Damage

2.3.1 High Radiation Doses Cause Bone Atrophy by Damaging Bone Cells and
Vasculature
Bone atrophy is a well-documented response of osseous tissue following exposure to
the ionizing radiation characteristic of high-dose radiation therapy (Baxter et al., 2005a;
Ergun and Howland, 1980; Howland, 1975). Reduction in bone mass and overall bone
quality is dependent on several factors, including the dose absorbed, the energy of the
radiation beam, the fraction size of the radiation dose, and the age and developmental
stage of the patient (Mitchell and Logan, 1998; Overgaard, 1988). Osteopenia is often
reported in patients one-year post-therapy, though the observed timing of reduced bone
mass, overall loss of bone mineral density compared to controls, and changes in
mineralization are variable (Hopewell, 2003; Mitchell and Logan, 1998). Despite this,
demineralization of bone, thinning of bones, and loss of trabecular number has been
described qualitatively following radiotherapy (Ergun and Howland, 1980; Hopewell,
2003; Howland, 1975; Mitchell and Logan, 1998). Quantitatively, a significant (~30%)
reduction in bone mineral density (BMD) was observed in patients with uterine cervix
carcinoma using qCT from the 3rd lumbar vertebrae within 5 weeks after pelvic
irradiation with either 45 Gy or 22.5 Gy total dose of high energy photons (Nishiyama et
al., 1992).
Bone loss following radiotherapy is thought to be a result of physiological changes
that occur to both vasculature and bone cells (Bliss et al., 1996; Ergun and Howland,
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1980; Gal et al., 2000; Hopewell, 2003; Huh et al., 2002; Konski and Sowers, 1996;
Mitchell and Logan, 1998; Rohrer et al., 1979). The first report of radiation-mediated
bone damage (termed “osteitis”) described a reduction in bone vasculature following
obliterative endartitis and periartitis (Ewing, 1926). Early loss of vascularization occurs
as a result of swelling and vacuolization of endothelial cells within the vascular channels
of the osteons (Ergun and Howland, 1980; Hopewell, 2003; Rohrer et al., 1979).
Ultimately, this results in the formation of sclerotic connective tissue within the marrow
cavity. Fibrosis occurring in the sub-intima and replacement of vascular smooth muscle
cells with hyaline-like material within the tunica media occur as late injuries, constricting
the vessel lumen. Constriction of vascular lumen diameter within the periosteum, marrow
cavity, and haversian system of rhesus monkey mandibles up to 6 months after exposure
to 45 Gy total dose of gamma irradiation (cobalt-60) was a component of intimal fibrosis
without changes in medial anatomy (Rohrer et al., 1979). The timing of the reduction of
blood flow to bone seems dose-dependent. Rats exposed to a range of X-ray doses (5, 10,
15, 20, 25 Gy at 250 kV) exhibited reduced blood flow to the femora at one month postirradiation following 20 Gy and 25 Gy exposure, yet blood flow was significantly
reduced following all doses at 3 months (Pitkanen and Hopewell, 1983). Blood flow
changes were more severe within the distal epiphysis than the shaft. A normal rate of
blood flow returned for all groups except 25 Gy at 7 months; however, despite this
restoration of blood flow, a reduction in bone mass (15-25 Gy) and mineralization (20-25
Gy) were observed from the rats 7 months following exposure (Pitkanen and Hopewell,
1983).
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Damage to bone cells (osteoblasts, osteocytes, and osteoclasts) is thought to be a
primary contributor to reduced bone mineral density following irradiation (Bliss et al.,
1996; Ergun and Howland, 1980; Hopewell, 2003; Howland, 1975; Mitchell and Logan,
1998; Sams, 1966b). A reduction in the overall number of bone-forming osteoblasts
occurs following irradiation (Bliss et al., 1996; Ergun and Howland, 1980; Hopewell,
2003; Howland, 1975). In primate models, osteoblasts and mesenchymal progenitors
within the periosteum and marrow of mandibles were largely absent after 45 Gy total
dose applied in fractions over 12 days, but evidence of remodeling (e.g. resorption pits)
were still evident (Rohrer et al., 1979). Interestingly, in the few areas where osteoblasts
and progenitors remained viable, the cells seemed to be proliferating with new osteoid
being produced, forming exophytes. Normal vascular supply was found within these
discreet areas despite widespread loss throughout the irradiated field. Likewise, a
decrease in osteoblast numbers occurs within a day following high dose (> 15 Gy)
gamma and carbon irradiation in rat models, remaining lower than non-irradiated controls
for several months (Sawajiri et al., 2003).
A decrease in osteoblast proliferation and both collagen and alkaline phosphatase
generation following irradiation has been reported (Ergun and Howland, 1980; Gal et al.,
2000; Hopewell, 2003; Sams, 1966a). A reduction in the production of these markers
indicates a loss of osteoblast function that lowers both the generation of mature bone
matrix and impairs bone mineralization. In vitro cell culture studies of preosteoblasts
(MC3T3 E1) have revealed a reduction in collagen production and proliferation
following irradiation of 4 Gy (Gal et al., 2000). Another study reporting reduced
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proliferation in cultured preosteoblasts across a range of doses (0 – 60 Gy) also noted that
even at high acute doses > 30Gy, direct cell killing was not induced (Szymczyk et al.,
2004). Rather, osteoblasts underwent cell cycle arrest and became more sensitive to
proapoptotic agents (i.e., Ca2+Pi). Whatever the mechanism reducing osteoblast
populations may be, the general accepted paradigm is that a greater reduction in the
number and activity of osteoblasts relative to bone-resorbing osteoclasts results in a net
loss of bone (Ergun and Howland, 1980).
Osteocytes, which are responsible for the maintenance of mature bone, are thought be
killed within irradiated bone following exposure to high doses (Ergun and Howland,
1980; Mitchell and Logan, 1998; Rohrer et al., 1979). Osteocytes were shown to be killed
within the irradiated field inside cortical lamellar and Haversian bone of 45Gy irradiated
monkey mandibles, though were not affected within trabecular bone. However,
osteocytes seem to be relatively radioresistant in several animal models. They remained
viable for several months after a single 15 to 40 Gy application of irradiation in mice and
rabbits (Jacobsson et al., 1987; Sams, 1966b; Sugimoto et al., 1991).
The effect of irradiation on osteoclast health and function is unclear from the studies
examining presence and activity from varied anatomical locations. Results from studies
range from decreased osteclasts (Scheven et al., 1985), to stable numbers (Goblirsch et
al., 2005; Vit et al., 2006), to data suggesting a transient, non-significant increase in
osteclasts (Sawajiri et al., 2003) immediately after irradiation. Very high (30 Gy) acute
doses of carbon and γ-radiation induced a very rapid (by 24 hours) decrease in osteoclast
numbers in the metaphyses of three week old rats (Sawajiri et al., 2003). Also noted in
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this investigation, no significant change in osteoclast numbers were apparent after
exposure to doses of 15 and 22.5 carbon and γ-radiation until a sharp decline near day 5
(Sawajiri et al., 2003). However bone volume in the gamma-irradiated groups began to
decline by day five post-irradiation, although all quantification was assessed via a
histological analysis of a small fraction of the metaphysis (50µm2 area) (Sawajiri and
Mizoe, 2003). By 12 weeks after irradiation from these animals, histological analyses of
gamma-irradiated animals revealed large increases in fat within the marrow and virtually
no trabeculae. Another investigation applying 25, 50, and 100 Gy X-rays to rabbit tibia
resulted in significantly increased porosity within the primary spongiosa by the first
histolgical examination at 4 weeks post-exposure, with no subsequent changes in porosity
(Takahashi et al., 1994). This seems to indicate that the increase in resorption occurred
prior to 4 weeks. Eight days after exposure to 20 Gy X-rays (40 Gy absorbed dose by the
bone) osteoclast numbers within the distal femoral epiphysis of mice were unchanged
relative to non-irradiated controls (Goblirsch et al., 2005). Likewise, both TRAP+
osteoclast numbers along the cortical bone of the humeral epiphysis in a mouse remain
stable eight days following targeted 6 Gy X-ray irradiation, although ALP stained
osteoblast numbers surrounding the proliferating growth plate were also unchanged
relative to the control (Vit et al., 2006).
Osteoblast progenitors in rabbit and mouse bone marrow were found to have been
largely eliminated following acute exposures of 20 Gy X-rays and 50 Gy from a 14 MeV
electron beam, respectively.

While bone formation was arrested, resorption was

maintained at the endosteal surface and throughout the bone (Sams, 1966b; Sugimoto et
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al., 1991). The bone formation within mice ceased for 9 weeks following exposure to 20
Gy of X-rays, and in rabbits was decreased by 4 weeks with complete cessation at both
12 and 24 weeks. Yet the reduction in bone formation was observed concurrently with
massive bone atrophy and increased porosity within both animal models. Indeed, almost
complete obliteration of the metaphyseal trabecular bone was observed in both the
growing and nearly mature mice early post-irradiation (3 weeks and 5-6 weeks,
respectively).

2.3.2 Radiation Impairs Bone Growth
The overall growth of bones in the body is impaired following irradiation
(Brownstein et al., 2004; Eifel et al., 1995). Growth rate diminishes yet recovers
following 4-5 Gy of irradiation, with permanent effects occurring at doses greater than 12
Gy (Dawson, 1968; Sams, 1966b). Administration of a 14 Gy dose of radiation to a
rodent will result in a massive, 85% reduction in growth rate, followed by an incomplete
recovery at the cessation of puberty (Eifel and Sampson, 1991). Bone growth was found
to completely stop in rodents following a single exposure to 20 Gy of radiation (Eifel and
Sampson, 1991; Sams, 1966b).
Reduced bone growth and density following radiation therapy for cancer is a concern
for both patients and medical care providers. However, radiation-induced inhibition of
bone growth and bone loss (3.4% of patients display osteoporosis 5 years after treatment)
are still conditions associated with therapeutic radiation treatments (Gurney et al., 2003;
Odame et al., 2005; Schmiegelow et al., 2003). A reduction in height and the length of
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limbs and bones can be observed several years after treatment. Several clinical studies of
cancer survivors have indicated that total doses between 25 and 60 Gy can retard growth
of skeletal elements, with the greatest reduction found at approximately 33 Gy (Eifel et
al., 1995; Krasin et al., 2005; Mitchell and Logan, 1998; Probert and Parker, 1975). For
instance, children with acute lymphoblastic leukemia, Hodgkins disease, musculoskeletal
disorders such as rhabdomyosarcoma or central nervous system tumors like
medulloblastoma, astroglioma, ependymoma, and nasopharyngeal carcinoma, receive
high total doses of external radiation (in excess of 24 Gy), which can result in reduced
long bone length (especially to bones within the irradiated field) and adult height
(Brownstein et al., 2004; Darzy and Shalet, 2005; Eifel et al., 1995; Gleeson et al., 2003;
Krasin et al., 2005; Mitchell and Logan, 1998). Moreover, doses on the order of 10-30 Gy
can have a major impact on vertebrae, reducing the overall vertebral height (Mitchell and
Logan, 1998).
Since mitotically active cells are particularly sensitive to radiation, damage to the
proliferative chondrocytes within the epiphyses of long bones contributes greatly to
impaired skeletal growth. Mature long bones of the limbs (e.g. humerus, femur, and tibia)
are created through endochondral ossification as a cartilage template forms during fetal
development which will ultimately be replaced by bone. Linear growth of bones within
the limbs occurs at the epiphyseal growth plates, which are bands of cartilage that include
rapidly proliferating chondrocytes. This growth plate ossifies to form an epiphyseal line
in mature bone. Proliferative chondrocytes are arranged in columns perpendicular to the
growth plate within the cartilaginous matrix (Figure 2.12) (Eifel et al., 1995; Kember,
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1978; Roach et al., 2003; Silbermann and Kadar, 1977; van der Eerden et al., 2003). The
rate of bone growth depends on the rate of chondrocyte proliferation and the height of the
mature cell within the column. Exposure to ionizing radiation can damage these
chondrocytes, or change the columnar arrangement of the proliferative cells, thus slowing
growth (Horton et al., 2006; Sams, 1966b). Cartilage is an avascular tissue, relying on
diffusion of gases from nearby vasculature. Any radiation-induced change in blood
supply to the surrounding tissue can also damage cells within the growth plate. Radiation
doses of < 1.8 Gy per fraction are typically used during cancer therapy to minimize the
damage to epiphyseal cartilage (Eifel et al., 1995).
Within a bone, disparity can exist between the growth rate at specific sites (i.e. distal
vs proximal epiphysis; epiphysis vs diaphysis), such that radiation localized to one region
can have a greater impact than at another. The epiphyses are generally more sensitive to
radiation than the diaphysis (Eifel et al., 1995; Mitchell and Logan, 1998). Most growth
of the humerus and tibia occurs in the proximal epiphysis, while for the femur, growth
rate is highest in the distal epiphysis. Thus, placement of the knee or shoulder in the
irradiated field can have a relatively high impact on limb bone length (Eifel et al., 1995;
Mitchell and Logan, 1998). Bone growth at the periosteal surface seems to be impaired
within the diaphysis, which can ultimately result in a reduction of shaft diameter
(Mitchell and Logan, 1998)
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2.3.3 Compounding Factors of Radiation-induced Reduction in Bone Growth and Bone
Mineral Density
The direct action of radiation on bone cells cannot entirely account for reduction in
bone length and final height of the survivor. Radiation damage to the hypothalamicpituitary axis during cranial-only or cranial-spinal radiotherapy can result in growth

Figure 2.12. The cellular arrangement of chondrocytes and bone cells within the
epiphyseal cartilage of a growing individual as well as the primary spongiosa (zone
3). Reproduced from (Martini, 2004).
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hormone deficiency (GHD), the most frequent endocrine disorder among childhood
cancer survivors (Brownstein et al., 2004; Darzy and Shalet, 2005; Gleeson et al., 2003;
Gurney et al., 2003; Odame et al., 2005; Schmiegelow et al., 2003). While a range of
doses are indicated as thresholds for GHD following therapy (i.e. 24-36 Gy total dose),
the majority of patients receiving total doses exceeding 27 Gy will have GHD as a result
of damage to the hypothalamic-pituitary axis within 2-5 years of radiotherapy, although
these changes can be observed after only 18 Gy application (Gleeson et al., 2003; Shalet
et al., 1976; Xu et al., 2004).
Additionally, chemotherapeutic agents such as methotrexate and mercaptopurine, and
glucocorticoid therapies prescribed for cancers such as acute lymphoblastic leukemia
(ALL) may contribute to the development of osteopenia (Davies et al., 2005; HoorwegNijman et al., 1999; Jenney and Levitt, 2002; Odame et al., 2005). Incidence of
osteopenia during therapy is very common, with 83% of patients suffering from
osteopenia in the lumbar spine within two years of therapy (Halton et al., 1996).
Leukemic cells can themselves damage bone upon infiltration to the bone marrow and
trabecular network. Impaired recovery of osteoblast progenitors can be observed
following chemotherapy treatment (Davies et al., 2002). However, adult survivors
frequently have lowered bone mineral density despite normal turnover, providing support
to the hypothesis that a failure to achieve normal bone mineral density prior to skeletal
maturation is a primary cause of osteopenia (Hoorweg-Nijman et al., 1999).
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2.3.4 Fractures Following Irradiation
Impaired bone growth, osteopenia, osteoporosis, cell and vascular changes, and bone
atrophy following irradiation can contribute to bone fractures in children and adults
(Konski and Sowers, 1996; Moreno et al., 1999; Staatz et al., 2006). The effects of
radiation on fractures are confounded by the increased risk associated with
postmenopausal status and glucocorticoid treatment (Grigsby et al., 1995; Moreno et al.,
1999). High total doses of radiation, both acute and fractionated, can reduce the ultimate
strength of irradiated bones (Baxter et al., 2005a; Hopewell, 2003; Nyaruba et al., 1998;
Pitkanen and Hopewell, 1983). Pelvic bones absorb 60-70% of the total dose targeting
nearby anal, prostate, or gynecologic tumors (Konski and Sowers, 1996; Moreno et al.,
1999). Insufficiency fractures of the sacrum, sacroiliac joint, pubis, ilium, acetabulum,
femoral neck, knee, clavicle, humerus, ribs, and mandible are well documented in
patients receiving radiotherapy (Bliss et al., 1996; Blomlie et al., 1996; Grigsby et al.,
1995; Howland, 1975; Huh et al., 2002; Moreno et al., 1999; Ogino et al., 2003;
Overgaard, 1988). These fractures occur without significant trauma following atrophy
and reduced elastic resistance. Approximately 3-6% of patients receiving radiotherapy
will show symptoms of a pelvic fracture at some point following therapy, however,
incidents in all patients (including asymptomatic individuals) has been estimated to be as
high as 34% (Abe et al., 1992).
The incidence of fracture seems to be correlated with fraction size. In one study, a
significant proportion of patients experienced fractures after 1.8-2 Gy fractionated doses
of radiation up to 60 Gy total, while no patients experienced pathological fractures with
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twice-daily 1.2 Gy fractions (Bolek et al., 1996). Likewise, spontaneous rib fracture
incidence is elevated in patients receiving high dose fractions compared with standard
dose fractions (Hirbe et al., 2006; Overgaard, 1988; Pierce et al., 1992). Risk of rib
fracture has been reported from these reports to be approximately 1.8% (Pierce et al.,
1992). Palliative care radiotherapy is often applied directly to bones as an effective means
to reduce bone pain for bone metastases: 50-80% of patients experience reduced pain,
with estimates of approximately 30-60% achieving complete pain relief (Hartsell et al.,
2005; Sze et al., 2003). These doses are often administered in single fractions of 8-10 Gy
or multifractions of 3-5 Gy, yielding a total of 20-30 Gy doses. However, incidence of
pathological fracture has been shown to be higher following single-dose therapy than
multifraction treatments, increasing fracture risk by 82% (Sze et al., 2003).
Recently, Baxter et al reported that radiation therapy significantly increased the risk
of pelvic fracture within a population of more than 6,000 women over the age of 65
treated for anal, cervical, and rectal cancer (Baxter et al., 2005a). This increased
likelihood of fracture within the irradiated group was elevated at all time points posttreatment. Hip fractures accounted for approximately 90% of all pelvic fractures. Relative
fracture risk was increased 66%, 65% and 216%, for cervical, rectal and anal cancers,
respectively. These fractures result in substantial morbidity and mortality: nearly 20% of
hip fracture patients will die within a year of injury (Baxter et al., 2005a; Lane, 2006).
Mechanically, this may be in part due to reduced toughness of bone exposed to ionizing
radiation as a result of collagen damage, though evidence is limited (Burr, 2002a). As
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such, radiation clearly compromises bone health and can have a severe impact on the
patient’s functional capabilities.
Animal models of radiation injury have revealed that very high doses of irradiation
can impact overall fracture strength of cortical bone (Nyaruba et al., 1998; Sugimoto et
al., 1991). After exposure to a single 50 Gy dose, rabbit tibiae showed increased
endosteal bone resorption by 4 weeks and increased intracortical porosity between 12 and
52 weeks (Sugimoto et al., 1991). Sections of cortical bone from these irradiated
proximal metaphysis showed reduced ultimate strength via three-point bending tests by
12 weeks, with slight recovery by 52 weeks, coincident with the increase in porosity.
Fractionation seems to have a profound effect on changes in fracture strength of the middiaphysis of rat tibiae (Nyaruba et al., 1998). High doses of irradiation (40-60Gy)
administered in 1.25 Gy twice-daily fractions resulted in no changes in maximal load to
fracture, while single total dose application, or higher fractionated doses (2.5 Gy daily),
reduced maximum load to fracture at 40 Gy and 60 Gy, respectively. These changes
occurred despite no observed reduction in bone mineral content; however, it should be
noted that 18 weeks following a single dose of 35 Gy, no change in fracture strength was
reported in rat femora (Maeda et al., 1988).

2.3.5 RANKL: Primary Regulator of Bone Mass and Immune Function
As previously noted, bone mass is a primary contributor to overall bone strength.
(Ammann and Rizzoli, 2003; Heaney, 2003; Lane, 2006). The balance between the rate
of bone formation and resorption directly determines mass. Central to this process is the
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regulation of the number and the activity of cells involved in bone metabolism, namely
osteoblasts and osteoclasts (Blair et al., 2006). Osteoblasts can regulate the
differentiation and activity of osteoclasts, primarily through production of chemical
messengers. Foremost among the cytokines inducing osteoclast formation are receptor
activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG).
RANKL, exists in both soluble and membranous forms. Membrane-bound RANKL is
a member of the tumor necrosis factor superfamily, expressed on the osteoblast/stromal
cell surface as well as by activated T cells (Hofbauer and Heufelder, 2001; Lacey et al.,
1998). RANKL binds to its receptor on the surface of osteoclasts and their precursors,
stimulating osteoclast differentiation, activation, and inducing bone resorption (Lacey et
al., 2000; Lacey et al., 1998; Suda et al., 2001; Suda et al., 1999; Takahashi et al., 1999).
OPG, also a member of the tumor necrosis factor receptor superfamily, competes with
RANK / RANKL binding as a soluble decoy receptor for RANKL, blocking the
pathway (Kostenuik and Shalhoub, 2001; Simonet et al., 1997). Previous studies
confirm this important role of the RANKL/OPG system: Transgenic mice
overexpressing RANKL and OPG-knockout mice (OPG- / -) develop severe osteoporosis
accompanied by increased osteoclast differentiation and activation, low bone-mineral
density, and high bone turnover (Kostenuik and Shalhoub, 2001; Lacey et al., 1998;
Mizuno et al., 2002).
The RANKL / RANK / OPG signaling axis functions as an important mediator of the
immune system in addition to directing skeletal homeostasis (Figure 2.13) (Clowes et al.,
2005; Kong et al., 1999b; Park, 2005). RANK is expressed on dendritic cells, specialized
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cells capable of activating lymphocytes (T and B cells) after detecting foreign molecules
(i.e., bacteria or viruses) and abnormal cells. Helper (CD4+) and cytotoxic (CD8+) T
cells express RANKL as a surface molecule and in soluble form. RANK – RANKL
binding between dendritic cells and T cells functions as a costimulatory signal, enhancing
an initial activation signal that results in T-cell activation (Anderson et al., 1997; Josien et
al., 1999; Park, 2005). Macrophages exposed to RANKL show increased survival,
phagocytic activity, and the capability to activate T cells through antigen presentation
(Park, 2005). Additionally, RANKL has been shown to enhance the role of the immune
system by increasing proliferation and survival of T cells and inhibiting apoptosis in
dendritic cells. The increased survival period for dendritic cells is directly proportional to
the increased stimulation of T cell proliferation (Wong et al., 1997). Thus, RANKL
enhances macrophage and dendritic cell-mediated T cell proliferation and activation.
Furthermore, RANKL stimulates the production of proinflammatory cytokines from
dendritic cells and T cells (Josien et al., 1999; Park, 2005). These cytokines, including
TNFα, IL-1β and IL-6, serve to further mediate immune responses.

2.3.6 T Cell Activation, RANKL, and Bone Loss
Pathological bone loss is partially due to elevated RANKL production following
inflammation and elevated T cell activation (Clowes et al., 2005; Takayanagi et al., 2000;
Tanaka et al., 2005; Walsh et al., 2005; Weitzmann and Pacifici, 2005). The relatively
new scientific field of “osteoimmunology” has arisen as a result of this very close
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Figure 2.13. The activity of the immune system (dendritic cells, activated T
lymphocytes) and osteoblasts on osteoclast differentiation. Production of RANKL is
the primary mediator of these events. Reproduced from: (Boyle et al., 2003).

relationship between bone metabolism and activity of the immune system (Arron and
Choi, 2000). During certain pathological states, T cell activation is enhanced
viainteractions between these lymphocytes and antigen presenting cells, such as dendritic
cells or macrophages. RANKL production from activated T cells can help with the
immune response, but also elevates osteoclast maturation, activity, and bone erosion.
RANKL-induced bone loss is observed in conditions such as rheumatoid arthritis (Kong
et al., 1999a; Stolina et al., 2003; Walsh et al., 2005), periodontis (Liu et al., 2003;
Tanaka et al., 2005), Crohn’s disease (Franchimont et al., 2004), Paget’s disease
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(Hofbauer and Heufelder, 2001), and aseptic loosening of hip implants following the
production of wear-particles (Masui et al., 2005). Mouse models of post-menopausal
(estrogen deficiency) osteoporosis five-weeks after ovariectomy have increased
CD3+/RANKL+ T cells in the bone marrow with increased indicators of bone resorption
(e.g. resorption pits in bone, serum calcium), and decreased markers of bone formation
(e.g. serum alkaline phosphatase activity) (Garcia-Perez et al., 2006). Other cytokines
characteristic of inflammation and immune responses can enhance (TNFα, IL-1β, IL-6)
and potentially inhibit (via IFNγ, though this cytokine can also promote
osteoclastogenesis in vivo) the osteoclastic activity of RANKL, addressing the
complexity of the relationship mediating immune and skeletal responses (Masui et al.,
2005; Takayanagi, 2005; Takayanagi et al., 2000).

2.3.7 Reactive Oxygen Species, Cytokines, and Inflammation: Causes of Pathological
Bone Loss
The production of reactive oxygen species within tissue and cells, as a result of both
normal and pathological stressors can induce bone destruction by directly activating
osteoclasts. Oxidants can lead to tissue damage and inflammation, and are also generated
during these conditions (Anscher et al., 2005; Lean et al., 2005). Oxidative stress has
been shown to increase osteoclast differentiation (Fraser et al., 1996; Lean et al., 2003;
Suda et al., 1993). The administration of antioxidants such as glutathione, Nacetylcysteine (NAC) and alpha lipoic acid (α-La) has been shown to reduce bone
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resorption both in vitro and from in vivo murine studies (Ha et al., 2004; Kim et al., 2006;
Lean et al., 2003)
ROS also can contribute to bone loss during post-menopausal osteoporosis.

In

addition to perhaps promoting osteoclastogenesis by upregulating expression of RANKL
on T cells, a reduction in circulating estrogen can contribute to bone loss by reducing
antioxidant defenses within bone cells (including superoxide dismutase, glutathione,
glutathione reductase, and glutathione peroxidase), resulting in oxidant-induced
osteoclast activation (Garcia-Perez et al., 2006; Ha et al., 2004; Jagger et al., 2005; Lean
et al., 2003; Muthusami et al., 2005). Estrogen-deficiency-induced bone resorption is
reversed in vivo by administration of NAC and mimicked by administration of an
inhibitor of glutathione synthesis, L-buthionine-(S,R)-sulphoximine (BSO) (Jagger et al.,
2005; Lean et al., 2003).
Oxidants act as second messengers within cells. Many of the intracellular molecular
signals required for osteoclast differentiation, activation, and survival, including: NF-кB;
c-Jun amino-terminal kinase (JNK); p38 mitogen-activated protein kinases (MAPKs)
such as extracellular signal-regulated kinases (ERKs); and Akt are activated by oxidative
stress (Bai et al., 2004; Ha et al., 2004; Lean et al., 2005; Nagata, 2005). RANK-RANKL
binding results in an increase in ROS concentration within cells, particularly hydrogen
peroxide (Ha et al., 2004; Kim et al., 2006). Antioxidants (i.e. NAC, glutathione, and αLa) have been shown to reduce RANKL-induced elevation in intracellular ROS with
subsequent impacts on signaling cascades. For example, these antioxidants inhibit the
activation of NF-кB and ERK following osteoclast stimulation with RANKL and
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RANKL/TNFα, as well as blocking NF-кB-DNA binding (Ha et al., 2004; Kim et al.,
2006). Typically, osteoclasts are short-lived cells with survival prolonged due to
RANKL-mediated activation of transcription factors such as Akt, which upregulates the
antiapoptotic molecules of the Bcl-2 family and inhibits the apoptotic molecule Bad (Ha
et al., 2004). ROS are required for RANKL activation of Akt. Additionally, oxidants
produced following RANKL stimulation enhances formation of actin rings, structures
required for the osteolytic function of osteoclasts (Ha et al., 2004).
Hydrogen peroxide can also serve an autocrine or paracrine role in bone resorption.
Activated osteoclasts and their precursors secrete hydrogen peroxide, which can activate
surrounding osteoclasts upon diffusion through the cell membrane, particularly following
stimulation with RANKL (Bax et al., 1992; Ha et al., 2004; Hall et al., 1995; Kim et al.,
2006; Lean et al., 2003; Lean et al., 2005; Steinbeck et al., 1998). The RANKL-induced
increase in ROS are at least partially dependent on NADPH oxidase within osteoclasts
(Kim et al., 2006). As previously noted, NADPH oxidase plays a critical role in the
generation of ROS, especially during respiratory burst activity in phagocytes (Bokoch,
1995; Forman and Torres, 2001; Forman and Torres, 2002). Thus, hydrogen peroxide
may serve as a local autocrine or paracrine factor, further enhancing the resorbing activity
of ostoclasts in the surrounding tissue and leading to pronounced bone loss during
conditions such as post-menopausal osteoporosis (Bax et al., 1992; Hall, 1994;
Muthusami et al., 2005; Steinbeck et al., 1998).
Cytokines also play vital roles in bone loss, particularly in combination with ROS.
The production of RANKL itself can be modified by reactive oxygen species (Bai et al.,
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2005). Both hydrogen peroxide and superoxide stimulate RANKL production from
osteoblasts and primary mouse bone marrow stromal cells. Proinflammatory cytokines
such as TNFα, IL-1β, and IL-6 are active stimulators of bone resorption and characteristic
of many inflammatory diseases leading to bone loss (Lam et al., 2000; Walsh and Choi,
2003; Walsh et al., 2005; Wang et al., 2004; Weitzmann and Pacifici, 2005). Hydrogen
peroxide can cause an increase in TNFα, IL-1, and IL-6 (Lean et al., 2005). These
cytokines have been shown to induce osteoblast production of RANKL and to directly
activate osteoclasts (Clowes et al., 2005; Walsh and Choi, 2003). TNFα is a strong
promoter of osteoclastogenesis, even synergyistically acting together with small
quantities of RANKL to promote osteoclast development in macrophages (Lam et al.,
2000). IL-1 and TNFα increase intracellular ROS, which elevate osteoclast survival and
function by impacting molecular signaling pathways, such as NF-κB. (Roggia et al.,
2001; Sauer et al., 2001; Thannickal and Fanburg, 2000). As extracellular calcium levels
increase, expression of IL-6 and IL-6 receptor genes increases (Zaidi et al., 2003). As IL6 can prevent osteoclast recognition of extracellular calcium levels that otherwise would
serve an inhibitory role in bone resorption, IL-6 can act as an autocrine and paracrine
signal resulting in elevated bone resorption. Increased levels of TNFα, IL-1β, IL-6 are
also associated with post-menopausal osteoporosis, as estrogen normally suppresses
expression of these cytokines (Clowes et al., 2005; Lean et al., 2003; Roggia et al., 2001).
Though the majority of studies examining the effects of reactive oxygen species on
bone metabolism have reported increased osteoclast activation, survival, and function
leading to elevated resorption, some evidence suggests that bone formation may also be
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impaired by oxidants. Conditions of oxidative stress have been shown to inhibit
osteoblast differentiation in mouse and rabbit osteoblasts and stromal cells (Bai et al.,
2004; Mody et al., 2001). Hydrogen peroxide leads to reduced alkaline phosphatase
expression and production and type I collagen formation, both markers of bone
formation. ROS were shown to inhibit phosphorylation of the transcription factor Runx2
due to downstream effects on ERK and NF-кB activation. Runx2 controls expression of a
variety of genes within the osteoblast, including osteocalcin, ALP, and type I collagen
(Bai et al., 2004; Lian et al., 2004).

2.3.8 Radiation, Inflammation, and Late Effects
Inflammation and related normal tissue injury are characteristic of various tissues
following exposure to ionizing radiation, and elevated inflammatory cytokine levels is an
early yet sustained response of tissues to radiation (Hosoi et al., 2001; Robbins and Zhao,
2004; Rubin et al., 1995; Van der Meeren et al., 2003; Yeoh et al., 2006). The response is
characterized by the early activation of stress-sensitive kinases, proinflammatory
transcription factors, and the upregulation and production of proinflammatory cytokines
and chemokines, enhancing the attraction and activation of leukocytes. Elevated cytokine
levels increase in both irradiated tissue and in circulating serum, contributing to the local
and systemic inflammation observed after irradiation (Anscher et al., 2005; Rubin et al.,
1995; Van der Meeren et al., 2003). The increase in the production of proinflammatory
and profibrotic cytokines is near immediate after tissue irradiation and includes IL-1α ,
IL-1β, IL-6, TNF α , and IFNγ (Akmansu et al., 2005; Barcellos-Hoff, 1998; Bentzen,
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2006; Ibuki and Goto, 1999; Liu, 2003; Narayanan et al., 1999; O'Brien-Ladner et al.,
1993; Rubin et al., 1995; Van der Meeren et al., 2003; Vujaskovic et al., 2001).
Monocytes, macrophages, lymphocytes, fibroblasts, and endothelial cells have been
observed to increase expression and production of these chemicals post-irradiation.
The inflammatory response post-irradiation is also characterized by increases in cell
adhesion molecules necessary for leukocyte arrest and extravasation of these cells into
damaged tissue (Quarmby et al., 1999; Robbins et al., 1993). Leukocyte arrest within the
vasculature of irradiated tissue and accumulation in the tissue is present in this tissue for
weeks post exposure (Molla et al., 2003; Robbins et al., 1993). The expression of
glycoproteins involved in slowing leukocytes by rolling prior to transmigration (E- and PSelectin) has been shown to increase after irradiation and by proinflammatory cytokines
IL-1 and TNFα (Molla et al., 2001; Quarmby et al., 1999). P-selectin expression has been
shown to increase on pulmonary vasculature within minutes following irradiation
(Quarmby et al., 1999). An increase in ROS-mediated elevation in NF-κB activation
following irradiation may play a role in the increased expression of E-selectin, as this
transcription factor binds to the promoter region of the E-selectin gene (Hallahan et al.,
1995).

Likewise,

increasing

the

concentration

of

glutathione

can

decrease

proinflammatory cytokines and chemokines (recruit leukocytes) produced from lung cells
by reducing hydrogen peroxide-mediated activation of the transcription factors NF-κB
and AP-1 (Rahman et al., 2005). Intercellular adhesion molecule 1 (ICAM1), an adhesion
molecule involved in leukocyte arrest, will exhibit increased expression for several days
after irradiation in urinary bladder and intestinal endothelial cells (Hallahan et al., 1996;
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Jaal and Dorr, 2005; Molla et al., 2003). Both IL-1 and ionizing radiation can cause
endothelial cells to increase production of IL-8, a chemokine that can activate β2
integrins on leukocytes (Gaugler et al., 2001; Quarmby et al., 1999). ICAM1 binds β2,
assisting with arrest. Vascular cell adhesion molecule 1 (VCAM1) expression on
endothelial cells is also expressed, binding to α4β1 integrin on circulating monocytes and
neutrophils and are important in leukocyte recruitment into tissue at later time-points than
ICAM1 following exposure (Molla et al., 2003). CD-31, a molecule important in the
transmigration of leukocytes from vasculature into tissue, is likewise increased on
irradiated endothelial cells following irradiation (Gaugler et al., 2001). Activated
leukocytes within tissues will then produce ROS (Rahman et al., 2005). Taken together,
an inflammatory response occurs following irradiation.
The inflammatory response that occurs post-irradiation resembles a wound healing
response. However, the response becomes ongoing, with waves of cytokines produced as
a result of ongoing cell and tissue damage ultimately leading to tissue necrosis, fibrosis,
atrophy, and vascular damage (Bentzen, 2006; Robbins and Diz, 2006; Robbins and
Zhao, 2004; Stone et al., 2003). These late effects are viewed in several organs and organ
systems, including chronic renal failure, obstructive lung disease, idiopathic pulmonary
fibrosis, fibrosis and tissue necrosis of the skin, demyelination of nervous structures,
brain vascular damage, necrosis of white matter, and cognitive impairment (Anscher et
al., 2005; Robbins and Zhao, 2004; Vujaskovic et al., 2001). Radiation-induced damage
to microvasculature, endothelial cells, and increased numbers of activated macrophages
within irradiated rat lungs were shown to be associated with long-term hypoxia
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(Vujaskovic et al., 2001). The observed hypoxia, increased proliferation and activity of
macrophages, and profibrotic cytokine production from macrophages and fibroblasts
resulted in lung fibrosis over a period of 6 months. Hypoxia itself can increase the
cellular production of ROS (Vujaskovic et al., 2001). Chronic oxidative stress is
associated with radiation-induced late tissue injury in several organs, including the
kidney and lungs (Robbins and Zhao, 2004). The production of proinflammatory and
profibrotic cytokines in irradiated tissues such as the lung as well as the presence and
progression of late functional damage can be reduced by treatment with antioxidant
enzymes (such as SOD) (Khan et al., 2003; Robbins and Zhao, 2004). Elevated hypoxic
conditions, increased ROS, immune activation, and cytokine production following
irradiation can thus interact to enhance cell death, and further tissue injury (Akmansu et
al., 2005; Quarmby et al., 1999; Robbins and Zhao, 2004; Vujaskovic et al., 2001).
Within the bone microenvironment, an inflammatory-type response involving
increased macrophage activity and massive reduction in the number of hematopoietic
cells within marrow has been documented from C57BL/6 mice very early after 4 Gy
gamma irradiation (Lorimore et al., 2001). Phagocytic activity from macrophages was
increased within bone marrow by 24 hours post-irradiation, as indicated by elevated
membrane ruffling, lysosomal number and size, lysosomal acid β-galactosidase activity,
and iNOS production coincident with a 74% reduction in tissue cellularity of the marrow.
Although phagocytic clearing of the apoptotic marrow cells following irradiation is
associated with this inflammatory response, neither apoptosis nor necrosis of tissue could
not account for the entirety of the response as the activity remained high despite
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clearance of the majority of apoptotic cells. Despite the cause of the increased phagocytic
activity, the increase in activated macrophages and inflammation within bone after
irradiation as well as physiological changes that occur as a result of irradiation (including
the aforementioned reduction in vascularity in bone) could induce osteoclastogenesis and
bone loss.
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CHAPTER 3: INVESTIGATION OF BONE ARCHITECTURAL AND
STRUCTURAL PROPERTIES IN SHIELDED HIND LIMB LONG BONES
FROM RATS EXPOSED TO 56Fe26+ RADIATION

3.1 Introduction
Understanding health risks associated with exposure to the space environment has
become a priority as plans develop for long-duration, manned exploration of the Moon
and Mars. Astronauts face unique environmental conditions in space that have an impact
on normal physiological processes and health. Numerous investigations have provided
insight into the body’s response to microgravity and have documented the resultant
muscle atrophy, cardiovascular effects, and immune system impacts, among others
(Gridley et al., 2006; Smith et al., 2005; Tesch et al., 2005; Vazquez, 1998). Bone loss is
observed in astronauts exposed to microgravity, particularly within skeletal support
elements (i.e., lower extremities, pelvic girdle, or lumbar vertebrae) (Lang et al., 2004;
Turner, 2000). Radiation exposure is another challenge of the space environment that will
be faced during exploratory missions. During long voyages, astronauts will receive doses
of ionizing radiation due to constant bombardment by high energy (E), high charge (Z)
particles (HZE) of galactic cosmic rays. Intense bursts of protons released from the sun
during solar particle events, such as solar flares and coronal mass ejections, will also
contribute (Mortazavi et al., 2003; Todd, 2003). However, it is uncertain what role
radiation exposure may play in microgravity-induced bone loss.
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During missions outside the magnetosphere, astronauts will be exposed to chargedparticle species from all stable elements (H, He, C, O, and Fe are considered the most
important) (Guida et al., 2005; Vazquez, 1998). Protons make up approximately 87% of
the fluence of galactic cosmic radiation, which is present at an essentially constant, low
dose rate approximately 100-fold greater than at the Earth’s surface (Durante and
Kronenberg, 2005). Additionally, unpredictable solar particle events can deliver high
doses of proton radiation: as much as 3 Gy over a period of hours to days (Townsend et
al., 1991). However, the health risks from heavy-ion radiation may be even greater. Highenergy

56

Fe26+ nuclei are of particular interest because their dense tracks of ionization

result in high relative biological effectiveness, which is associated with concentrated,
poorly repairable damage within organisms. Production of secondary fragments by
56

Fe26+ nuclei is also of concern (Brooks et al., 2001).
Bone damage occurs following exposure to low linear energy transfer (LET) ionizing

radiation (gamma and X-rays) and is thought to be a result of physiological changes that
occur to both vasculature and bone cells, such as bone-forming osteoblasts and resorbing
osteoclasts (Hopewell, 2003; Konski and Sowers, 1996; Mitchell and Logan, 1998).
Previous studies suggest that osteoclast numbers remain unchanged in cultures of γ- and
carbon-irradiated preosteoblasts cultured with normal bone marrow (Sawajiri et al.,
2006). Nevertheless, clinical studies have demonstrated an increased fracture risk
following radiotherapy (Baxter et al., 2005a; Huh et al., 2002). The type and dose of
radiation used for clinical purposes is quite different than those relevant to space
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exploration; therefore, it is unclear if these observations are applicable to the space
environment.
Although the effects of HZE radiation on bone health are relatively unknown, we
recently identified profound loss of trabecular bone following whole-body exposure to 2
Gy doses of iron (-34%), carbon (-39%), gamma (-29%), or proton (-35%) radiation
(Hamilton et al., 2006). Despite the qualitative differences in these types of ionizing
radiation, their detrimental effect on mouse bone health appears to be similar. These
doses and types of radiation are relevant to space exploration and raise questions about
the potentially substantial impact of radiation on astronaut bone health.
The purpose of the present study was to quantify the long-term systemic effects of
56

Fe26+ radiation on bone architecture and turnover by excluding the hind limbs

(particularly the tibiae) from whole-body irradiation.

56

Fe26+ ions are among the most

potent HZE particles present in the space environment and contribute disproportionately
in terms of their numbers to significant health risks (Durante and Kronenberg, 2005). For
that reason, we intend to quantify how various levels of

56

Fe26+ irradiation affect bone

physiology and microarchitecture in rats, which have greater bone mass than mice. Our
primary

objective

was

to

conduct

an

observational

comparison

of

bone

histomorphometric parameters between shielded tibiae from irradiated rats and tibiae
from non-irradiated rats.
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3.2 Materials and Methods
3.2.1 Animals and Whole-Body Irradiation
Forty 9-week old male Sprague-Dawley rats (Harlan; Indianapolis, Indiana) were
shipped directly from the vendor to Brookhaven National Laboratory (BNL) and
acclimatized for one week. All protocols were approved by the appropriate Institutional
Animal Care and Use Committees at BNL and Loma Linda University (LLU). Rats were
given access to food and water ad libitum and kept in a temperature-controlled (18-26°C)
and light-controlled (12 hour light/dark cycle) environment. Thirty rats were randomly
selected for radiation exposure (treatment groups), while ten control rats received no
radiation. For irradiation, all rats were anesthetized using 1.5% isoflurane and placed
supine in an acrylic chamber in which their head positions were established using a bite
bar fixture. The chamber was mounted on a pre-aligned beam line fixture using fiducial
pins. The beam dimensions for the Alternating Gradient Synchrotron (AGS) A-3 beam
line were established by the 15.24 cm diameter beam pipe and upstream beam plug
elements which served to collimate the beam to an approximately 15 cm wide by 14 cm
high elliptical profile with a 0.5 cm concave lower shielded margin. This beam line used
for AGS experiment 960 has been described (Zeitlin et al., 1998). The animals were
centered vertically and placed horizontally such that the nose was a few millimeters from
the right beam margin. The left beam margin was near the anterior femoral head such that
all major internal organs were irradiated except the posterior gastrointestinal tract. The
original experimental design had behavioral objectives and did not include bone
measurements. The use of the archived bone tissue was arranged post-irradiation so the
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exposure conditions were not optimized for the latter purpose. Kodak X-Omat X-ray
films (Eastman Kodak; Rochester, NY) were placed behind the animals to define the
irradiated portions of the body and to establish dose uniformity. The films were scanned
with a clinical X-ray scanner along the animals’ long axis which established a spot width
at this position of 14.3 cm (FWHM) and a dose uniformity of +/- 6%. At the edge of the
field the intensity dropped to 10% of the plateau value over 8.4 mm and 5% over an
additional 6 mm. The dose beyond 14.5 mm was 0 Gy (background levels); this includes
the proximal tibia, the primary area of analysis. The proximal femur received
approximately 5% of the central beam dose. These partial doses (10% and 5%) are made
up scattered secondary particles of lower LET (not iron particles). They are generally
small Z value particles, and having less momentum are more likely to scatter.
The experiment was part of NASA-funded experimental collaboration BNL-9 in
November 2002. The primary radiation was 5 GeV/μm 56Fe26+ ions delivered at dose rate
of approximately 1.5 Gy/min as eighteen half-second spills per minute. The track
averaged LET for the particles was approximately 143 keV/μm. It should be noted that
for such high energy particles, scattered secondary electrons (delta rays) may have
maximum ranges exceeding 1 cm which would contribute to the structure of the beam at
its margin. Treated animals received 1, 2, and 4 Gy of radiation. Following irradiation,
the rats were returned to their cages; no abnormal behaviors were observed during or
after irradiation. Within 72 hours of irradiation, the rats (both treatment and controls)
were shipped to LLU. The rats were humanely killed nine months after exposure.
Animals were examined for the presence of tumors; animals with tumors were removed
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from analyses, thus reducing the number of samples in the study (0 Gy n = 8; 1 Gy n = 9;
2 Gy n = 7; 4 Gy n = 7). Hind limbs were removed and fixed in a solution of 4%
paraformaldehyde in 0.12 mM Millonig’s buffer (pH 7.3) and shipped to Clemson
University.

3.2.2 Serum Analyses
Samples of whole blood were collected and serum was separated. Markers of bone
turnover present in the serum were analyzed using a Toshiba Chemistry Autoanalyzer,
including phosphorus, calcium, alkaline phosphatase (ALP) and tartrate-resistant acid
phosphatase (TRAP). An ELISA (Biomedical Technologies Inc; Stoughton, MA) was
performed to detect serum levels of the anabolic marker osteocalcin.

3.2.3 Bone Architectural Analyses
Architectural analyses were performed on right hind limbs: bones were cleaned of soft
tissue, and the tibiae and femora were separated. Right femora were weighed and
morphological data obtained. Tibiae were evaluated for trabecular microarchitecture and
cortical parameters using microcomputed tomography (microCT, Scanco Medical;
Bassersdorf, Switzerland), allowing cortical structure and trabecular microarchitecture to
be imaged at 11 μm voxel size (Figure 3.1). To analyze the trabecular architecture, a 5
mm section of bone distal to the proximal growth plate was selected for evaluation.
Evaluation was performed on a total of 80 slices at identical locations within each tibia
distal to the growth plate. Trabecular bone volume fraction (BV/TV), connectivity
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Figure 3.1. MicroCT images of the proximal tibiae from rat bones irradiated with 0
Gy (A), 1 Gy (B), 2 Gy (C), and 4 Gy (D) 56Fe26+ radiation. The image is from a
superior perspective (top of tibia) down through the tibial plateau toward the ankle.
Scale bar is 1 mm.
density (Conn.Dens) trabecular thickness (Tb.Th), trabecular number (Tb.N), and
trabecular spacing (Tb.Sp) were determined by the software for each sample.
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The diaphyses of these same tibiae were analyzed to examine cortical bone volume
and porosity. Fifty slices from the shaft immediately proximal to the tibial-fibular
junction were analyzed using the microCT to calculate volume, cortical porosity, and
polar moment of inertia (pMOI). For polar moment of inertia, the Scanco software
provided the principle moments of inertia for each chosen cross section (Ixx and Iyy).
Polar moment was determined as the composites of these principle moments of inertia
(Ixx + Iyy) for the many (infinite) neutral axes for a given cross section.

3.2.4 Mineral Composition
Compositional constituents of the femora and tibiae were assessed. Bones were
weighed using a Mettler-Toledo scale (MT2, Mettler-Toledo; Greifensee, Switzerland)
and then placed in an oven at 105°C for 24 hours to obtain a dry mass (Dry-M) and then
ashed at 800°C for 24 hours to remove all the organic constituents. A final weight was
used to obtain a mineral mass (Min-M). The percent mineralization (% Min) of the bones
was calculated using the following formula: %Min = Min-M/Dry-M x 100

3.2.5 Statistical Evaluation
These data were tested for statistical significance using SAS/STAT software (SAS,
Inc.; Cary, NC). Initial differences in bone histomorphometric indices and final analyses
of serum and mineralization data were determined using one-way ANOVA, with a Tukey
post hoc test to determine differences between groups.
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The stresses and strains imparted upon cortical and trabecular bone as a result of body
mass through the lifespan of the rat will influence histomorphometric indices. Therefore,
an analysis of covariance (ANCOVA) was performed in order to more appropriately
comment on the effects of radiation dose on bone status by accounting for animal mass.
Tukey’s post hoc analyses of ANCOVAs were performed to determine significant
differences between groups. A P-value of < 0.05 was considered statistically significant.
All data are presented as mean + standard error of the mean.

3.3 Results
3.3.1 Animal, Tibial, and Femoral Masses
Animal mass for all treatment groups was less than control-group mass at 9 months
post-irradiation (Table 3.1), though the difference for the 2 Gy group was not significant.
Individual animals in the 1 Gy and 4 Gy groups were significantly smaller than control,
having approximately 10% and 19% less mass, respectively (P < 0.001). At sacrifice, no
differences were observed in tibial mass between groups. Femoral mass from only the 4
Gy group was significantly different from control: The femoral mass from the 4 Gy group
was ~ 10% smaller (P < 0.05).
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Control
554 + 8
0.721 + 0.008
0.987 + 0.028
20.8 + 1.0
43.4 + 3.3
3.18 + 0.11
90.0 + 1.7
284 + 12
1.45 + 0.03
3.29 + 0.06
9.27 + 0.29
66.1 + 0.9
62.8 + 0.6

1 Gy
500 + 7 a
0.686 + 0.012
0.912 + 0.020
20.0 + 0.9
38.7 + 2.5
3.04 + 0.09
90.0 + 1.8
298 + 9
1.49 + 0.02
2.99 + 0.05 b
7.48 + 0.27 b
64.8 + 0.9
62.5 + 0.2

2 Gy
522 + 11
0.728 + 0.008
0.937 + 0.012
16.7 + 1.3 c
29.5 + 3.3 c
2.77 + 0.13
88.0 + 0.9
336 + 21
1.60 + 0.14
3.14 + 0.07
8.38 + 0.40
64.4 + 0.6
61.5 + 0.4

449
0.679
0.889
15.3
31.2
2.84
82.0
328
1.53
3.03
7.99
64.6
62.1

4 Gy
+ 12 a
+ 0.017
+ 0.024 c
+ 0.7 b
+ 2.2 c
+ 0.09
+ 1.5 c
+ 12
+ 0.04
+ 0.04 c
+ 0.41 c
+ 0.5
+ 0.4

Table 3.1. Comparison of the absolute means for animal mass, tibial and femoral masses, cortical parameters, and percent
mineralization of the shielded femora and the tibiae
Animal Mass at Sacrifice (g)
Tibial Mass (g)
Femoral Mass (g)
BV/TV (%)
Conn.Dens. (1/mm3)
Tb.N. (1/mm3)
Tb.Th. (µm)
Tb.Sp. (µm)
Cortical Porosity (%)
Cortical Volume (mm3)
pMOI (mm4)
% Mineralization (Femora)
% Mineralization (Tibiae)

Notes: Mean + SEM. Statistics performed using one-way ANOVA with Tukey post hoc tests. a P < 0.001; b P < 0.01; and c P <
0.05 versus control.
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3.3.2 Percent Mineralization
The percent mineralization was calculated for a) the proximal epiphysis, diaphysis,
and whole tibia, and b) the head, proximal epiphysis, diaphysis, and whole right femur
from each rat. No changes were observed in the percent mineralization of any specific
site within the bones or between the whole bones of the different groups. Only wholebone mineralization data are reported (Table 3.1).

3.3.3 Trabecular Microarchitecture
BV/TV within the proximal epiphysis were significantly less than the control in the 2
and 4 Gy groups by approximately 20% (P < 0.05) and 26% (P < 0.01), respectively,
when compared using ANOVA (Figure 3.2). The connectivity density of trabeculae
within the epiphyses was also significantly reduced at these higher radiation levels
(Figure 3.2). Conn.Dens, for each of the 2 and 4 Gy groups was 32% and 28% less than
control, respectively (P < 0.05). Tb.Th. was significantly lower in the 4 Gy group then
control and the 1 Gy group (P < 0.05). No differences were observed in Tb.N. or Tb.Sp.
(3. 1, Figure 3.2).
Significant radiation effects were reported for BV/TV, Conn.Dens., and Tb.Th. after
testing the variables with an ANCOVA, which accounts for final animal mass (3.2).
BV/TV was significantly lower in the 2 Gy group as compared with the control and 1 Gy
groups (P < 0.05). Likewise, Conn.Dens. from 2 Gy individuals was significantly less
than control and 1 Gy individuals (P < 0.05). Animals in the 2 Gy group were larger than
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Figure 3.2. Bone histomorphometric indices from the proximal tibiae of rats after
Fe26+ radiation. Panel A: Bone volume fraction (BV/TV); Panel B: Trabecular
thickness (Tb.Th.); Panel C: Trabecular spacing (Tb.Sp.); Panel D: Connectivity
density (Conn.Dens.); Panel E: Trabecular number (Tb.N.). Plotted values are
means + standard error of the mean (SEM). Data were compared using a one-way
ANOVA and a Tukey post hoc analysis to identify significant differences established
at α = 0.05. (+) indicates P < 0.01 and (*) indicates P < 0.05.
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other treatment groups (Table 3.1), and thus the lower BV/TV and Conn.Dens. relative to
non-irradiated control remained significant despite accounting for final size of the
individuals. After accounting for mass, no differences were observed in Tb.N. and Tb.Sp.
However, Tb.Th. from the 4 Gy group is significantly less than all other groups even after
adjusting for body mass (P < 0.05).

3.3.4 Cortical Bone
The diaphyses of the scanned tibiae were analyzed for changes in cortical parameters
using absolute means (Table 3.1) and adjusting for final animal mass (Table 3.2).
Comparing absolute means, the volume of cortical bone located approximately 0.5 mm
proximal to the tibial-fibular junction was significantly decreased (P < 0.01) from the
control in animals irradiated with 1 Gy (-9.5%) and 4 Gy (-8.1%) (P < 0.05).

56

Fe

radiation. PMOI was significantly smaller at this location in the 1 Gy (-19%, P < 0.01)
and 4 Gy (-14%, P = 0.05) groups (Table 3.1). However all differences became
insignificant when accounting for body mass (Table 3.2). Cortical porosity was
unchanged in the irradiated diaphyses.

3.3.5 Serum markers
Table 3.3 summarizes the bone turnover markers from plasma. Tartrate Resistant Acid
Phosphatase (TRAP), a biochemical indicator of bone resorption, was significantly
elevated in the 1 Gy group over control by approximately 35% (P < 0.05). No differences
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were observed in the concentration of the other indicators of bone metabolism (i.e.,
alkaline phosphatase, osteocalcin, calcium, or phosphorus) in irradiated groups.

F value
3.49
3.24
3.43
2.37
2.64
1.01
2.41
2.66
P
0.03
0.04
0.03
0.09
0.07
0.91
0.40
0.07

Control
LSM
SE
19.3 + 1.1
39.5 + 3.5
90.4 + 2.0
2.99 + 0.12
309 + 15
3.22 + 0.07
1.45 + 0.08
8.79 + 0.45

1 Gy
LSM
SE
20.1 + 0.9
38.4 + 2.7
90.2 + 21.5
3.02 + 0.09
298 + 12
3.01 + 0.05
1.48 + 0.06
7.62 + 0.30

2 Gy
LSM
SE
16.0 + 1.0 a
27.9 + 3.1b
88.3 + 1.8
2.69 + 0.11
345 + 14
3.10 + 0.07
1.60 + 0.07
8.14 + 0.41

4 Gy
LSM
SE
17.4 + 1.5
36.7 + 4.4
81.5 + 2.5 c
3.09 + 0.15
291 + 19
3.13 + 0.10
1.49 + 0.10
8.64 + 0.74

Table 3.2. Parameters of trabecular architecture in the proximal tibiae of rats following irradiation analyzed
for covariant relationship with animal mass

BV/TV (%)
Conn.Dens. (1/mm3)
Tb.Th (µm)
Tb.N. (1/mm3)
Tb.Sp (µm)
Cortical Volume (mm3)
Cortical Porosity (%)
pMOI (mm4)

Notes: Least Squares Mean (LSM) + Standard Error of the Mean (SE). Statistics performed using one-way
ANCOVA with Tukey post hoc tests. Degrees of freedom = 3,1. Significant differences determined by P < 0.05
and indicated numerically in the table. a = significant difference versus control; b = differences versus control and
1 Gy; c = difference versus control, 1 Gy, and 4 Gy.
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Table 3.3. Serum markers of bone resorption and formation in rats nine months
after irradiation
TRAP (U/L)
Osteocalcin (ng/ml)
Alkaline Phosphatase (µg/L)
Calcium (mg/dL)
Phosphorus (mg/dL)

Control
2.96 + 0.19
4.07 + 0.36
137 + 13.0
10.5 + 0.11
4.97 + 0.20

3.96
4.07
156
10.5
5.09

1 Gy
+ 0.28 a
+ 0.32
+ 10.5
+ 0.13
+ 0.29

3.30
4.65
170
10.3
4.95

2 Gy
+ 0.30
+ 0.13
+ 13.3
+ 0.11
+ 0.14

3.70
4.51
168
10.3
5.69

4 Gy
+ 0.29
+ 0.43
+ 19.2
+ 0.35
+ 0.72

Notes: Mean + SEM. For comparisons of serum markers at control and 1, 2, and 4 Gy
56
Fe, statistics performed using one-way ANOVA with Tukey post hoc tests. a P < 0.05
versus control.

3.4 Discussion
The present study reports that exposure to 56Fe26+ irradiation has a negative impact on
bone microarchitecture and structure in rats even when hind limbs are excluded from the
radiation beam. Compared to control, irradiated animals exhibited less BV/TV, Conn.
Dens., and Tb.Th. after exposure to doses greater than 2 Gy. These changes in bone
parameters were directly related to final animal body mass. Indicators of bone
metabolism (mineral content, cortical porosity, serum protein analyses) were generally
unchanged between groups, suggesting stabilized bone turnover at nine-months.
Therefore the reduction in bone volume and impaired microarchitecture are likely
permanent adaptations.
By affecting trabecular bone volume and connectivity, higher doses (especially above
2 Gy) of 56Fe26+ radiation have the potential to weaken trabecular microarchitecture, even
in bones that are not directly exposed to radiation. The connectivity of the struts and the
number and thickness of trabeculae can affect efficient transfer of forces throughout the
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bone. The greater the Conn. Dens., the shorter the length of the unsupported strut length
within the trabecular lattice of the metaphysis. The strength of the trabecular bone strut is
inversely proportional to the square of the unsupported length (Currey, 2002; Davison et
al., 2006). Thus, by increasing the length of existing trabeculae through a reduction in
connectivity, the critical buckling load can be reduced.
Changes in cortical bone (including structural properties such as polar moment of
inertia) occurred following irradiation. Although absolute cortical volume measurements
decreased with increasing doses of 56Fe26+ radiation (within the 1 and 4 Gy groups), the
observed differences in volume were no longer present when changes in mass were
considered. Polar moment of inertia, a structural measure of resistance to torsion, is the
composite of bending moment of inertia in a sample. The calculated values for pMOI are
therefore concise methods of representing structural competency for torsional loads. This
parameter is also therefore dependent on geometry of the bone (the amount and
distribution of the bone within the area of interest), and has been shown to be directly
related with body mass (Tommasini et al., 2005). Accordingly, the values for pMOI
decreased following radiation treatments. Again, the significant differences were
removed when adjusting values of PMOI for mass.
Variation in final animal mass accounted for much of the observed variance in bone
parameters (Table 3.2). Smaller animal mass presumably reduced skeletal loads on nonirradiated bone and in accordance with Wolff’s Law, resulted in lesser volume of bone.
Body mass is closely linked with health status of an animal. Several factors may have
affected body mass and bone volume following irradiation. Observations from the
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primary immune component of this study seems to indicate compromised health of these
animals, such as kidney or liver dysfunction, indicated by decreased blood glucose,
albumin, uric acid, and increased blood urea nitrogen (Manuscript Submitted). Impaired
growth following irradiation could also account for these changes in bone, as the rats
were ten weeks old at the time of irradiation and skeletal growth has been shown
previously to slow until approximately sixteen weeks of age (Roach et al., 2003). It is
known that irradiation impairs the overall growth of bones in the body (Brownstein et al.,
2004; Eifel et al., 1995), and radiation damage to the hypothalamic-pituitary axis can
result in growth-hormone deficiency and reduced growth (Darzy and Shalet, 2005;
Odame et al., 2005; Schmiegelow et al., 2003).
Systemic factors produced as a result of tissue irradiation cannot be discounted as
contributing to the observed bone atrophy. The reduction in mass alone did not account
for the significantly smaller Tb.Th. in the 4 Gy group relative to control (Table 3.2).
Elevated cytokine levels (including IL-1α , IL-1β, IL-6, TNF α) have been observed to
increase in both irradiated tissue and in circulating serum, resulting in local and systemic
inflammation (Akmansu et al., 2005; Anscher et al., 2005; Hosoi et al., 2001; Robbins
and Zhao, 2004). Analysis of cytokine production from splenocytes cultured from these
animals indicate that TNFα levels are elevated at levels approaching marginal
significance nine months after 4 Gy irradiation (P = 0.056, Manuscript Submitted). TNFα
is an active stimulator of bone resorption and is characteristic of many inflammatory
diseases, leading to bone loss (Walsh et al., 2005; Weitzmann and Pacifici, 2005). As the
limbs were excluded from the beam, circulating cytokines could affect bone metabolism
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at distant sites, including the tibia. TNFα levels are also associated with conditions of
cachexia, which is characterized by weight loss due to abnormal catabolism of muscle,
fat, and carbohydrates (Saini et al., 2006). Circulating TNFα could therefore influence
body mass and bone metabolism directly, affecting bone volume in multiple ways.
There is a paucity of studies that have examined the effects of particle radiation on
bone quantity, quality, and turnover. Our previous investigations have revealed that direct
exposure to photon, proton, and heavy ion radiation can significantly reduce bone volume
and impair microarchitecture in a mouse animal model, as quantified via microCT
(Hamilton et al., 2006). The loss of bone after HZE irradiation is in contrast with a
histological investigation documenting an increase of BV/TV in the proximal tibia of
weanling rats (irradiated at 3 weeks) after exposure to very high acute doses (>15 Gy) of
carbon ions (Sawajiri and Mizoe, 2003). Other studies of 2-6 Gy carbon-irradiated preosteoblasts co-cultured with bone marrow revealed that the osteoclast numbers tend to
decrease versus non-irradiated cells (Sawajiri et al., 2006). Similarly, the concentration
ratio of the Receptor Activator of NF-κB Ligand (RANKL) to osteoprotegrin (OPG)
mRNA tended to decrease in these cultures. RANKL binds to its receptor (RANK) on
osteoclasts and progenitors and serves as the primary stimulator of osteoclastogenesis and
activity (Reddy, 2004). OPG is a soluble decoy receptor for RANKL. This could result in
an increase in bone formation, although no significant differences from non-irradiated
control were observed.
Exposure of rodents to doses of 56Fe26+ radiation can result in reduced trabecular bone
microarchitecture and volume within the proximal tibia, a bone not directly exposed to
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56

Fe26+ ions. It is unclear if or how systemic factors influence the observed changes in

bone. Thus, the mechanism and timing of any changes in bone after HZE irradiation
remains poorly understood. Any insight into the effects of

56

Fe26+ and particulate

irradiation on bone may be important to the health of astronauts on future long-duration
spaceflights (e.g., Mars) (Nelson, 2003). The link between health status, body mass, and
bone needs to further investigated particularly at doses, dose rates, and energies modeling
spaceflight scenarios. A thorough time-course investigation of changes in bone
microarchitecture and structure following HZE irradiation will help clarify the
mechanisms of bone loss as we prepare for exploratory space missions. Older, more
mature animals are needed for study to properly identify direct or indirect impacts of
HZE irradiation (or ionizing radiation in general) on bone tissue and cell metabolism,
bone quantity, and bone quality.

87

CHAPTER 4: A MARROW ABLATING DOSE OF WHOLE-BODY RADIATION
CAUSES A RAPID REDUCTION OF TRABECULAR BONE IN MICE

4.1 Introduction
Radiation therapy for cancer compromises the mechanical properties of bone
contained within the treatment volume. Fractures of the pelvic bones, femoral neck, knee,
clavicle, humerus, and ribs are well documented in cancer patients receiving ionizing
radiation (Abe et al., 1992; Bliss et al., 1996; Howland, 1975; Huh et al., 2002; Pierce et
al., 1992). Radiation-induced bone atrophy and reduced elastic resistance lead to
fractures, even in the absence of a traumatic event (Grigsby et al., 1995; Moreno et al.,
1999). Indeed, Baxter et al. recently reported that radiation therapy significantly
increased the relative risk of pelvic fracture (65-216%) within a population of more than
6,000 women over the age of 65 treated for anal, cervical, and rectal cancer (Baxter et al.,
2005a). Hip fractures accounted for approximately 90% of all pelvic fractures. Within
this demographic, these fractures can result in substantial morbidity and mortality; nearly
20% of hip fracture patients will die within a year of the injury (Baxter et al., 2005a;
Lane, 2006).
The mechanisms leading to this increased likelihood of fracture after radiotherapy are
unclear. Bone damage following radiotherapy is thought to be a result of physiological
changes that occur in both the vasculature and osteoblasts (Dudziak et al., 2000;
Hopewell, 2003; Sakurai et al., 2007). Vascular changes in bone have been observed 3
months after exposure to X-ray doses as low as 5 Gy (Pitkanen and Hopewell, 1983). A
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radiation-induced reduction in the overall number of osteoblasts has been reported, which
affects bone formation (Bliss et al., 1996; Ergun and Howland, 1980; Hopewell, 2003). In
contrast, the effect of irradiation on osteoclasts is poorly understood. Osteoclast number
and activity has been reported to remain stable or decrease after irradiation, while bone
formation is reduced or arrested (Goblirsch et al., 2005; Sawajiri et al., 2003; Sugimoto et
al., 1991).
Among uterine cervix carcinoma patients, a significant (~30%) reduction in bone
mineral density (BMD) has been observed using quantitative computed tomography
(QCT) from the third lumbar vertebrae within five weeks of initiating pelvic irradiation
(Nishiyama et al., 1992). Such a profound and acute loss of trabecular bone so early after
exposure may indicate an increase in osteoclast activity, although a similar phenomenon
has not been confirmed experimentally.
Recently, we reported that exposure of mice to 2 Gy doses of both low- and highlinear energy transfer (LET) radiation was associated with a significant reduction in
trabecular bone volume fraction and connectivity four months after irradiation (Hamilton
et al., 2006). Clinically, these doses are relevant in terms of daily fractions of radiation
therapy applied to localized tumors. Larger single doses are often given for bone
metastases for effective palliative care (Hartsell et al., 2005; Sze et al., 2003). These
doses are often administered in single fractions of 8-10 Gy or multifractions of 3-5 Gy,
yielding a total of 20-30 Gy doses. The analgesic mechanism for palliative-care
irradiation is unclear, though inhibitory effects of osteoclasts within the irradiated field
have been postulated (Hartsell et al., 2005). However, the incidence of pathological
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fracture is higher following high, single-dose palliative therapy than after fractionated
treatments (Sze et al., 2003). Additionally, whole-body irradiation is administered to
ablate marrow preceding bone marrow transplantation, and though not directly attributed
to the irradiation component of this procedure, this population has a demonstrated decline
in bone mineral density (BMD) after treatment (Schulte and Beelen, 2004).
The purpose of this study was to quantify the effects of a single, whole-body, marrow
ablating dose of 7 Gy γ-radiation on trabecular and cortical bone in mice. We investigated
the structural properties of bone acutely after irradiation to determine if any observable
changes in bone at this stage may provide insight into whether increased resorption is a
cause for documented late radiation injuries, such as pathological atrophy and bone
fracture.

4.2 Materials and Methods
4.2.1 Mice
Nine-week-old female C57BL/6 (B6) mice (Charles River Breeding Labs;
Wilmington, MA) were examined in this study. The animals were allowed an acclimation
period of one week prior to irradiation; food and water were available ad libitum. The
examination of bone was secondary to an immunological investigation performed at
Loma Linda University (Loma Linda, CA); therefore, bone labels were not possible.
Animal sacrifice was performed with 100% CO2 fourteen days after exposure. The
dissected hind limbs were shipped overnight to Clemson University (Clemson, SC) for
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examination of skeletal effects. The Institutional Animal Care and Use Committee of
Loma Linda University Medical Center approved all procedures.

4.2.2. Radiation Exposure
Nine-week-old mice (n = 6) were exposed to total-body irradiation using 60Co-source
gamma (γ) rays. A control group (n = 6) was not irradiated. Gamma irradiations were
performed at the Loma Linda University Medical Center as previously described (Gridley
et al., 2002; Gridley, 2001). A vertical beam from a retired AECL (Atomic Energy of
Canada, Ltd.; Commercial Products Division; Ottawa, Canada) Eldorado therapy unit
was employed. Prior to radiation exposure, non-anesthetized mice were placed into
rectangular polystyrene containers with air holes (30 mm x 30 mm x 60 mm) as
previously described (Gridley et al., 2002). Each mouse was irradiated with a single 7 Gy
dose at a dose rate of ~0.7 Gy/min. Assuming an α/β ratio of three for bone, this dose
represents a biologically equivalent dose (BED) of 20.3 Gy, and is the same to that used
in human bone marrow ablation regimens (13.5 Gy total dose administered in 9 fractions;
BED = 23.3) (Fowler, 1992).

4.2.3 Bone Architectural Analyses
Hind limbs were fixed in a solution of 10% formalin. After 48 h, the right hind limbs
were placed in 70% ethanol. Architectural and histological analyses were performed on
the right tibia: hind limbs were cleaned of soft tissue. Tibial lengths were also recorded.
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Prior to histological analyses, the right tibiae were evaluated for trabecular
microarchitecture using microcomputed tomography (microCT 20, Scanco Medical AG;
Bassersdorf, Switzerland), permitting the trabecular microarchitecture to be imaged using
a 9 µm voxel size. An approximately 1 mm section of bone immediately distal to the
proximal growth plate was scanned, and 3D images were reconstructed (Figure 4.1).
Trabecular bone volume fraction (BV/TV), connectivity density (Conn.Dens.), trabecular
thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) were
calculated for each sample.
For cortical analyses, eighty slices of the tibial diaphysis were analyzed over a
distance of 8 mm proximal to the tibial-fibular junction, with 100µm increment lengths
between each slice. To determine cortical volume, traces were made at both the periosteal
and endocortical surfaces. Intracortical porosity was also calculated for each sample by
determining the percentage of the total volume of bone relative to the total volume of the
area of interest.

4.2.4 Histology and Histomorphometry
Following microCT analysis, tibiae were decalcified in a weak formic acid solution
(Immunocal™, Decal Chemical Corporation; Tallman, NY). Radiographs were made to
assess the earliest time point of complete decalcification. Samples were embedded in
paraffin and cut into sagittal sections 5 μm thick. Slides were examined prior to staining
to identify landmarks consistent among bones, and these slides were then chosen for
subsequent staining. Several slides from each bone were stained with hematoxylin and
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A

B

Figure 4.1. MicroCT image of (A) nonirradiated control and (B) 7-Gy irradiated
bones. Images were reconstructed from slices obtained during analysis of the
proximal tibia in mice two weeks after 7 Gy gamma-irradiation. The images extend
approximately 1 mm distal from the growth plate. These images are oriented from a
posterior view with the front of the tibial plateau tilted upward at 45º. Scale bar
indicates 1mm.
eosin (H&E), and then each was reanalyzed visually prior to histomorphometry to
identify those samples containing the consistent landmarks among the different bones.
Multinucleated osteoclast presence was determined by tartrate-resistant acid phosphatase
staining (TRAP, EC3.1.3.2) of the paraffin sections using a commercial kit (Sigma; St.
Louis, MO) and then counterstaining with hematoxylin. TRAP-stained slides were
prepared from adjacent sections to support histomorphometric analyses of the H&Estained slides. Images of the growth plate were also systematically captured for
qualitative evaluation. Micrographs were captured using a Zeiss AxioSkop 2 Plus
microscope (Carl Zeiss Light Microscopy; Göttingen, Germany) and a Zeiss AxioCam
HR digital camera with AxioVision 3.1 software (Carl Zeiss Vision GmbH; München-
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Hallbergmoos, Germany). Quantitative histomorphometric analysis on the bone sections
was performed using SigmaScan Pro software (SPSS; San Rafael, CA).
Histomorphometric analyses were performed throughout the metaphysis, extending
0.5 mm distal from the growth plate. Histomorphometric parameters presented follow
standard definitions and nomenclature (Parfitt et al., 1987). The total length of trabecular
bone within each metaphysis, or trabecular bone surface, was determined (BS, mm). Each
subtype of surface was expressed as a proportion of total bone surface. These
measurements along the trabeculae included the osteoclast surface (Oc.S/BS, %;
percentage of bone surface covered by osteoclasts), eroded surface (ES/BS, %;
percentage of bone surface containing Howship’s lacunae), and osteoblast surface
(Ob.S/BS, %; percentage of bone surface containing cuboidal osteoblasts). The height of
the cartilaginous growth plate was also measured. Mean growth plate height was
determined for each bone by eighteen equidistant measurements taken parallel to the long
axis of the tibia across the transverse length of the growth plate.

4.2.5 Statistical Analysis
All histomorphometric data were examined for statistical significance using
SigmaStat Version 3.5 (Systat Software Inc.; Richmond, CA). A one-tailed Student’s ttest was performed to reveal statistical differences between the control and irradiated
groups. A P-value of less than 0.05 was considered a significant difference. All data are
presented as mean + standard error of the mean (SEM).
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4.3 Results
4.3.1 Animal Behavior
No substantial qualitative behavioral differences were observed following irradiation.
Irradiated animals exhibited a significant (~ 18%) reduction in body weight (P < 0.01,
Table 4.1) compared with control mice two weeks postirradiation.

Table 4.1. General bone, cortical microCT, and growth plate data from irradiated
tibiae two weeks post-exposure
Control
20.6
16.6
20.7
129
58.7
4.56
200
5.81
4.23
105

Animal Mass at Sacrifice (g)
Tibial Length (mm)
BV/TV (%)
Conn. Dens. (1/mm3)
Tb.Th. (µm)
Tb.N. (1/mm3)
Tb.Sp. (µm)
Cortical Volume (mm3)
Cortical Porosity (%)
Growth Plate Height (µm)

+ 0.5
+ 0.2
+ 0.1
+7
+ 0.7
+ 0.05
+ 2.2
+ 0.05
+ 0.10
+3

7 Gy
16.9
16.6
9.2
40
57.3
3.35
300
5.73
4.32
115

+ 1.0a
+ 0.1
+ 0.1b
+ 6b
+ 1.4
+ 0.09b
+ 6.0b
+ 0.05
+ 0.20
+3

Notes: Abbreviations for bone volume fraction (BV/TV); connectivity density
(Conn.Dens.); trabecular thickness (Tb.Th.); trabecular number (Tb. N); and trabecular
spacing (Tb. S.). Mean + SEM. aP < 0.05 following Student’s t-test; bP < 0.001 following
Student’s t-test
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4.3.2 Quantitiative MicroCT Analysis of Trabecular and Cortical Bone
Absolute values for trabecular histomorphometric parameters are listed in Table 4.1.
In the tibial samples scanned by microCT, irradiated bones exhibited significantly
reduced BV/TV (-54%), Conn.Dens. (-69%), and Tb.N (-26%) compared with controls
(all comparisons P < 0.001; Figure 4.2). Tb.Sp was significantly increased in the
irradiated samples by approximately 49% (P < 0.001). No difference was observed in
Tb.Th, cortical bone volume or porosity within the tibial diaphysis (Table 4.1).

A

B

C

D

Figure 4.2. Effects of 7 Gy γ-rays on bone microarchitectural parameters two weeks
after irradiation, including (A) trabecular bone volume fraction (BV/TV); (B)
connectivity density (Conn.Dens.); (C) trabecular number (Tb. N); and (D)
*
trabecular spacing (Tb. S.) Results are expressed as mean + SEM. P < 0.001
following t-test.
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4.3.3 Histology and Quantitative Histomorphometry
Qualitative evaluation of micrographs identified several differences between
histological samples from nonirradiated and irradiated bones (Figure 4.3). Trabecular
struts extended longitudinally from the physis through the metaphysis in nonirradiated
bones, whereas these lengthy struts were usually missing within the irradiated mice.
Similarly, the hematopoietic tissue present within the marrow of the controls was almost
entirely missing within the metaphysis of the irradiated bones. Tissue containing the
morphological features of adipose tissue was present within the metaphysis in place of
the normal marrow cellularity (Figure 4.3).
In terms of bone anatomy and histology of the physis, the two groups shared some
similarities. No difference was observed in bone length or total height of the growth plate
between the irradiated and control bones (Table 4.1). Histologically, the physes within
both groups contained a core of hyaline cartilage with overall decreased cellularity and
irregular cartilage cell columns (Figure 4.3). For both groups, the columnar arrangement
of the chondrocytes in the proliferative and hypertrophic zone cells was often largely lost.
Hypertrophic zone cells were greatly reduced. Large expanses of acellular cartilage could
be identified between the chondrocytes. A terminal bar of bone was present along the
distal edge of the physes in both groups (Figure 4.3).

4.3.4 Histomorphometry and TRAP Staining
Histomorphometric analysis indicated a significant reduction in BS (P < 0.05) and no
difference in Oc.S/BS, ES/BS, or Ob.S/BS between groups (Table 4.2). Measurements of
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A

B

Figure 4.3. 100X images of H&E-stained proximal tibiae from control (A) and 7-Gy
γ-irradiated (B) mice two-weeks after exposure. The arrows indicate bone present
along the distal edge of the physis. Scale bars represent 100 µm.
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Table 4.2. Bone histomorphometry from mouse tibiae two-weeks after irradiation
Control
5.00
3.40
7.9
12.7

BS (mm)
Oc.S/BS (%)
ES/BS (%)
Ob.S/BS (%)

+ 0.50
+ 1.36
+ 1.8
+ 1.4

7 Gy
3.25
2.40
12.5
11.5

+ 0.34a
+ 0.96
+ 2.2
+ 2.1

Notes: Abbreviations represent total bone surface (BS) and parameters relative to BS
including osteoclast surface (Oc.S); erosion surface (ES); and osteoblast surface (Ob.S).
Mean + SEM. aP < 0.05 following t-test.

osteoclasts and erosion surface were verified via TRAP staining and by validating the
presence of TRAP+ osteoclasts within resorption pits (Figure 4.4).

4.4 Discussion
The findings of the present study demonstrate that a single dose of 7 Gy γ-radiation
resulted in a rapid and substantial reduction of trabecular bone in mice. Several possible
interpretations can be made regarding the nature of the observed reduction in bone
following irradiation. Of these, radiation-induced reduction of bone growth, smaller body
masses after irradiation, impaired bone formation, and increased resorption must be
considered. While all of these can affect bone quantity and quality, an increase in
resorption and osteoclast activity represent a novel possibility. Though these observations
occurred in an animal model, early reduction in vBMD from radiotherapy patients as
measured by QCT has also been shown to occur (Nishiyama et al., 1992), and patients

99

A

B

Figure 4.4. 400X images following tartrate-resistant acid phosphatase (TRAP)
staining within the proximal metaphysis from control (a) and 7 Gy irradiated (b)
mice two-weeks after exposure. TRAP+ osteoclasts stain reddish-brown. Arrows
indicate the presence of TRAP+ osteoclasts within resorption pits. Scale bars
represent 30 µm.
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receiving whole-body, marrow ablating doses of radiation prior to bone marrow
transplantation also have reduced BMD, as measured by traditional dual energy X-ray
absorptiometry (DXA). An early increase in the resorption of bone following therapeutic
irradiation and subsequent acute bone loss may be an important contributor to the
increased fracture rates observed as late effects in radiotherapy patients.
Reduced longitudinal bone growth with subsequent remodeling of the primary
spongiosa due to chondrocyte damage alone cannot explain the extreme trabecular bone
loss observed at such an early time-point after irradiation. The mice in this study were 9
weeks old at the time of irradiation. The animals were not skeletally mature and were
presumably still growing; complete maturation occurs prior to 6 months of age
(Somerville et al., 2004). However, BV/TV within the proximal metaphysis of B6 mice
normally reaches a maximum at 6 weeks of age and decreases until 24 months of age
(Bouxsein, 2005; Halloran et al., 2002). Therefore, a cessation or reduction of
longitudinal growth for two weeks might not translate into a reduction in BV/TV within
this area.
Additional histological analysis of the bones indicated that growth was at least slow
within both groups at the time of sacrifice (Figure 4.4). In rodents, the cartilage within the
growth plate remains into old age, although it can be effectively sealed by a transverse
terminal bar of bone, thereby reducing additional growth (Martin et al., 2003; Roach et
al., 2003). The terminal bar of bone has been described as a feature of aged rodents with
reduced growth rate (Roach et al., 2003). This bar was present along the metaphyseal side
of the physis of both groups (Figure 4.4). Similarly, within the growth plate of both the
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control and irradiated tibiae, the cartilage exhibited several documented features of slowgrowing murine physes. For example, chondrocytes are typically organized within
columns divided into zones arranged perpendicular to the growth plate; growth rate
depends on the proliferation and the height of the mature cells within the column (Eifel et
al., 1995). Moreover, decreased cellularity, widely scattered groups of cells, and
irregular, short columns of chondrocytes separated by widened areas of hyaline cartilage
within both groups provide evidence that growth was slow (Roach et al., 2003;
Silbermann and Kadar, 1977). Finally, no difference was observed in growth plate height
or tibial lengths between groups. Thus, we believe that growth was slow at the time of
sacrifice.
The smaller masses of the irradiated animals could contribute to the observed
difference in bone between groups. Body mass and loading influence bone morphology
in accordance with Wolff’s law (Currey, 2002). A reduction of mechanical stress on
limbs results in bone loss, as evident in tail-suspension murine studies and during
spaceflight (Judex et al., 2004; Lang et al., 2004; Sakai et al., 2002). The skeletal
response to reduced loading in murine models is influenced by strain and site (Amblard et
al., 2003; Judex et al., 2004). Although exact strain, age, duration of unloading, and sitespecific comparisons of previous tail-suspension studies and the current two-week
irradiation study are unavailable, substantial bone loss has been observed from B6 hind
limbs following unloading. Studies have documented approximately 40% less BV/TV
from the proximal tibia of 8 week old B6 mice suspended for 1 week (Nakai et al., 2006),
and approximately 25% less BV/TV in both proximal (Judex et al., 2004) and distal
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(Amblard et al., 2003) femoral metaphyses from 4 month old B6 suspended for 2 weeks.
However, the limbs in this study were not unloaded: Final animal masses were 18% less
than control after irradiation, but substantial loading of the hind limbs still occurred.
Locomotor behavior was also similar between groups, as no marked change in behavior
was observed. Reduced loading can also impact cortical porosity and volume, which were
unchanged between groups. Therefore, the difference in body mass between groups
cannot entirely account for the observed 54% less bone volume or degradation of
trabecular connectivity. The effect of lower doses, which are less likely to cause reduced
animal mass, should be studied at these early time points nonetheless.
Any effect of radiation on osteoblast number and activity certainly could contribute to
a reduction in bone volume following irradiation. A reduction in the overall number of
osteoblasts and bone formation is generally accepted to occur following irradiation
(Hopewell, 2003; Sawajiri et al., 2003). Absolute numbers of osteoblasts were observed
to decline within the secondary spongiosa from this study as indicated by similar
Ob.S./BS between groups despite significantly reduced BS in the irradiated groups (Table
4.3). Formation rates could not be determined as the administration of flourochrome
labels was not possible, and thus represents a limitation of this study. However, as
previously stated, B6 mice achieve a peak BV/TV at approximately 6 weeks of age,
therefore it would be unlikely for a reduction in bone formation to be largely responsible
for the radiation-induced decline in trabecular volume fraction. It could, however, be a
contributing factor.
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The magnitude of the difference in bone morphometric parameters between irradiated
groups is substantial and occurred early after radiation exposure. As previously stated,
such large differences are observed following conditions that induce osteoporosis, such as
tail-suspension. The mechanism of bone loss during hind limb unloading is a
combination of reduced bone formation and increased bone resorption (Bikle et al., 2003;
Nakai et al., 2006). While we cannot firmly conclude that osteoclast activity was
increased, more than half the BV/TV and nearly 69% of the connectivity was gone from
the proximal metaphysis after two weeks. We believe this justifies exploring the
possibility that bone resorption is elevated very early after irradiation.
The effect of irradiation on osteoclast activity remains unclear. A dose-dependent
decrease in osteoblast number has been reported to occur immediately within immature
rat tibiae after high-dose (15-30 Gy) γ and carbon irradiation. An increase in osteoclast
numbers was discussed in this context, however no statistical evidence supported this
evidence (Sawajiri et al., 2003). Other studies show no change in osteoclast numbers in
culture after marrow was mixed with osteoblasts irradiated with 2-6 Gy gamma-radiation
(Sawajiri et al., 2006). To date no study has definitively shown an increase in osteoclast
numbers after radiation.
For this study, histological samples were examined for evidence that bone resorption
was elevated at the time of sacrifice. TRAP staining identified the presence of osteoclasts
by identifying TRAP+ multinucleated cells along the remaining trabeculae of both control
and irradiated bones (Figure 4.4). No significant differences existed between Oc.S/BS or
ES/BS, providing evidence that the number and activity of osteoclasts relative to bone for
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both groups were equivalent at the time of sacrifice. Since a large percentage of bone was
lost (> 50%), we believe that the increased resorption was a very early response
following irradiation and that osteoclastic resorption subsequently stabilized. These
interpretations are made within the limits of histological analysis and without serum or
protein analyses of bone resorption markers, which were unavailable due to the primary
use of these mice in an immunological study as noted above.
The observed differences from this study were limited to trabecular bone. There is a
paucity of literature regarding radiation effects on cortical bone, and those that exist
primarily focus on changes in bone strength. We also have observed a similar absence of
cortical effects with multiple radiation types, but at lower doses than examined here
(unpublished data, 2007). Studies in animal models indicate that very high doses of
irradiation can affect overall fracture strength of cortical bone (Nyaruba et al., 1998;
Sugimoto et al., 1991). After exposure to a single 50 Gy dose, rabbit tibiae showed
increased endosteal bone resorption by 4 weeks and increased intracortical porosity by 12
weeks (Sugimoto et al., 1991). Sections of cortical bone from the irradiated proximal
metaphysis showed reduced ultimate strength via three-point bending tests by 12 weeks,
with slight recovery by 53 weeks. In rat models, high total doses of radiation (40-60 Gy)
applied to the tibia resulted in reduced ultimate strength by 24 weeks whether applied as
an acute dose or as > 2.5 Gy daily fractions (Nyaruba et al., 1998). The effects of
radiation on cortical bone generally appear to occur following much higher total doses
and are seen at longer time points after treatment than are the changes in trabecular bone.

105

One striking feature of our micrographs is the near total absence of hematopoietic
cells within the metaphyses; tissue containing morphological features of adipose was
present instead of normal marrow (Figure 4.3). The reduction in hematopoietic function
and number is primarily caused by radiation-induced apoptosis among hematopoietic
stem cells present within the marrow (Chen et al., 2006). An inflammatory-type radiation
response involving increased numbers of activated macrophages and a reduction in the
number of hematopoietic cells within tibial bone marrow of the metaphysis has been
documented in C57BL/6 mice within 24 hours after 4 Gy γ-irradiation (Lorimore et al.,
2001). In fact, inflammation within tissue is a common early feature following
irradiation, with elevated production of proinflammatory cytokines and reactive oxygen
species (Bentzen, 2006; Stone et al., 2003). This process of increased phagocytosis within
the marrow and inflammation and have the potential to initiate osteoclastogenesis and
bone loss by production of proinflammatory cytokines and/or reactive oxygen species
after irradiation.

4.4.1 Study Limitations
The constraints of this study were primarily due to the original immunological nature
of the investigation. As previously mentioned, histological analysis and microCT results
were the principal basis for inferring elevated resorption as causing the substantial bone
deficits post-irradiation, as serum, protein analyses, and bone labels were unavailable
from these growing mice. While these markers need to be included in future studies, we
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feel the very large differences in bone (including histological and microCT data)
observed at only two weeks after treatment substantiate our interpretations.
In summary, an acute, whole-body dose of 7 Gy γ-rays induced substantial loss of
trabecular quantity and microarchitecture at an early (14 day) time-point after exposure.
A similar reduction in bone quantity may be associated with the increased risk of fracture
that has been documented in humans receiving radiotherapy for various tumors. In
contrast, no changes were observed in cortical bone. This study was designed to facilitate
observations at what was thought to be at an early time-point after exposure, yet it is
possible that resorption of metaphyseal trabecular bone (although perhaps stabilized at
this point) was initiated much earlier. Further investigations, perhaps at time-points of
hours to days, into the acute radiation response of osseous tissue is warranted to identify
the complete mechanistic cause of bone damage following irradiation.
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CHAPTER 5: INVESTIGATION OF OSTEOCLAST DIFFERENTIATION AND
RESORPTION FROM MICE EXPOSED TO 2 GY X-RAYS

5.1 Introduction
Bone atrophy and increased risk of bone fracture is a well-documented response of
osseous tissue following exposure to high-dose radiation therapy (Baxter et al., 2005a;
Ergun and Howland, 1980). Bone loss following radiotherapy is thought to result from
damage that occurs to bone vasculature as well as reduced proliferation and activity of
bone-forming osteoblasts (Bliss et al., 1996; Gal et al., 2000; Hopewell, 2003; Huh et al.,
2002; Mitchell and Logan, 1998; Szymczyk et al., 2004). While atrophy is typically
observed as a late effect, loss of bone mineral density (> 30% from the lumbar spine)
after irradiation in cancer patients has been reported as early as five weeks post treatment
(Nishiyama et al., 1992). Despite evidence that substantial bone loss can occur soon after
irradiation, an increase in osteoclast activity following exposure has received little
attention as a potential contributor to radiation-induced osteoporosis.
The effect of radiation on osteoclast number and function are varied in published
reports. Results range from decreased osteclasts (Scheven et al., 1985), to stable numbers
(Goblirsch et al., 2005; Vit et al., 2006), to a non-quantitative description of a transient
increase in osteclasts (Sawajiri et al., 2003) after irradiation. Reports of osteoclast
numbers significantly elevated at several weeks after exposure use radiation in
combination with another osteoclastogenic challenge (i.e., force applied to bone via an
orthodontic implant) (Tsay et al., 1999). However, atrophy is a long-term effect following
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irradiation used as a single skeletal challenge, and has been quantified at early (2 week;
Chapter 4) and late (4 month) (Hamilton et al., 2006) time points using microCT.
Questions related to the direct effects of radiation on bone resorption and osteoclast
number need to be addressed in order to reduce or prevent related bone atrophy.
The purpose of this study is to examine osteoclast presence, number, and activity
following an acute, whole-body dose of 2 Gy X-rays applied to mice. Since we have
documented substantially less bone in mice two weeks after irradiation as compared with
non-irradiated control, but shown evidence of stable resorption at that time, we will
examine the response of osteoclasts and bone from marrow harvested at Day 1 (in vitro
portion) and Day 3 (histology and microCT) after exposure. We hypothesize that
radiation will induce an increase in osteoclast number and activity within the first few
days after exposure

5.2 Materials and Methods
5.2.1 Mice
Thirteen-week-old C57BL/6 (B6) mice (n = 24 total; 6 per group) were examined in
this study (Charles River Breeding Labs; Wilmington, MA). The animals were allowed
an acclimation period of one week prior to irradiation; food and water were available ad
libitum. The Institutional Animal Care and Use Committee of Clemson University
approved all procedures.
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5.2.2 Irradiation
While under anaesthesia (isoflourane), mice were exposed to single, 2 Gy total-body
dose of irradiation using a Philips 150KV industrial portable X-ray unit. The 2 Gy dose
was chosen based on results from a preliminary study using 2, 4, and 6 Gy-irradiated
mice and comparing changes in bone two weeks after exposure. Significant reduction in
bone architecture were observed following all doses; thus the lowest dose (2 Gy) was
chosen. Additionally, single fractions of radiation used during radiotherapy are typically
1.8-2 Gy. A total of 12 mice were irradiated. The dose was administered at 140 kVp with
an exposure time of 1.46 min. Two groups (n = 6 each) were not irradiated.

5.2.3 Bone Marrow Culture
Two groups of mice (6 irradiated; 6 non-irradiated control) were examined for a cell
culture study. Bone marrow cells were harvested from mouse femora one day after
irradiation. The femora were removed from each mouse. Soft tissue was removed from
each femur while under a sterile hood. The epiphyses were clipped off, and the marrow
flushed out using a 5 mL syringe and 25 g 5/8” needle (WHO) with Alpha modified
Eagle Medium (αMEM; Invitrogen; Carlsbad, CA) supplemented with 10% fetal bovine
serum (FBS; Life Technolgies; Long Island, NY), 10 nM 1,25(OH)2 Vitamin D3
(Calbiochem;

LaJolla,

CA),

and

1%

penicillin-streptomycin-Fungizone

(Life

Technologies). Marrow from two animals from the same treatment group was pooled in a
sterile, tissue-culture polystyrene dish (Corning; Corning, NY). The cells and media were
transferred to a 50 mL centrifuge tube through a 40 µm nylon cell strainer (BD-352340).
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Cells were centrifuged for 10 min at 1200 rpm, resuspended in 1 mL of fresh αMEM
supplemented with 10% FBS, 10 nM 1,25(OH)2 Vitamin D3, and 1% penicillinstreptomycin-Fungizone. Cells were counted using a hemocytometer. Six million cells
were seeded on one of two substrates (see below) and flooded with 1 ml fresh αMEM
then incubated at a 37°C, humidified, 5% CO2/95% air environment.
To quantify osteoclast number, cells were seeded on two-well Lab-Tek II chamber
slides in triplicate for each sample (Electron Microscopy Sciences; Hatfield, PA) and
inclubated for 14 days. To remove adherent cells other than osteoclasts, cells were
incubated at 37°C with 5% CO2 for 5 minutes in 0.25% EDTA/Trypsin. Osteoclast
presence was determined by tartrate-resistant acid phosphatase staining (TRAP,
EC3.1.3.2) of the slides using a commercial kit (Sigma; St. Louis, MO) and then
counterstaining with hematoxylin. All multinucleated, TRAP+ cells were counted within
each chamber.
To examine the resorptive capacity of the cultured osteoclasts, cells were seeded on
hydroxyapatite discs (BD BiocoatTM OsteologicTM; San Jose, CA) in a 24-well plate in
duplicate for each sample. At two weeks, disks were rinsed using deionized water and 1
mL of bleach solution (6% NaOCl, 5% NaCl) was added to each disk at 37°C. After a
final wash, discs were allowed to air dry.
Resorption pits were visualized via Von Kossa staining for mineralized bone. For the
procedure, 1 mL of silver nitrate solution (5% AgNO3) was added to the wells containing
a disk. The well plate was taken outdoors and exposed to sunlight for 1 hour. Disks were
again rinsed three times with deionized water. Disks were placed in 1 mL of sodium
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bicarbonate (5% NaHCO3) in 25% formalin solution for 1 minute, rinsed 3 times, and
fixed using 1 mL of 5% nathiosulfate (HYPO) solution.
Quantification of the number and area of the resorption pits was calculated from
images captured using a 5X objective on a Zeiss AxioSkop 2 Plus microscope (Carl Zeiss
Light Microscopy; Göttingen, Germany) and a Zeiss AxioCam HR digital camera with
AxioVision 3.1 software (Carl Zeiss Vision GmbH; München-Hallbergmoos, Germany).
Determination of the resorption pit size and number was quantified throughout the disk
surface from images spliced together in SigmaScan Pro software (SPSS; San Rafael, CA)
After splicing was complete, the white background surrounding each disk was filled
using Photoshop 7.0.1 (Adobe Systems Incorporated; San Jose, CA). Images were
opened again in SigmaScan, and the color was inverted. The threshold was set to match
the resorption pit surfaces on the inverted color image. Very small pits were excluded
from the analysis to avoid mistaking small artifacts on the surface of the disk with
resorption surfaces: size of the excluded surfaces was previously determined from stained
and unstained hydroxyapatite disks. All pits below an area of 100 µm2 were removed
from analysis. Examination of stained and unstained HA disks revealed inconsistencies in
staining along the outer perimeter of each disk. Therefore, the outermost portion of each
disk was cropped using Photoshop in a consistent fashion, such that the total circular
surface examined from each disk was 96.68 mm2. Total resorption area, resorption pit
number, and average pit area were calculated from the micrographs.
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5.2.4 Blood Serum Analysis
Blood serum concentration of TRAP5b was determined via ELISA using a
commercially available kit (Quantikine; Minneapolis, MN) from animals sacrificed oneday after exposure to provide additional evidence of overall osteoclast activity at this
point. An ELISA was also performed using this serum to determine concentration of
osteocalcin, a marker of osteoblast activity (Biomedical Technologies Inc; Stoughton,
MA).

5.2.5 Bone Architectural Analysis
To examine the early post-irradiation presence and activity of osteoclasts within
irradiated mouse bones, the other set of irradiated and control mice (n = 6 per group)
were sacrificed on Day 3. Hind limbs were removed and tibiae were separated from
femora. Soft tissue were removed from the tibiae then fixed in a solution of 10%
formalin. After 48 hours, the hind limbs were placed in 70% ethanol. Prior to histological
analyses, the right tibiae was evaluated for trabecular microarchitecture using
microcomputed tomography (microCT 20, Scanco Medical AG; Bassersdorf,
Switzerland), permitting the trabecular microarchitecture to be imaged using a 9 µm
voxel size. An approximately 3 mm section of bone immediately distal to the proximal
growth plate was scanned. Evaluation of the scans began 0.5 mm distal to the growth
plate and extended 1 mm. Trabecular bone volume fraction (BV/TV), connectivity
density (Conn.Dens.), trabecular thickness (Tb.Th), trabecular number (Tb.N), and
trabecular spacing (Tb.Sp) was calculated for each sample.
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5.2.6 Histology
Following microCT analysis, each tibia was decalcified in a weak formic acid
solution (Immunocal™, Decal Chemical Corporation; Tallman, NY). Radiographs
assessed the earliest time point of complete decalcification. Samples were embedded in
both paraffin (left tibia) and resin (right tibia) and cut into sagittal sections 5 μm
(paraffin) and 1.5 μm (resin) in thickness. Multinucleated osteoclast presence was
determined by TRAP staining of the paraffin sections using a commercial kit (Sigma) and
then counterstaining with hematoxylin.
Histomorphometric analysis from captured micrographs was performed throughout
the metaphysis, starting approximately 0.5 mm distal from the growth plate (in order to
exclude the primary spongiosa) and extending 0.5 mm distal. Total trabecular bone
surface (BS, µm) within each metaphysis was determined. Subsequent surface
measurements were quantified relative to total bone surface. Osteoclast surface (Oc.S/BS;
%), erosion surface (ES/BS; %), and osteoblast surface (Ob.S/BS; %) was also
calculated.

5.2.7 Statistical Analyses
For the cell culture study, a repeated measures ANOVA was performed using SPSS
Version 15.0 (SPSS Science Inc.; Chicago, IL) to examine any differences between
irradiated and control groups, accounting for the replicate samples within each group.
Serum and other histomorphometric analyses were examined for statistical significance
using SigmaStat Version 3.5 (Systat Software Inc.; Richmond, CA). A one-tailed
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Student’s t-test was performed to reveal statistical differences between the control and
irradiated groups. A P-value of less than 0.05 was considered a significant difference. All
data was presented as mean + standard error of the mean (SEM).

5.3 Results
5.3.1 In Vitro Osteoclast Number
After one week of culture on chamber slides in osteoclastgenic media, the number of
TRAP+, multinucleated osteoclasts was greater from irradiated marrow harvested one day
after exposure then than from control animals (Figure 5.1; Table 5.1). No Within
Replicate or Replicate*Group interactions were observed from any repeated measures
ANOVA used for this study (Table 5.1). A significant Between Group effect was
observed for osteoclast number. A mean increase of approximately 395% was observed
from irradiated marrow relative to non-irradiated marrow (P < 0.05; Table 5.1).

5.3.2 In Vitro Resorption
The area of mineral resorbed on the HA disks after culture with irradiated marrow for
2 weeks was significantly greater than when cultured with non-irradiated marrow (Figure
5.2; Table 5.1). Total resorbed area was approximately 390% greater after irradiation (P
< 0.05). The average area of each resorption pit was also significantly greater than
control; irradiated pits were 78% larger than non-irradiated pits (P < 0.01). No group
effect was observed for resorption pit number (P > 0.05).
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Figure 5.1. Multinucleated, TRAP+ cells from marrow harvested one day after 2
Gy whole-body irradiation from mice femora and cultured on chamber slides for
one week. TRAP+ cells appear reddish-browh, nuclei are counterstained with
hemotoxylin. Arrows indicate multinucleated, TRAP+ cells. (A) Non-irradiated
(control); (B) 2 Gy irradiated; (C) histogram comparing osteoclast numbers from
non-irradiated (left) and irradiated (right) cultures. Bars represent standard error
of the mean. (*) P < 0.05 following repeated measures ANOVA comparing replicates
from each sample between groups.
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Figure 5.2. Composite images of hydroxyapatite disks cultured for two weeks with
(A) non-irradiated marrow and (B) 2 Gy irradiated marrow after harvesting the
marrow from mice femora one day after exposure. White areas represent sites of
osteoclastic resorption of hydroxyapatite.
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Table 5.1. Osteoclast numbers and resorption parameters from cells harvested
from control and 2 Gy-irradiated mouse bone marrow one day after exposure

Mean Control
Osteoclast number
Reorption pit number
Total resorption pit area (µm)
Average resorption pit area (µm)

322
294
101000
22400

+ 30
+ 86
+ 26700
+ 5000

Mean 2 Gy
1600
350
413000
37700

+ 207
+ 156
+ 184000
+ 16900

P Value
0.018
0.080
0.043
0.007

Notes: A repeated measures ANOVA was used to compare Between Group effects
(control vs. 2 Gy irradiated) by analyzing data from each replicate for each of three
samples within each group. For osteoclast numbers, 3 replicates were perfomed for each
sample within a group. Resorption pit assays were performed in duplicate. P values are
for Between Group effects. No significant differences (P > 0.05) were observed for
Within Replicate or Replicate*Group interactions and are thus not listed. Significance
indicated at P < 0.05.

5.3.3 Serum Chemistry
Levels of TRAP5b in serum harvested one day after exposure (12.84 U/L + 0.52) were
significantly increased relative to non-irradiated serum (8.53 U/L + 0.52), representing
an increase of approximately 50% over control (P < 0.01; Figure 5.3). No differences
were observed in concentration of osteocalcin between irradiated (165 ng/mL + 13) and
non-irradiated (169 ng/mL + 11) serum (P > 0.05).

5.3.4 Microarchitecture
The microachitecture and histological analyses were performed on irradiated tibiae 3
days after exposure to 2 Gy X-rays. Relative to control, no significant changes were
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Figure 5.3. Histograms comparing serum concentrations of (A) tartrate-resistant
acid phosphatase (TRAP)5b and (B) osteocalcin from non-irradiated and 2 Gy
whole-body irradiated mice one day after irradiation. (*) P < 0.01 following t-test.
observed in any bone microachitectural parameters as quantified via microCT analysis
starting 0.5 mm from the growth plate and extending 1 mm (P > 0.05; Table 5.2).
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Table 5.2. Histomorphometric parameters from mouse tibiae three-days after
receiving no radiation or 2 Gy X-rays

Control
2.22
3.16
44.9
2.06
515
6.26
4.83
14.1
14.6

BV/TV (%)
Conn. Dens. (1/mm3)
Tb.Th. (µm)
Tb.N. (1/mm3)
Tb.Sp. (µm)
BS (mm)
Oc.S/BS (%)
ES/BS (%)
Ob.S/BS (%)

+ 0.19
+ 0.78
+ 0.7
+ 0.13
+ 33
+ 0.57
+ 0.89
+ 1.96
+ 2.23

2 Gy
2.90
3.45
41.6
2.06
498
5.69
14.99
19.2
14.2

+ 0.37
+ 0.53
+ 1.4
+ 0.13
+ 33
+ 0.33
+ 1.53
+ 2.15
+ 1.94

Notes: Abbreviations for bone volume fraction (BV/TV); connectivity density
(Conn.Dens.); trabecular thickness (Tb.Th.); trabecular number (Tb. N); and trabecular
spacing (Tb. S.); (BS) and parameters relative to BS including osteoclast surface (Oc.S);
erosion surface (ES); and osteoblast surface (Ob.S). Mean + SEM. All P values > 0.05
when compared using Student’s t-test

5.3.5 Histological Analysis
TRAP stained sections of bone were used to identify osteoclasts within tibial metaphyses
and quantify surface measurements (Figure 5.4). No significant differences were
observed in BS between control and irradiated bones (P > 0.05; Table 5.2). Moreover,
Ob.S/BS and ES/BS were unchanged between groups (Figure 5.4 and Table 5.2).
However, a significantly greater Oc.S/BS was observed within the irradiated tibiae (P <
0.001). The difference represents a 310% greater Oc.S/BS in irradiated bones.
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Figure 5.4. 200X images following tartrate-resistant acid phosphatase (TRAP)
staining within the proximal metaphysis from control (A) and 2 Gy irradiated (B)
mice three-days after exposure. TRAP+ osteoclasts stain reddish-brown. Sections
are stained to indicate the presence of reddish-TRAP+ osteoclasts along the
trabecular surfaces (C) Histograms indicating the erosion surface (ES/BS),
osteoclast surface (Oc.S), and osteoblast surface (Ob.S) as a percentage of total bone
surface quantified within the trabecular metaphyses extending 0.5 mm distal to the
primary spongiosa. Bars represent standard error of the mean. (*) P < 0.001
following t-test.
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5.4 Discussion
Osteoclast number and activity, and bone resorption, increase early following
exposure to ionizing radiation from mouse marrow and within a mouse metaphysis. From
marrow taken from the diaphysis of a long bone (femur) one day after exposure,
osteoclast number is highly elevated by one week of culture, as is total mineral resorption
after two weeks of culture (Table 5.2). TRAP5b levels were significantly increased in
circulating serum one day after irradiation (Figure 5.3). These markers are indicators of
bone metabolism (specifically resorption) within the mouse as a whole. Three days after
exposure, the relative surface of trabecular bone within the tibia covered by osteoclasts (a
proxy for osteoclast number) is also higly elevated over non-irradiated control (Table
5.2). The stimulation of osteoclasts by ionizing radiation therefore has the capacity to
induce resorption in vitro and in vivo. Early radiation-induced elevation of bone
resorption (within the first week) may represent a cause of the reduced bone mineral
density after exposure to therapeutic doses of radiation.
In the bones harvested from mice three days after exposure, no differences were
observed for BV/TV or other microarchitectural indices as determined by microCT
analysis. Decreased BV/TV has been described in mice by 2 weeks after exposure to 7
Gy γ-radiation (Chapter 4). Despite the reduction in BV/TV, surface measurements
suggested stabilized osteoclast activity. In the present study, Oc.S was ~310% greater at
three days. The other indicator of resorption (ES/BS; or surface without an osteoclast but
containing a Howship’s lacunae) was not elevated, as might be expected if resorption had
been substantially increased prior to Day 3. These observations (together with the
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significantly elevated serum levels of TRAP5b) therefore provide insight into the onset of
increased osteoclast resorption within an irradiated bone, perhaps with appreciable and
quantifiable bone loss within one particular bone occurring over the following days.
Cells harvested from bone marrow one day after irradiation exhibited greater mineral
resorption in vitro than from non irradiated cells, further support for elevated osteoclast
activity after irradiation. Both total resorbed area and average resoption pit area were
significantly elevated. However, the number of pits per HA disk were not different, but
represent an increasing trend (P = 0.08; Table 5.1). It is possible that fusion of adjacent
pits could account for this observation (Figure 5.2), reducing the number of pits per cell
while increasing the average pit area. Therefore, the elevated total resorbed area per pit
should be highlighted from this assay.
Studies commenting on the presence and activity of osteoclasts within irradiated bone
and culture examine effects at various timepoints, doses, sources of radiation, energies,
and ages/strains of murine models. Not surprisingly, results have varied. One week after
irradiating osteoblasts with 2,4, and 6 Gy γ and carbon radiation then culturing with nonirradiated mouse bone marrow resulted in no change in osteoclast number relative to
control (Sawajiri et al., 2006). Eight days after exposure to 20 Gy X-rays (40 Gy
absorbed dose by the bone) osteoclast numbers within the distal femoral epiphysis of
mice were unchanged relative to non-irradiated controls (Goblirsch et al., 2005).
Likewise, osteoclast numbers along the cortical bone of mouse humeri remain stable
eight days following targeted 6 Gy X-ray irradiation (Vit et al., 2006). After a week of ex
vivo culture, 16 day old embryonic mouse metatarsals receiving doses greater than 2.5 Gy
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X-rays (200 kv) exhibited a decrease in osteoclast number and progenitor proliferation,
but no change in number was observed in day 17 metatarsals from any dose up to 20 Gy
(Scheven et al., 1985). Very high (30 Gy) acute doses of carbon and γ-radiation induced a
very rapid (by 24 hours) decrease in osteoclast numbers in three week old rats (Sawajiri
et al., 2003). In another study, application of 25, 50, and 100 Gy X-rays to rabbit tibia
resulted in significantly increased porosity by the first histological examination at 4
weeks post-exposure, with no subsequent changes in porosity (Takahashi et al., 1994).
This seems to indicate that the increase in resorption occurred prior to 4 weeks.
To date, this study represents the first definitive evidence of increased number and
osteoclast number and activity following exposure to ionizing radiation and in the
absence of other applied challenges (i.e., orthodontic force) (Tsay et al., 1999). Increased
osteoclasts have been mentioned in papers that performed descriptional non-quantitative
histological evaluation of irradiated weanling rat tibiae. (Furstman, 1972). Other studies
that have discussed an increase in osteoclast numbers have done so in the context of nonsignificant data from animals irradiated during periods of high growth rate (Sawajiri et
al., 2003). From our studies of older mice (slower growing), we have documented 54%
decrease in BV/TV and 69% decrease in trabecular connectivity within the tibial
metaphysis two weeks after exposure to 7 Gy γ-radiation, but with histological evidence
of stabilized resorption at this point. For the current study we report significantly elevated
serum concentration of TRAP5b by Day 1, increased numbers of osteoclasts lining
trabeculae by Day 3, and both elevated in vitro osteoclast number and resorption from
marrow harvested one day after exposure and allowed to culture for 1 and 2 weeks,
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respectively. Therefore, based on published histological observations of early changes in
bone after irradiation as well as the results of this study and our previous investigations
(Chapter 4), we propose that an acute and marked increase in osteoclast number and bone
resorption occurs early (0-7 days) following radiation exposure. This initial increase in
osteoclast number and resorptive capacity is transient. The resulting atrophy of skeletal
elements and compromised bone microachitecture (at least in more mature individuals) is
a lasting response.
Several possibilities exist as to why an early and transient increase in osteoclast
number and activity could translate into chronic osteoporosis. Early and late
preosteoclasts within the marrow are thought to be relatively radioinsensitive (Sawajiri et
al., 2003; Tsay et al., 1999). Somehow radiation may (through direct or indirect effects)
induce osteoclast differentiation, proliferation, and ultimately create an osteoporotic state.
The subsequent radiation-induced death of less differentiated osteoclast precursors (i.e.,
promonocytes or granulocyte-monocyte colony forming units) would result in reduced
osteoclast number following the initial increase in osteoclasts (Sawajiri et al., 2003).
Osteoblasts within the irradiated field are also negatively affected and can therefore
prevent recovery via new bone formation. Ionizing radiation has been shown to reduce
osteoblast proliferation, promote final differentiation, induce cell cycle arrest, increase
sensitivity to apoptotic agents, and reduce collagen production (Dudziak et al., 2000; Gal
et al., 2000; Hopewell, 2003; Sakurai et al., 2007; Szymczyk et al., 2004). Arrested in
vivo bone formation can persist for months after exposure (Sugimoto et al., 1991).
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Osteopenia and osteoporosis are chronic conditions that occur following radiation
therapy targeting a tumor (Baxter et al., 2005a; Hopewell, 2003; Mitchell and Logan,
1998; Nishiyama et al., 1992). Normal bone surrounding tumors will absorb some of the
radiation dose. For instance, pelvic bones absorb 60-70% of the total dose targeting
nearby anal, prostate, or gynecologic tumors (Konski and Sowers, 1996; Moreno et al.,
1999). Additionally, whole-body irradiation is administered to ablate marrow preceding
bone marrow transplantation. Likewise, this population demonstrates osteoporosis and
osteopenia after treatment (Schulte and Beelen, 2004). An early and acute increase in
osteoclast activity could account for these conditions, in concert with confounding factors
such as reduced osteoblast function and damaged vascularity. As such, the short term
elevation of osteoclast number and activity may, with expansion of the model, prove to
be a viable target to mitigate or prevent osteoporosis in bone following radiation therapy.
In summary, we quantified increased osteoclast number during the first week
following exposure to ionizing radiation. An associated increase in in vitro mineral
resorption accompanies this increase in osteoclast number, as determined both in vivo and
in vitro. If similar processes are occurring within normal bone present in an irradiated
field during radiotherapy, this may account for the observed atrophy present in
radiotherapy patients. Further work must identify if similar processes are occurring in
bone using photons of energies employed during radiotherapy. Additionally, biological
equivalent doses should be administered in order to determine if increased resorption is a
cause of pathological atrophy among cancer patients.
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CHAPTER 6: VOLUMETRIC AND ARCHITECTURAL CHANGES IN BONE
FOLLOWING CLINICALLY-MODELED RADIATION AND POTENTIAL
MITIGATING EFFECTS OF ANTIRESORPTIVE (BISPHOSPHONATE)
ADMINISTRATION

6.1 Introduction
Improvements in treatment, delivery and diagnosis have led to increases in the
number of long-term cancer survivors (Robbins and Zhao, 2004). However, this has been
accompanied by a growing population of long-term survivors at risk of developing
deleterious effects in normal tissues resulting from the use of therapeutic radiation.
Increased incidence of spontaneous hip fractures is demonstrated by patients receiving
radiation to treat pelvic cancers, with incidents generally being documented between one
to five years after therapy (Abe et al., 1992; Baxter et al., 2005b; Grigsby et al., 1995;
Ogino et al., 2003). Atrophy of bone occurring as a result of exposure to ionizing
radiation may represent a potential cause of this increased fracture risk. Osteopenia and
osteoporosis are documented conditions among cancer patients receiving radiation, either
as a means to reduce tumor size or to ablate marrow prior to stem cell transplantation
(Baxter et al., 2005b; Hopewell, 2003; Nishiyama et al., 1992; Rodgers and Monroe,
2007). We have recently identified an increase in osteoclast number along the
metaphyseal trabeculae of tibiae three days after mice were exposed to 2 Gy whole-body
X-rays (Chapter 5). Additionally, after marrow was harvested from these mice one day
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after irradiation, cultures of marrow in osteoclastogenic media revealed an increase in
osteoclast number (after one week of culture) and in vitro resorption (two weeks of
culture). Single application of ionizing radiation has also resulted in a substantial
reduction in bone volume fraction (BV/TV; ~54%) and trabecular connectivity
(Conn.Dens.; ~69%) from mice tibiae two weeks after exposure to 7 Gy γ-radiation
(Chapter 4). An increase in osteoclast number and activity in normal bone surrounding a
tumor following exposure to radiation during treatment would represent a therapeutic
target to prevent radiation-induced osteoporosis. Therefore, the observations of increased
number and activity from irradiated mouse bones must be verified using animal models
of different strains and species to establish a clear link between bone resorption and
radiation. Specifically, these observations must be confirmed using equivalent doses and
energies of photons (or protons) used clinically for treatment purposes.
Bisphosphonates are a commonly used antiresorptive drug for treatment of
osteoporosis and diseases of elevated bone turnover. These chemicals represent a class of
pyrophosphate analogues that bind to the hydroxyapatite component of bone matrix
(Coxon et al., 2006; Robey and Boskey, 2006). Osteoclasts can endocytose
bisphosphonates during resorption, leading to inhibition of farnesyl diphosphate synthase,
a key enzyme of the mevalonate pathway (Hirbe et al., 2006). The resulting disruption of
proteins involved in osteoclast proliferation, cytoskeletal structure, and survival results in
decreased osteoclast activity and apoptosis (Chapurlat and Delmas, 2006). As such,
resorption is prevented and turnover is suppressed. Clinical use of these drugs has been
shown to improve patients’ bone mineral density, preserve microarchitecture (i.e.,
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trabecular thickness and connectivity), and decrease the risk of fracture at several skeletal
sites (Benhamou, 2006; Borah et al., 2006; Kamel, 2007)
The purpose of the study is to use a female rat model (higher bone density than mice)
to identify and quantify any changes in bone at early time points after radiation exposure
(two and four weeks). Our intent is to identify if atrophy and evidence of increased
resorption is also observed using another rodent. In addition, a currently available
osteoporosis therapy (the bisphosphonate risedronate) will be tested for its ability to
reduce radiation-induced bone loss and alterations in trabecular microarchiture by
decreasing osteoclast-mediated bone resorption. Our hypothesis is that bone loss
following irradiation is a result of early osteoclast activation and increased turnover, and
that treatment with an antiresorptive agent, such as risedronate, will reduce the extent of
bone loss.

6.2 Materials and Methods
6.2.1 Rats and Groupings
Twenty-week-old female Sprague Dawley rats were procured from Harlan (84 total).
All protocols were approved by the appropriate Institutional Animal Care and Use
Committees at Clemson University and Wake Forest University. The animals were
acclimated at Wake Forest University School of Medicine (WFUSM) animal-care
facilities for one-week prior to the initiation of the study. A total of 72 were selected for
this study, with 12 extra procured to eliminate outliers by mass. At twenty one weeks of
age, animals were carefully grouped by mass. The treatment groups included: Non-
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irradiated control + placebo (Control; n = 24); Irradiated + Placebo (Irr; n = 24); and
Irradiated + risedronate (Irr + Ris; n = 24). Twelve rats from each treatment group were
sacrificed at 2 and 4 weeks after the initiation of irradiation.

6.2.2 Injections
On Day 0 (Monday), rats received their first subcutaneous (dorsal midline) injection
of either placebo (PBS) or bisphosphonate (risedronate; Procter and Gamble
Pharmaceuticals; Cincinnati, OH) at a concentration of 0.04µg/kg/injection. Injections
were given at the same time on each subsequent Monday, Wednesday, and Friday until
the animals were euthanized. A total dose of 0.12 µg/kg of risedronate was thus delivered
over the course of each week.

6.2.3 Radiation Exposure
Irradiation procedures were initiated on Day 1 (Tuesday). The right hind limb of
animals receiving radiation (n = 48) were exposed to 4 Gy of 6 MV X-rays (while
anesthetized using ketamine) using a linear accelerator (LINAC) in the WFUSM
Department of Radiation Oncology. The control group was anesthetized but not exposed
to X-rays. We are relying on the biological equivalent dose (BED) calculation, assuming
an α/β ratio of 3 for both human and rat bone (Fowler, 1992). Treatment regimens for
pelvic cancers commonly include administration of 30 x 1.8 Gy fractions (M-F for 6
weeks) for a total dose of ~54 Gy to the tumor. Each hip receives 50% of each fraction
(0.9 Gy) totaling 27 Gy, resulting in a BED of 35.1 Gy (Fowler, 1992). This human
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exposure was therefore modeled by a total dose to the right hind limb of 16 Gy, given as
4 fractions of 4 Gy each twice a week for two weeks (T,F/M,Th), resulting in a BED of
36.8 (Fowler, 1992). The small difference in BED between human-hip and rat-limb
exposure is within the error represented by the BED equation. Rats were transported back
to Clemson University immediately following the final irradiation procedure.

6.2.4 Bone Architectural Analysis
At sacrifice, right and left hind limbs were removed and disarticulated. Tibiae were
cleaned of soft tissue and fixed in a solution of 10% formalin. After 48 hours, the tibiae
were placed in 70% ethanol. The femora were immediately frozen for future mechanical
testing studies.
The right tibiae were evaluated for trabecular microarchitecture using microcomputed
tomography (microCT 20, Scanco Medical AG; Bassersdorf, Switzerland), permitting the
trabecular microarchitecture to be imaged using a 9 µm voxel size. An approximately 3.5
mm section of bone immediately distal to the proximal growth plate was scanned.
Evaluation was performed starting 1 mm from the growth plate. A total of 227 slices (2.5
mm) were traced and evaluated. Three dimensional images were reconstructed.
Trabecular bone volume fraction (BV/TV), connectivity density (Conn.Dens.), trabecular
thickness (Tb.Th), trabecular number (Tb.N), trabecular spacing (Tb.Sp), and trabecular
structural model index (SMI, an unitless indicator of plate vs. rod shaped trabeculae scores near 0 for parallel plate-like trabeculae, 3 for rods), were calculated for each
sample.
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6.2.5 Statistical Analyses
All statistical analyses were performed using SigmaStat Version 3.5 (Systat Software
Inc.; Richmond, CA). Correlation between body mass and time following irradiation was
evaluated using a linear regression. Within each group, a paired t-test was performed in
order to assess any differences in body mass between Day 0 and either Day 15 (Week 2
group) or Day 29 (Week 4 rats). Tests to indicate between group differences from initial
animal mass, animal mass at sacrifice, tibial lengths, and microarchitectural analyses
were performed using one-way-ANOVA with a Tukey follow-up test (α = 0.05). Data are
presented as mean + standard error of the mean (SEM).

6.3 Results
6.3.1 Animal Behavior, Masses, and Tibial Lengths
No qualitative differences were noted in animal behavior between groups, either
locomotor or diet, throughout the course of the study. All data for animal masses at the
beginning of the study (Day 0) and at 2- and 4-week sacrifice timepoints are listed in
Table 6.1. No significant differences were observed between any of the groups with
regards to both mass on Day 0 (initial body mass) and animal mass at sacrifice (final
body mass) (P > 0.05). The initial and final mass for each individual rat was compared
via paired t-test to determine if masses differed from the start to the end of the study: no
differences were observed within any group (P > 0.05, Data not shown). A linear
regression was performed within each group to determine if a change in body mass
occurred over the course of the study, as masses were determined at Day 0 ,4, 7, 10, 15,
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and 29. Plots for the linear regressions as well as equations for each regression line are
provided in Figures 6.1 and 6.2. No correlation existed between time and body mass:
animal masses were unchanged within each group over the course of the study (P > 0.05).
Tibial lengths at sacrifice were unchanged between all groups, comparing both 2 and 4
Week data (P > 0.05; Table 6.1).
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Figure 6.1. Plot of animal masses recorded for all the rats sacrificed at 2 weeks after
the initiation of the study. A linear regression was performed to identify a
correlation between time and animal mass over 2 weeks. No significant correlation
was observed for any group (P > 0.05). The equation for the regression line are as
follows: Control y = 0.275x + 264; Irradiated y = -0.07x + 258; Irradiated +
Risedronate -0.18x + 264.
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Figure 6.2. Plot of animal masses recorded for all the rats sacrificed at 4 weeks after
the initiation of the study. A linear regression was performed to identify a
correlation between time and animal mass over 2 weeks. No significant correlation
was observed for any group (P > 0.05). The equation for the regression line are as
follows: Control y = 0.275x + 264; Irradiated y = -0.07x + 258; Irradiated +
Risedronate -0.18x + 264.

6.3.2 MicroCT Analysis: Week 2
Bone volumetric and microarchitectural data are summarized in Table 6.2. BV/TV
was significantly less for Irr compared with Control (-14%; P < 0.05) and Irr + Ris (17%; P < 0.01; Figure 6.3). Conn.Dens. was also significantly reduced for the Irr group
relative to Control (-34%; P < 0.001; Figure 6.4). However, Conn.Dens. for the Irr + Ris
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group was also significantly reduced relative to Control (-22%; P < 0.01; Figure 6.4).
Tb.Sp was significantly higher (P < 0.01) and Tb.N. was significantly lower (P < 0.01).

Table 6.1. Body masses and tibial lengths during the course of the 4 week rat
irradiation study
Initial Body
Mass (g)
2 Week Examination
Control
Irradiated
Irradiated + Risedronate
4 Week Examination
Control
Irradiated
Irradiated + Risedronate

Final Body
Mass (g)

Tibial Length
(mm)

266 + 4
265 + 4
267 + 3

268 + 4
261 + 4
264 + 4

38.3 + 0.2
38.5 + 0.1
38.4 + 0.2

264 + 3
266 + 3
264 + 2

267 + 4
270 + 3
267 + 3

38.7 + 0.2
38.7 + 0.1
38.4 + 0.1

Note: Group body masses and tibial lengths were compared using a one-way ANOVA,
(α) = 0.05. No statistical differences were present between body masses or tibial lengths.

for the Irr group compared with Control (Table 6.2). No difference was observed for
these parameters between Irr and Irr + Ris. While values for Tb.N and Tb.Sp. were not
statistically different between Control and Irr + Ris animals, the non-significant data
trend resembles the response of the Irr group (increase in Tb.Sp., P = 0.094; decrease in
Tb.N, P = 0.057). SMI was significantly higher in the Irr group (1.31 + 0.11; P < 0.01;
Table 6.2) as compared with the Irr + Ris (0.83 + 0.07). No difference in SMI existed
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between Control (0.99 + 0.11) and Irr + Ris (Table 6.2). Tb.Th. from irradiated hind
limbs was increased relative to Control, though significant only from the Irr + Ris group
(P < 0.01; Table 6.2).
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Figure 6.3. Histograms representing the mean bone volume fraction (BV/TV) for
rats sacrificed at 2 Weeks (left set) and 4 Weeks (right set) after receiving no
radiation (Control), 16 Gy fractionated radiation (Irr), or 16 Gy fractionated
radiation and administration of risedronate (Irr + Ris). Error bars represent
standard error of the mean. Means were compared using a one-way ANOVA. (*) P
< 0.05 versus Control; (+) P < 0.01 versus Irr + Ris; (#) P < 0.001 versus Irr + Ris.

6.3.3 MicroCT Analysis: Week 4
BV/TV was significantly elevated from drug-treated animals over Control (P < 0.01)
and Irr (P < 0.001) rats (Figure 6.3; Table 6.2). Conn.Dens. from Irr rats remained less
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than Control (P < 0.01), however by Week 4 no difference was observed between
risedronate treated animals and Control (P > 0.05; Figure 6.4). Tb.N. from Irr rats
remained lower than Control with a corresponding significant increase in Tb.Sp. (P
<0.001).
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Figure 6.4. Histograms representing the mean connectivity density (Conn.Dens.) for
rats sacrificed at 2 Weeks (left set) and 4 Weeks (right set) after receiving no
radiation (Control), 16 Gy fractionated radiation (Irr), or 16 Gy fractionated
radiation and administration of risedronate (Irr + Ris). Error bars represent
standard error of the mean. Means were compared using a one-way ANOVA. (*) P
< 0.05 versus Control; (+) P < 0.01 versus Irr + Ris; (#) P < 0.001 versus Control.

The observation that Tb.N. and Tb.Sp. within the Irr + Ris were marginally different
relative to Control from Week 2 was not the case by Week 4. SMI was significantly
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lower in the Irr + Ris group than the Irr (P < 0.001) group, but by Week 4 was different
than the Control group as well (P < 0.05). The same pattern for Tb.Th. from Week 2 was
observed at Week 4: thicker trabeculae were present from Irr + Ris animals than Control
animals (P < 0.001; Table 6.2).

6.4 Discussion
Rat tibiae exposed to ionizing radiation at doses biologically equivalent to that which
human hips receive during radiotherapy for pelvic cancer exhibited significant bone
atrophy. Compromised bone volume and microarchitecture are evident by two weeks
after exposure. Though some degree of recovery is evident by Week 4 (particularly
reattainment of normal BV/TV), microarchitecture largely remains compromised (Tables
6.2 and 6.3). The pattern of microarchitectural deterioration (i.e., decreased Tb.N.,
Conn.Dens, BV/TV, increased Tb.Sp and SMI) resembles the response of bone to
conditions of increased bone resorption, such as ovariectomy-induced or postmenopausal
osteoporosis (Benhamou, 2006; Borah et al., 2004). The difference in bone is unlikely
caused by radiation-induced changes in body mass, growth of the limb, or behavior, as no
differences in these parameters were observed between groups (Table 6.1 for mass and
tibial length data). Previous results from our laboratory have identified an increase
osteoclast number and activity within the first two weeks following exposure to ionizing
radiation (Chapter 5). Therefore, an increase in osteoclastic resorption following modeled
therapeutic radiation should be considered a potential cause of the radiation-induced
atrophy of bone among rats and mice.
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Control
26.4 + 1.38a

30.8 + 1.3

BV/TV (%)

95.4 + 4.4b

80.1 + 16.5c

122.5 + 4.6

Conn.Dens.
(1/mm3)

4.02 + 0.11g

3.78 + 0.09b

4.38 + 0.11

Tb.N.

216 + 8g

235 + 8b

193 + 7

Tb.Sp. (µm)

0.83 + 0.07e

1.31 + 0.11g

0.98 + 0.11

SMI

90.1 + 1.4b

86.8 + 1.5g

81.6 + 1.7

Tb.Th

Table 6.2. Bone histomorphometric indices determined at Week 2 and Week 4 from non irradiated control, irradiated
only, and irradiated + risedronate treated rat tibiae

Irradiated
31.9 + 0.79e

2 Week Examination

Irradiated + Risedronate
Control

26.6 + 1.2
34.4 + 1.2b,f

28.6 + 1.1

87.8 + 4.23a
109.3 + 4.6e

104.2 + 2.6

3.87 + 0.07a
4.37 + 0.09f

4.19 + 0.09

227 + 5a
193 + 5f

203 + 7

1.33 + 0.10
0.68 + 0.12a,f

1.12 + 0.09

85.4 + 1.5
90.9 + 1.1c,h

81.2 + 1.9

4 Week Examination
Irradiated
Irradiated + Risedronate

Notes: Abbreviations for bone volume fraction (BV/TV); connectivity density (Conn.Dens.); trabecular thickness (Tb.Th.);
trabecular number (Tb. N); trabecular spacing (Tb. S.) and structural model index (SMI). Values are presented mean + SEM.
Statistics were performed using a one-way ANOVA with a Tukey follow-up test. Italicized superscripted letters indicate P
values determined from the one way ANOVA. Superscripted a, b, and c represents significance versus control: a P < 0.05; b P
< 0.01; c P < 0.001. Superscripted d, e, and f represent significance versus irradiated only rats: d P < 0.05; e P < 0.01; f P <
0.001. Superscripted g and h indicate trends (P < 0.1) versus control (g) and irradiated only (h) groups.
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The application of the bisphosphonate risedronate, an antiresorptive agent, provided
sparing effects that were observed at both examined time points in this study and support
the hypothesis that bone resorption is increased as a response to irradiation. Bone
microarchitecture was damaged in rats receiving both radiation and risedronate, as
Conn.Dens. and Tb.N. were reduced at Week 2 (Table 6.2). Thus resorption was likely

Table 6.3. Change in mean values for bone histomorphometric parameters relative
to control for rats receiving radiation only or radiation + risedronate
Mean Change Relative to Control (%)
Parameter
BV/TV
Conn.Dens.
Tb.N.
Tb.Sp
SMI
Tb.Th

Irradiated Only
Week 2
-14.2
-34.7
-13.6
+21.9
+32.9
+6.4

Week 4
-7.2
-14.7
-7.8
+11.8
+18.9
+5.2

Irradiated + Risedronate
Week 2
+3.7
-22.2
-8.3
+11.9
-15.4
+10.4

Week 4
+20.1
+4.9
+4.1
+4.9
-39.2
+11.9

increased in both treatment groups. However, BV/TV was unchanged relative to control,
and the reductions in Conn.Dens. and Tb.N. were less than what occurred after radiation
alone (Table 6.3). This provides evidence that application of risedronate blocked the
increase in turnover to a limited degree relative to untreated rats. Risedronate was applied

140

one day prior to the initial irradiation. A lag in time over the course of the first two weeks
perhaps occurred between the increase in resorption and the effectiveness of the drug. By
week 4 the risedronate treated tibiae were fully recovered, as the increased BV/TV,
Tb.Th, and more plate-like trabeculae (lower SMI) would not be considered
compromised (Table 6.2). A shift toward lower SMI values (more rod-like trabeculae)
indicate a compromise in trabecular structure (Borah et al., 2006), while more plate-like
trabeculae would be more efficient in resisting bending moments (Stauber and Muller,
2006).
The results from this study are consistent with the effects of risedronate (and
bisphosphonates in general) administered to prevent osteoporosis and reverse bone loss
during conditions of elevated turnover (Rodan and Reszka, 2003). From longer-term
animal studies, the resulting decrease in turnover due to bisphosphonate treatment has
been shown to maintain trabecular integrity (Borah et al., 2002; Otomo et al., 2004).
Likewise, bisphosphonates have been shown to effectively increase bone volume and
maintain trabecular architecture in shorter term animal studies (~ 1 month) examining
modeled conditions of increased turnover (Dalle Carbonare et al., 2007; Iwamoto et al.,
2006). For example, rats treated with high-dose glucocorticoids exhibit osteoporosis;
risedronate administration decreases turnover and thus prevents this loss and increases
BV/TV and TB.N relative to control (Iwamoto et al., 2006). Our results are similar to
others documenting that suppression of turnover accounted for the bone-sparing effect of
bisphosphonates. Thus, we assume our results demonstrate a risedronate-induced
decrease in turnover, or at least osteoclast activity. The mode of action of
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bisphosphonates is to induce osteoclast apoptosis and reduce bone resorption (Chapurlat
and Delmas, 2006). By reducing osteoclast activity, bisphosphonates ultimately reduce
bone formation as result of coupling, though delayed relative to osteoclast suppression
(Rodan and Reszka, 2003). Future investigations must not only further identify the
cellular and molecular response of cells within the marrow leading to osteoporosis after
irradiation, but how antiresorptives affect each of these components.
For both irradiated groups, Tb.Th was increased relative to Control by Week 2,
though the elevation in the Irr group represented marginal significance (P = 0.067). By
Week 4, values for Tb.Th. showed virtually no change in absolute terms or relative to
Control, unlike the other histomorphometric parameters (Table 6.2 and 6.3). While
administration of risedronate may explain the thicker trabeculae within that group, it
would not explain this phenomenon within the Irr group. A decrease in trabecular
thickness would be expected during states of elevated osteoclast activity, as resorption
pits increase along the surface of trabeculae and ultimately perforate the struts while
trabecular plates shift to rod-like structures (Ammann and Rizzoli, 2003; Felsenberg and
Boonen, 2005).
Examination of the struts from the individual slices on the microCT provides some
indication as to the nature of these observations regarding Tb.Th. One interesting
observation from this study is that an area lacking bone is present at near the same spatial
location within the metaphysis of both irradiated groups (especially from the Irr group),
and that this observation is pronounced at Week 4 (Figure 6.5). This area is an absence of
trabeculae located approximately mid-metaphysis. Trabeculae surrounding this
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consistently located “whole” generally seem thicker than other struts. One may speculate
that the Tb.Th. is actually elevated following irradiation as a compensatory mechanism to
deal with bone loss throughout the center of the metaphyseal envelope, though no
conclusive evidence is provided. If a change of strain distribution in the trabecular
network surrounding the resorbed region resulted in higher strains experienced by these
struts, a resulting increase in bone formation could produce thicker trabeculae (Robling et
al., 2006). This may also provide a potential explanation as to the lack of a difference in
BV/TV between irradiated and control animals at Week 4 despite decreased Conn.Dens.,
Tb.N., and increased Tb.Sp. Determining a method to consistently analyze site-specific
locations within metaphyses using conventional microCT or peripheral quantitative
(qCT) should be employed in future studies to identify if increased resorption following
irradiation occurs at preferential sites within the bone microenvironment.
In general, trabeculae exhibited an unusual morphology from both irradiated groups
in comparison with the long, parallel struts present within Control rats (Figure 6.5).
Unusual trabeculae and areas of abnormal bone growth have been described from other
studies examining irradiated bones (Rohrer et al., 1979; Sawajiri and Mizoe, 2003).
These structures may be attributed to osteoblast activity. Ionizing radiation has been
shown to affect osteoblasts in several manners, including: decrease proliferation; promote
final differentiation; induce cell cycle arrest; and increase the likelihood of apoptosis
(Dudziak et al., 2000; Gal et al., 2000; Hopewell, 2003; Sakurai et al., 2007; Szymczyk et
al., 2004). However, active production of new osteoid and bone formation have been
shown to occur within irradiated monkey mandibles wherever osteoblasts remain (Rohrer
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et al., 1979). It is possible that within an environment of increased osteoclast activity,
surviving osteoblasts exhibit increased activity due to coupling. Despite the cause of the
irregular struts, the increased thickness of these disconnected trabeculae would likely do
very little to preserve the mechanical integrity of the structure.
A

B

C

Week 2

Week 4

Figure 6.5. Cross-sectional microCT images of rat tibiae. The images are each
taken from an identical location 1mm distal to the bottom edge of the growth plate.
Images are captured from: (A) Control bones; (B) Irr.; and (C) Irr. + Ris. bones.
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The radiation dosing regimen employed in this study modeled what a hip would
receive during treatment for pelvic cancers. The risk of hip fracture is significantly
elevated following radiotherapy (Baxter et al., 2005a). Therefore the bone loss after
irradiation documented from this study allows some insight into a possible mechanism
causing these fractures, and will be useful data for comparative purposes in future studies
examining bone volume, microarchitecture, strength, and cellular response following
clinically modeled irradiation. Similarly, the mitigating effects of risedronate in
preventing microarchitectural deterioration after modeled radiation might prove to be a
useful therapeutic tool in preventing these fractures, if future studies suggest any
radiation-induced changes in strength are prevented as well.
In summary, irradiated rat tibiae displayed reduced bone volume and compromised
architecture by 2 weeks. Recovery of bone volume was evident by 4 weeks, though the
remaining trabeculae had an unusual morphology with persistent decrease in Tb.N and
Conn.Dens. Treatment with an antiresorptive mitigated much of the loss, although some
microarchitectural deficits were present at 2 weeks. Recovery in the risedronate-treated
animals could be observed by Week 4. These data support the hypothesis that radiationinduced atrophy is due to elevation of bone resorption following irradiation. A greater
effect was seen at week 2 than week 4, providing some insight into the time-course of
loss. Future studies modeling doses the hip receives during cancer treatment must
determine if these changes in architecture translate into reduced strength in order to
assess if antiresorptive treatment should be considered an option to prevent atrophy and
fracture after cancer radiotherapy.
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CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS

7.1 Conclusions
The results from the studies included in this dissertation support the hypothesis that
radiation increases osteoclast activity within bones, specifically rodent tibiae. This
radiation-induced increase in bone resorption represents a new potential cause of the
atrophy observed in bone following clinical irradiation, alongside reduced osteoblast
numbers and damaged vasculature. This dissertation has quantified substantial bone
atrophy in mice and rats two weeks after exposure to radiation doses modeling clinical
regimens. Osteoclast number (in vivo and in vitro) and activity (in vitro) were increased
within the first two weeks after exposure. Treatment with an antiresorptive agent
(bisphosphonate) mitigated radiation-induced atrophy and loss of architecture, as would
be expected if a radiation-induced increase in resorption was suppressed following the
administration of the antiresorptive.
The incidence of fractures is elevated among patients receiving cancer radiotherapy.
These fractures result in substantial morbidity and mortality each year (Baxter et al.,
2005a; Lane, 2006). Survivorship among cancer patients is improving (Robbins and
Zhao, 2004). The possibility exists that increased resorption after irradiation could result
in this increased likelihood of fracture downstream from treatment. Therefore the
findings of this dissertation are useful for future research in terms of identifying the
nature of these fractures.
Novel findings include the following observations and interpretations:
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7.1.1 Conclusions Chapter 3
• Significantly reduced bone volume and compromised connectivity are observed within
bones shielded from doses of iron radiation > 2Gy. The impaired microarchitecture,
regardless of the cause, could translate into reduced mechanical strength (Keaveny et
al., 2001).
• A radiation-induced reduction in body mass is associated with this change in
trabecular microarchitecture. A systemic (i.e., cytokine) cause of the observed atrophy
after iron irradiation could not be assessed.
• Markers of bone metabolism were similar in the shielded hind limbs of these rats by
the sacrifice at nine months, suggesting that bone turnover was normal in the irradiated
animals.

7.1.2 Conclusions Chapter 4
• Substantial bone loss occurs in mice tibiae two weeks after exposure to a dose of
radiation (7 Gy γ-radiation). Bone atrophy after irradiation is well documented from
bones examined months to years after irradiation, and typically considered a response
due the the unavoidable damage to osteoblasts and vascularity (Ergun and Howland,
1980; Hopewell, 2003; Mitchell and Logan, 1998; Sakurai et al., 2007). The degree of
atrophy documented in this dissertation has never been quantified from other animal
studies examining radiation and bone. Our results indicate a ~54% in BVTV and
~69% in connectivity of the trabeculae. Trabecular quality is a major determinant of
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bone strength (Borah et al., 2002), thus these bones (especially with a 69% loss of
connectivity) should be considered compromised.
• The loss of bone volume and architectural indices from mouse tibiae after the single,
high-dose gamma radiation (7 Gy) likely occurs prior to two weeks after exposure.
Thus, bone loss occurs early following irradiation. The bone histomorphometric
parameters indicating the state of bone metabolism (particularly ES/BS and Oc.S./BS)
are similar between non-irradiated and irradiated tibiae at this time.

7.1.3 Conclusions Chapter 5
• Whole body exposure to ionizing radiation (2 Gy acute dose of X-rays) results in an
increase in osteoclast number. This increase can be seen within mouse tibiae only
three days after exposure. The difference represents an elevation of more than 300%
between control and irradiated individuals. However, at this time point no difference
in bone volume or microarchitectural indices is observed between groups as
determined by microCT. Thus, while Oc.S/BS is highly elevated, resorption is likely
being initiated near this time point.
• Although bone volume or surface are similar between control and 2 Gy irradiated
bones three days after irradiation, overall bone resorption is increased at day one.
Serum TRAP5b levels are significantly elevated in irradiated animals at this early time
point. Likely the processes observed within the proximal tibiae (increased Oc.S./BS)
are occurring thoughout the body. We cannot comment on any bone-specific temporal
responses to irradiation, such as to say increased resorption in the tibial metaphysis
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could occur even earlier than day 3 in bones other than the tibia. But overall bone
resorption is increased on day one, without observed an observed increase in serum
osteocalcin, indicative of elevated bone formation.
• Relative to non-irradiated bone marrow, the number of TRAP+, multinucleated
osteoclasts from marrow harvested one day after irradiation and cultured for one week
is significantly increased (~400% increase). Thus, radiation induces an increase in
osteoclast number that can be identified both from histological samples and in vitro
within the first week of irradiation.
• In vitro mineral resorption is significantly elevated after irradiation. From marrow
harvested one day after irradiation and cultured for two weeks on HA disks, the total
resorption area and average size of the resorption sites are greater following
irradiation. Thus, a radiation-induced increase in the number of osteoclasts and
subsequent increase in resorption likely is a factor that leads to bone atrophy. These
changes occur within the first two weeks after radiation from the mouse bones we
have examined.

7.1.4 Conclusions Chapter 6
• Irradiating the right hind limb of rats with doses of X-rays modeling what the pelvic
bones surrounding a tumor would receive during radiotherapy does not induce an
observed difference in body mass or long bone length (growth) during the course of a
4 week study. Body mass imparts loads on bones, which (if changed relative to
control) has the potential to impact bone morphology (See Chapter 3).
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• BV/TV is significantly reduced in irradiated rats relative to control by Week 2 after
exposure. The reduced bone volume occurred concurrently with decreased
connectivity of the trabecular network, trabecular number, and increased presence of
less efficient, rod-like trabeculae. These changes occur without corresponding changes
in body mass. Thus atrophy and compromised trabecular microarchitecture were
present by two weeks after exposure to clinically-modeled radiation.
• Some recovery of the compromised trabeculae was observed in the irradiated-only rat
tibiae by Week 4, particularly recovery of BV/TV. However connectivity of the
network remained reduced, as did number of struts.
• The trabeculae within irradiated (no drug) rat tibia are qualitatively odd in appearance
and quantitiatively thicker, even by Week 2. The pattern of thicker trabeculae is
inconsistent with trends typically associated with conditions of elevated resorption.
Odd, thick trabeculae and irregular bone growths within irradiated metaphyses have
been described in previous studies (Rohrer et al., 1979; Sawajiri and Mizoe, 2003),
attributed with active production of osteoid from remaining osteoblasts (Rohrer et al.,
1979). Thick trabeculae also surround a consistently located area absent of bone within
irradiated metaphyses of these rats. It may also be possible that increased strains
within the struts surrounding a gap in the trabecular network could induce the
remaining osteoblasts to remodel the trabeculae into thicker structures (Robling et al.,
2006).
• Administration of risedronate, an antiresorptive agent capable of reducing osteoclast
activity, reduces the deleterious effects of radiation on bone volume and
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microarchitecture. Connectivity of the trabecular network is reduced compared with
control by Week 2 after exposure. However the effects observed in the irradiated only
group in terms of BV/TV, Tb.N, Tb.Sp, and SMI are not present within the irradiated
+ risedronate group at this time. The difference in connectivity between these
bisphosphonate-treated rats and controls was also smaller then what was present in the
Irr group (12 % sparing effect). By Week 4, recovery of the trabecular network in
terms of bone histomorphometric parameters is observed among the irradiated +
risedronate treated animals. By reducing turnover and osteoclast activity, risedronate
seems to reduce atrophy in rat bones observed at Week 2 and Week 4.

7.2 Recommendations
Many questions remain regarding the effects of ionizing radiation on osteoclast
health, number, and function. This dissertation described increased activation and atrophy
following radation. However, no study examined the mechanism leading to an increase in
osteoclast activity. Our examinations of irradiated bones occurred between three days and
four weeks after exposure. It is unclear if these observations within the first month
remain true at longer durations after exposure. Also, the relationship between radiationinduced microarchitectural changes and bone strength remains unclear, particularly in
context of how antiresorptive therapies can affect both parameters. Ultimately, the goal is
to prevent fractures among cancer patients receiving radiotherapy, so this final question
should be the target focus of this field of research.
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7.2.1 Expansion of the Mouse Model
A thorough time course study should be performed in order to better describe the
mechanisms leading to induced osteoclast number and activity within tibiae. We used an
orthovoltage irradiator at Clemson University. Therapeutic irradiations are performed
with higher energy X-rays (i.e, 6 MV). To provide further evidence of osteoclast number
and activity after a single radiation exposure, groups of mice (B6) should be exposed to 6
MV X-rays (2 Gy total body exposure). The study should evaluate bone volume and
architectural changes at this energy (via microCT) as well as histological impacts of
radiation. Examination at very early (1 hour), early (Day 2, Day 4, Day 7), and later (Day
10, Day 14, Day 19, Day 21, Day 28) time points should be performed in order to
establish a time course response of bone and bone cells to irradiation. Particularly, one
focus of the histological investigation should be to provide insight into the cause of any
increase in osteoclast number. Conditions such as chronic oxidative stress and
inflammation have been documented in irradiated tissues and are associated with
radiation-induced late effects (Bentzen, 2006; Robbins and Diz, 2006; Robbins and Zhao,
2004; Stone et al., 2003; Vujaskovic et al., 2001). Both of these conditions can induce an
increase in osteoclast activity (Bai et al., 2005; Clowes et al., 2005; Lam et al., 2000;
Lean et al., 2005). Therefore stains should be used to identify cells apoptosis (e.g.,
TUNEL), inflammation (i.e., immunohistochemistry for macrophages, TNFα, IL-1), ROS
(e.g., Amplex red), and how these correlate with any observed changes in osteoblast and
osteoclast number and activity.
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7.2.2 Effects of Radiation on Osteoclast Proliferation and Activity Under Different In
Vitro Conditions
To date the effects of radiation on osteoclast function have been described from
cultured bone marrow. While an increase has been documented, the nature of the
increased number and resorption remains unclear. Could radiation induce direct effects
on mature osteoclasts present within the marrow that increases resorptive capacity? How
are osteoclast differentiation and proliferation affected by ionizing radiation both
independently of the marrow microenvironment as well as from within irradiated
marrow? Future studies should examine irradiated cell cultures in order to further identify
how osteoclast number and resorption is stimulated by radiation. For example, separate
studies could examine irradiated cultures of mature osteoclasts, osteoclast progenitors,
osteoclast progenitors + mature osteoblasts, and/or irradiated marrow (representing
osteoclasts, osteoclast progenitors, and other elements within the marrow capable of
inducing osteoclast activity including osteoblasts and inflammatory cells). Cells could
also be cultured on top of HA disks and be used to assess how differentiation, resorption,
or proliferation are affected by radiation in each of these environments. Agents could be
added to each culture before or after irradiation that may influence the affects of radiation
on resorption. Such factors could include α-La, hydrogen peroxide, antibodies for TNFα,
bisphosphonates, or OPG.
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7.2.3 Correlation between radiation-induced changes in bone and femoral neck strength
The femoral neck is the most frequently fractured location in patients receiving
radiation therapy for pelvic tumors (Baxter et al., 2005b). In this dissertation,
bisphosphonates proved useful in preventing deterioration of the microarchitecture within
the tibia by week 4. The tibia is a useful model for comparative purposes as many studies
use microCT to describe changes in trabecular bone of the proximal tibia following
various challenges. Future studies need to assess how changes of trabecular and cortical
bone within femoral regions of interest following clinically-modeled irradiation translate
into changes in strength, specifically within the femoral neck and large muscle
attachment sites such as the greater trochanter. Rats would be the preferred animal model,
since the size of the femur permits mechanical testing of the femoral neck. MicroCT
assessments of trabecular and cortical bone could be performed prior to mechanical
testing of the neck. Methods should be adapted using conventional microCT to identify
site-specific changes in trabecular bone. Tibial and femoral microCT could be performed
using the same irradiation protocol and risedronate-treated groups used in Chapter 6 of
this dissertation, only examinations would be performed at Week 2, 4, and 6, with
subsequent examinations at 6 months and 1 year after exposure. Therefore, this study
would not only provide some insight into short (<6 month) and long (6-12 month) term
correlation between radiation, bone morphology, and strength, but also if an
antiresorptive agent might be useful for consideration as a way to prevent fractures
among cancer patients receiving radiation.
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